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Chapter 1: General Introduction and 
Overview of Aims and Objectives 
People and plants have a long intertwined history. Before humans could manufacture what they 
needed, they had to use natural resources to provide the housing, food and clothes necessary for 
survival. People also relied on nature to provide medicines and more often than not these came in 
the form of medicinal plants. Early evidence of the use of medicinal plants dates back to 60 000 BCE. 
Pollen of several plant species was discovered in the grave of a Neanderthal man (species Homo 
neanderthalensis, a close relative of modern humans H. sapiens) at an archaeological site in Iraq. 
Several of the plant species discovered in the grave are still used today as traditional medicine in Iraq 
(Gurib-Fakim, 2006).  More recent records of medicinal plant use date to several thousand years 
ago. For example, Mesopotamian cuneiform clay tablets documenting the use of medicinal plants 
such as liquorice and poppy date to 2600 BC (Gurib-Fakim, 2006) and the Ebers Papyrus, which 
documents the Egyptian use of medicinal plants, dates back to 1500 BC. The use of medicinal plants 
assumed more significance in some cultures where it took on a deeper meaning beyond the physical 
healing properties. The Chinese for example, developed a sophisticated holistic medicinal system 
combining spirituality with the use of herbal mixtures to heal mind and body that dates back to 2700 
BC (Wang et. al., 2011). More modern records originate in Europe, where Dioscorides, a Greek 
physician, recorded the use of medicinal herbs across Europe in the first century AD. His 
observations resulted in the book “De Materia Medica” which was a leading reference book for 
European healers for almost 1000 years. 
For a large part of recorded history, people did not question how the plants worked, but just 
accepted their use in treating certain illnesses. However, in the early 19th century scientists became 
interested in investigating components or ingredients responsible for the observed therapeutic 
activity of plants. At this time chemistry was developing at a rapid pace with newly synthesised 
paints, dyes and industrial chemicals available for the first time (Rishton, 2008). Medicines however, 
were still mostly mixtures derived from bark, roots and leaves. Tonics and tinctures made by stewing 
whole plant parts in alcohol were popular (McChesney et. al., 2007). This led to a scientific 
investigation of the plants used to make these tonics, utilizing the simple tools available in turn of 
the century laboratories. Often working in dangerous conditions and using themselves as the test 
subjects, researchers began discovering compounds. For example, opium and poppy extract 
(Papaver somniferum) had been used to relieve pain for over 7000 years (McCurdy & Scully, 2005) 
and scientists were quick to isolate morphine as the active compound in poppy juice. A deluge of 
2 
 
newly discovered active compounds followed: strychnine, caffeine, quinine, cocaine, digitoxin and 
salicylic acid were among the first of these (Cordell, 2011; Butler, 2004; Rishton, 2008). 
The “synthetic” or “golden” era of drug discovery and manufacture began after the end of World 
War 2, when pharmaceutical companies turned their focus from the war time efforts of 
manufacturing antibiotics and pain medication to the discovery of new drugs. There was a flurry of 
discovery of plant based compounds to use as new drugs. Screening of plants in order to discover 
new bioactive compounds for use as leads in drug discovery, and related drug development 
programs became widespread. However, the screening process was often long and flawed with 
relatively few hits. For example, most of the plant extracts in a random collection are inactive when 
tested in a single assay. Of the small percentage that are active, up to 50% yield previously known 
compounds, rather than the desired novel compounds (Cordell & Colvard, 2005). Automated high 
throughput screening (HTS) programs capable of testing thousands of compounds daily increased 
the speed at which testing could be done in an attempt to increase the hit rate on bioactive 
compounds. However, natural product discovery programs could not meet the demand for large 
numbers of compounds to feed into HTS programmes (Baker et. al., 2007). In many instances HTS 
did not deliver the anticipated results and as a result, many pharmaceutical companies, considering 
the expense versus the potential benefits, downgraded their natural product discovery research in 
the 1990s and early 2000s. 
As an alternative to the unfruitful screening programmes, researchers turned to modern 
computational methods for discovering compounds to feed into the drug development pipeline. 
Many structural features common to natural products (e.g., chiral centers, aromatic rings, and 
degree of molecule saturation) have been shown to be highly relevant to drug discovery efforts 
(Balunas & Kinghorn, 2005). Several large natural products libraries existed as a result of 
considerable HTS efforts and these libraries seemed an attractive source of scaffolds for 
combinatorial synthesis and target-based computer modelling to design new drug compounds 
(McChesney et. al., 2007). Such efforts have yielded positive results such the discovery of 
aurantiamide acetate, an inhibitor of the main proteinase of severe acute respiratory syndrome 
coronavirus, from the Chinese traditional medicinal plant quinghao (Artemisia annua) (Barlow et. al., 
2012). 
Despite the advances of in-silico drug discovery there has been a return to natural products isolation 
and characterisation since the turn of the 21st century. The potential for finding novel, highly active 
compounds from natural sources is still high, but the hit rate remains low. So the question becomes: 
How do we make natural products a relevant and a viable option for drug discovery? Researchers 
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need to investigate different ways to improve hit rates and to discover active plant-based 
compounds faster and more easily. One way of doing this is by incorporating traditional knowledge 
into screening programmes. Of the currently available plant-derived prescription products 74% are 
used in a manner which parallels their traditional use (Cordell & Colvard, 2005) suggesting that 
traditional medicine may be a good starting point for discovering bioactive compounds (Bailly, 2009). 
However, in most studies the ethnographic information is poorly integrated with laboratory findings 
and many studies end up as just disjunctive lists of “they use this for that” or “this contains that” 
(Etkin, 2001). 
There are three main ways of integrating ethnographic information into drug discovery efforts. The 
first is to screen currently used medicinal plants for activity in assays that reflect their traditional use 
i.e. testing a plant traditionally used to treat diarrhoea for antibacterial activity. A second approach 
puts currently used medicinal plant species through a random selection of screens not related to 
their traditional use in the hope of a serendipitous discovery (Cos et. al., 2006). A third, less often 
used approach, is to mine old herbal texts such as “De Materia Medica” for indication of bioactivity 
in plants that are not necessarily still used traditionally. The first two methods rely on first hand 
information gained through discussion with people who currently use traditional medicine, with the 
input of a botanist being valuable in providing a definitive identification of the plant. However, 
language barriers may lead to misinterpretation of knowledge gained in this way. The third method 
presents additional problems as the knowledge is gained second or even third hand allowing errors 
to creep in. Many of these texts were written before the Linnaean system of nomenclature was 
introduced making plant identification from vague descriptions and poorly executed diagrams even 
more challenging. 
The question of how we can use traditional knowledge to increase hit rate and create a better 
overlap of traditional therapeutic objectives and biomedical ones remains valid. Attendant questions 
are how chemosensory properties may influence traditional medicinal use and plant choice, and how 
this knowledge can be applied to selection of plant screening targets for developing new 
pharmaceuticals or botanicals. A further challenge is to evaluate how the often disjointed views of 
the people who use the plants, the anthropologist who records the interviews, the biologist who 
identifies and harvests the plants, the microbiologist who performs the bioassays, and the chemist 
who isolates and characterises the active compounds overlap and complement each other. This 
challenge assumes further dimensions when one considers recent advances in technologies such as 
in the field of metabolomics, which permits detailed molecular profiling of plants, and thus provide 
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an increasingly rich and complex view of plants which can be juxtaposed with an equally rich 
traditional understanding of plants. 
The aim of this thesis is to investigate medicinal plants from different perspectives in an attempt to 
arrive at a new, integrated and streamlined method for the discovery of bioactive secondary 
metabolites of plant origin. This will be done through a focused study of the traditionally used 
medicinal plants of the Paulshoek region of Namaqualand and a demographic study of the people 
who use them. Trends in traditional medicinal plant choice will be investigated and methods of 
traditional knowledge acquisition and transfer will be examined. Additional assessment of bioactivity 
and trends in bioactivity will be conducted and a variety of physico-chemical and computational 
techniques will be used to determine the major metabolites present in selected plant species. These 
different approaches to medicinal plants will be brought together in a single holistic method put 
forward as a possible way of conducting future studies into discovering active metabolites for 
potential drug development. 
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Chapter 2: Use of Medicinal Plants by 
the People of Paulshoek, Namaqualand 
1. Introduction  
1.1 History of the Cape and early plant use 
There has been a long history and tradition of using plants for medicine at the Cape and in 
Namaqualand. The indigenous San, Nama and Khoekhoen1 people living in these areas generated 
their own knowledge of medicinal plants and plant-based remedies through an understanding of the 
healing effects of the local flora. In addition, European settlers brought with them their knowledge 
of European medicinal plants, and this, combined with their experience of the local plants and 
people, developed into the Cape Dutch medicinal traditional pharmacopeia (van Wyk, 2008a). 
Together, the indigenous knowledge of the San, Nama and Khoekhoen and healing practices of the 
Cape Dutch settlers provide a rich history of traditional plant use based on the healing properties of 
unique plants in a unique part of the world. Medicinal plant use is not a recent phenomenon in this 
area. The greater Cape Floristic Region (extending from the Cape Peninsula inland, towards the 
Overberg mountains and Little Karoo, and northwards towards the Cedarberg mountains and into 
Namaqualand) (Born et al., 2007) has been home to groups of pastoralist Khoekhoen and Namaqua 
people for at least the past 2000 years, as evidenced by archaeological findings of sheep bones at 
Spoegrivier Cave on the coast of Namaqualand (Webley, 2007; Boonzaier et al., 2000). The 
unearthed sheep bones provided some of the first evidence of a pastoralist lifestyle in southern 
Africa. Southern Africa, including Namibia, has been home to groups of hunter-gatherer 
San/Bushmen for considerably longer, and the area as a whole has been occupied by hominins for at 
least 1.5 million years (Deacon & Deacon, 1999). There is evidence that hunter-gatherers used 
medicinal plants to survive and this is where the roots lie for many of the traditional plant use 
practices still observed in rural parts of the same area today. 
Some of the first documents recording the use of plants in the Cape area and in Namaqualand were 
created by European (mostly Dutch and French) settlers who began occupying the Cape from the 
mid 1600’s. Most of these reports focused on food plants and the functional use of plants as, for 
example, building materials and leather curing agents (de Wet & Pheiffer, 1979; Forbes, 1986; van 
                                                          
1
 In this thesis the terms “khoikhoi” and “khoekhoe/n” refer to pastoralist groups of indigenous people while 
the terms “San” and “Bushmen” refer to hunter gather groups. The terms “Namaqua” and “Nama” refer 
specifically to Nama-speaking groups of pastoralist Khoekhoen and their modern-day descendants. 
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Wyk & Gericke, 2000; van Wyk, 2002; van Wyk, 2008b). Prior to this there are very few written 
records of plant use - as medicine or for other purposes - as the indigenous San and Khoekhoen 
people had an oral tradition of handing down knowledge from one generation to the next. Early 
scientific observations of the practice of traditional healing (e.g. Laidler, 1928) suggested that it was 
usual that a healer would take on an apprentice, often his own son, who would live with him and 
follow him to learn everything he knew. In some cases this meant certain tasks had to be performed 
to “strengthen” the apprentice to enable him to perform the duties of a healer. For example, a 
“snake man” or “poison doctor” was a healer who specifically treated snake and scorpion bites. In 
the course of his work he would collect snake venom to administer to patients in small amounts as 
an antidote, and would need resistance to snake bites himself. During an apprenticeship, a healer 
would administer incremental doses of poison to an apprentice so as to build tolerance to venom, as 
well as to produce antibodies against the venom (which in turn meant that eventually the 
apprentice’s own blood or sweat could be used to treat patients). The system of apprenticeship and 
oral tradition, which persisted into the early colonial period (Laidler, 1928) meant that that 
knowledge of medicinal plants remained almost exclusively in the hands of the healer and his 
apprentice. As a result and except in rare instances (e.g. the Bleek & Lloyd collection of notebooks 
written between 1870 and 1881, see http://lloydbleekcollection.cs.uct.ac.za/ for a digital version of 
this rare documentation of |xam and !kung culture) very little of this knowledge was documented.  
The establishment of a European colony at the Cape was a turning point after which it became more 
usual to keep written records. The indigenous knowledge of medicinal plants was recorded in colony 
“Flora’s” e.g. the works of Thunberg, Hermann, Oldenland and van der Stel (Gunn & Codd, 1981). 
This was not the only effect colonists had on the local pharmacopeia, traditions and people. A supply 
station was established at present day Cape Town by the Dutch East India Company (Vereenigde 
Oost-Indische Compagnie (VOC) in Dutch) to provide water and fresh food to passing ships sailing 
from Holland around Africa en route to the east. Ships also required medical supplies. Initially the 
VOC had a system whereby medicinal supplies, mainly herbals in the form of raw plants and 
powders, were sent via sea from Europe to a central distribution centre situated on Java, in the 
Indian Ocean. However, the plant material did not travel well and often degraded while in transit to 
the distribution centre, or during the subsequent trip to the intended recipients (Scott & Hewett, 
2008). The proposed solution to this supply problem was to establish a “half-way point” at the Cape, 
bringing plants from Europe and attempting to grow them at the newly established colony. Several 
European plants were naturalised in this way and were successfully grown in the VOC Company 
Garden e.g. Ruta graveolens (garden rue) (van Wyk, 2008a). Other species did not fare as well, and it 
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was decided to attempt to seek alternative species from the local indigenous flora (Scott & Hewett, 
2008). 
At the time, in the late 1600’s and early 1700’s, it was popular for colonists to travel northwards 
from the Cape on “journeys of exploration” to find exploitable resources and new areas suitable for 
farming (Scott & Hewett, 2008). These trips enabled colonists to examine and record plant use by 
San, Khoekhoen and Namaqua people in order to augment their existing knowledge of plants, 
particularly medicinal plants. The trips also afforded the opportunity for botanists to seek new or 
alternative medicinal plants to replace the European ones they were unable to grow at the Cape 
(Britten, 1920). Substitute plant species were often chosen on the basis of their resemblance to the 
European plants they were replacing. This method was not without merit as today we know that 
similar smelling plants may contain similar chemical compounds, and therefore, have a similar 
pharmacological action (Harborne, 1993; Harborne, 1998). In some instances colonists simply 
adopted the Khoekhoen and Namaqua use of particular plants (e.g. the use of Sceletium species as a 
calmative agent and mood enhancer (Gericke & Viljoen, 2008), juice from Aloe species to treat 
stomach complaints (Grace et al., 2008) and buchu (Agathosma species) to treat a variety of 
ailments) (Laidler, 1928). In other instances, entirely new concoctions were made from indigenous 
plants. For example, the oil of Osmitopsis astericoides (Asteraceae) was used in the form of a brandy 
tincture to create a remedy for treating chest troubles and for reducing inflammation and healing 
wounds when applied directly as a powder (Viljoen et al., 2003). Some of these new remedies and 
new methods of medicine preparation were adopted by the Khoekhoen and Namaqua people. 
Results of this back-and-forth intermingling of colonist and indigenous knowledge and practice can 
be seen today in the wide variety of plants used and the many different methods of treating illness 
currently employed by the people of Namaqualand. 
While the colonists were mounting their trips of exploration and interacting with local people to 
record traditional knowledge, the 1700’s proved to be a challenging time for many Namaqua people. 
Contact with settler farmers, runaway slaves and more generally with people from the ever-
expanding colony brought smallpox, measles, tuberculosis and venereal disease with them. More 
importantly, these were diseases for which indigenous traditional plant medicine had no remedy 
(Laidler, 1928). In response to this, new plants were sought and new treatments created from 
existing plant knowledge, changing the way that Namaqua people viewed medicine and plants 
(Cocks & Dold, 2000). It is generally thought that there were different types of healers to treat 
different types of illnesses, in a division similar to that still present in societies reliant on traditional 
medicine today.  A “bossiesdoktor” (plant doctor), for example, used herbal remedies to treat 
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“natural” illness. Other types of illness were considered spiritual and required a specialist with 
divining powers or the ability to call on ancestor spirits to assist in diagnosis and treatment (Cocks & 
Dold, 2000; Richter, 2003; van Wyk, 2008a; Dahlberg & Trygger, 2009). This, and the later 19th 
century influence of Christian missionaries, settling Dutch farmers and difficult drought years 
changed the traditional semi-nomadic pastoralist lifestyle. As lifestyles changed, and previously 
unseen diseases arose, the pharmacopeia changed accordingly to suit people’s requirements. Some 
knowledge was forgotten or lost, while other knowledge was added and plants were discovered to 
treat the new diseases (Grenier, 1998; Dold & Cocks, 2000, Berkes & Turner, 2006). This is also true 
of the modern day pharmacopeia which is dynamic and constantly evolving. 
While Namaqualand and its people were changing, so too was the structure and composition of 
society at the Cape. It became important to update and review existing documentation as practices 
and applications of traditional medicine changed. The old colony Floras were soon no longer 
sufficient and an attempt at documenting all medicinal plants known in the area was done by Pappe 
in the mid 1800’s (Pappe, 1847; Pappe, 1850). New reviews focusing only on the medicinal tradition 
of the Namaqua people were published. A particularly good review was done by Laidler (1928), who 
attempted to record the plant names in the local Namaqua language, along with the method of 
medicine preparation and the rationale for the choice of plant used. Reviews which focused on the 
medicinal plants in use at the Cape were collated and updated and botanists began to record more 
information in more detail. The most comprehensive and often cited general work on medicinal 
plants in southern and eastern Africa is the 1962 publication of Watt and Breyer-Brandwijk (1962), 
which provided a good summary of medicinal plant use by the major groups of people in South 
Africa. Since then there have been several works which document the use of medicinal plants by 
specific groups of people e.g. Xhosa, Zulu or Sotho in South Africa (Hutchings, 1989; Bhat & Jacobs, 
1995; van Wyk et al., 2008a are noteworthy) or which focus on the treatment of a specific category 
of illness (e.g. wound care) (Grierson & Afolayan, 1999; Archer, 1994). 
The late 20th century saw an increase in the interest in medicinal plants and traditional healing by 
scientists and as well as the general public. This interest was increased by the pharmaceutical 
industry’s investigations into using traditional medicines as starting points for drug development. 
Some non-scientists became interested for other reasons such as the popular trend in “alternative 
medicine”. With the shift to modern medicine and the supposed apathy of the youth to learning the 
“old ways” of traditional healing, it was thought that much of the knowledge which was previously 
passed on orally would be lost if not properly recorded (Dahlberg & Trygger, 2009).  This prompted a 
flurry of activity as scientists, anthropologists and ethnobotanists attempted to record as much of 
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what is known as possible at various locations around the world. The modern syntheses of authors 
such as van Wyk et al. (1997) focus on South African plant use and provide historical information as 
well as information on customs and traditions that are still observed. Books like these are invaluable, 
but unfortunately are not all-inclusive. The pharmacopeia and traditions of many regions of South 
Africa, and indeed the world, remain unexplored. 
1.2 Namaqualand - the broader context of the study 
1.2.1 Location and climate 
Namaqualand is an area of about 50 000 km2 and is located in the upper North West part of South 
Africa. The area is bounded by the Orange River in the north, the Olifant’s river in the South, the 
Bushmanland plains in the east and the Atlantic Ocean in the west (Desmet, 2007; Cowling et al., 
1999; Cowling & Pierce, 1999). This large area encompasses a variety of soil types, vegetation types, 
altitudes and rainfall regimes, resulting in Namaqualand being divided into seven biophysical 
regions: Bushmanland, East Gariep, Hardeveld, Knersvlakte, Sandveld, Richtersveld and Kamiesberg 
(Figure 1) (Desmet, 2007). 
The Kamiesberg Mountains form the highest part of Namaqualand, with the highest peak in the 
range - Rooiberg - standing at 1700 m above sea level. This rugged granitic mountain range is also 
the wettest part of Namaqualand, receiving up to 400 mm of rain annually, more than double the 
average annual Namaqualand rainfall of 150 mm (Desmet & Cowling, 1998). The rest of 
Namaqualand experiences a wide range in rainfall, with a general trend of decreasing annual rainfall 
amounts the further north (i.e. towards the deserts of Namibia) one travels. The driest parts receive 
as little as 50 mm of rain per year, which classifies most of Namaqualand as a semi-desert or desert. 
There is also a distinct difference in rainfall type across the breadth of Namaqualand, with the 
eastern parts (closer to the Nama-Karoo biome) receiving mostly summer rainfall (November to 
March), while the more westerly parts experience mostly winter rainfall (May and August) (Desmet, 
2007).  
Temperatures are generally mild for the region as a whole, but extremes do occur with peaks of up 
to 40 °C at the height of summer and occasional frost and snow falling in the Kamiesberg in winter 






Figure 1: Map of South Africa (insert) and detail of Namaqualand, showing the location of the communal 
reserves (from Rhode et al., 2006). 
 
1.2.2 Endemism and plant composition in Namaqualand 
Namaqualand is part of the Succulent Karoo biome2 (Milton et al., 1997) and makes up 
approximately a quarter of the total area covered by this vegetation type (Desmet, 2007). There are 
an estimated 6.5 endemic plant species per 100 km2 in the Succulent Karoo. This high level of 
endemism, combined with a wealth of biodiversity, means that the Succulent Karoo is one of two 
deserts to be recognised on the list of the top 25 priority “conservation hot spots” globally (Myers et 
al., 2000). The Succulent Karoo is so speciose that it supports 2.6 times more species than an 
equivalently sized area of the adjacent Nama-Karoo vegetation type (Cowling et al., 1999). 
There are approximately 3500 species in 135 families and 724 genera in Namaqualand, and it is 
estimated that between 25% and 40% of those are endemic (Desmet, 2007; Desmet & Cowling, 
1999). Some experts even suggest greater than 50% endemism within some families (Cowling et al., 
1999).  For example, there are estimated 850 species of Mesembryanthemaceae (the ‘mesembs’ – a 
sub-family within the Aizoaceae) in 100 genera in Namaqualand (Desmet & Cowling, 1999; Smith et 
al., 1998). The majority of these species have been proven, on the basis of molecular work, to have 
evolved relatively recently between the last 3.8 and 8.7 million years (Klak et al., 2004; Ihlenfeldt, 
1994). The family is characterized by having hygrochastic fruit capsules which favours short distance 
                                                          
2
 Naming of the biomes e.g. Nama-Karoo follows Mucina & Rutherford, 2006 
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seed dispersal. Rapid, adaptive allopatric speciation is thought to have been common in the 
evolutionary history of the family and is one explanation for the high degree of endemism in a 
relatively small region (Linder & Hardy, 2004; Ellis et al. 2006). 
A few families dominate the Namaqualand vegetation, in particular the speciose Aizoacae, 
Asteraceae and Crassulaceae families (Cowling et al., 1999). The great diversity in these, and several 
other dominant families, may be explained by looking to past climate conditions and changes in 
these conditions during the Pleistocene era (ca. 1.8my BP - 100ky BP) (Ridley, 1996; Mckenzie & 
Barker, 2008). Recent investigations using fossilised pollen from Eksteenfontein Spring Cave in the 
Northern Cape suggest that the climate shifted from cooler and more humid conditions to drier and 
warmer conditions resembling the modern day climate of Namaqualand around 12.5ky BP (Scott et 
al., 2012). Aridity is thought to encourage speciation in general, and it is particularly favourable for 
CAM adapted species, which many of the Namaqualand species are (Richardson et al., 2001; 
Landrum, 2002). It has been suggested that even under peak glacial conditions of the Last Glacial 
Maxim (LGM) (ca. 21 - 18ky BP) the Succulent Karoo biome retained a core bioclimatic range within 
Namaqualand i.e. there was a stable climatic refuge that didn’t vary too much with global trends 
(Midgley et al., 2005; Midgley & Thuiller, 2007). Thus Namaqualand may have acted as a glacial 
refuge for succulent species, as did frost free valleys in the Eastern Cape for succulent thicket 
vegetation during the Pleistocene (Cowling et al., 2009). It is possible that succulent species could 
have persisted under cooler global temps in the core refugia of the Succulent Karoo and may not 
have been displaced even under peak glacial conditions (Burgoyne et al., 2005; Ridley, 1996). Thus, 
Namaqualand provided a stable local climate during times of extremes elsewhere, thereby allowing 
the region to retain species diversity at a time when other areas were losing theirs (Desmet, 2007). 
This means regional persistence, fewer extinctions and more speciation once the climate returned to 
optimum, resulting in the wealth of species diversity in Namaqualand today (Cowling et al., 2009; 
Jansson, 2003). 
Despite this wealth of biodiversity, only a very small percentage of the land area is conserved in 
formally protected reserve areas. Threats to conservation include mining, poor farm management 
(specifically overgrazing) and illegal plant harvesting for medicine or black market trade (Lombard et 
al., 1999). Lombard (1999) proposes a method of choosing new areas for general reserves and many 
papers deal with restoring degraded rangeland and old mining areas using a variety of ecological 
restoration techniques (Visser et al., 2004, Carrick & Krüger, 2007; Simons & Allsop, 2007; Botha et 
al., 2008; Wassenaar et al., 2012), but it is also important to identify priority medicinal plants that 
may be under threat. 
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1.2.3 Plant life strategies and other survival adaptations 
In addition to high levels of endemism, plants in Namaqualand also exhibit a variety of unique life 
strategies and growth form adaptations that facilitate these life strategies. Many have specifically 
evolved to enable continued survival in the semi-desert conditions of the area. While annual rainfall 
is low for most parts of Namaqualand and individual rainfall events bring only light showers, the 
rainfall is predictable across the Succulent Karoo (Cowling et al., 1999). Rainfall is considered to be 
20% more reliable in Namaqualand than in the neighbouring Nama-Karoo. This is thought to have 
contributed to the predominance of leaf succulence (as opposed to stem succulence often seen in 
other semi-desert or desert vegetation types), dwarfism and shallow rooting (Carrick, 2003) as plants 
need to make the most of moisture when it is available (Figure 2). Together, small, shallow-rooting 
succulents and geophytes comprise over 50% of the species in Namaqualand, making these the most 
common growth forms (Desmet, 2007). 
  
 
Figure 2: Examples of dwarfism on the left (this specimen of Ornithoglossum vulgare B. Nord. is 
approximately 5 cm high) and leaf succulence on the right (the stem of Cotyledon cuneata Thunb. is hidden 
by succulent leaves in this picture). Photographs taken by N. Wheat. 
 
The relatively mild temperatures in autumn and early winter also means that most plants do the 
major part of their annual growth at these times - a time when light is not at its maximum 
availability (Esler & Rundel, 1999). Plants have to make the most of light but still be able to minimise 
the negative effects of heat and short term drought, a feat achieved via leaf succulence and CAM 
photosynthesis. CAM (Crassulacean Acid Metabolism) photosynthesis is one of the most important 
adaptations to living in these conditions. As the name suggests, it is commonly found in species of 
the family Crassulaceae, however it is not unique to that family. This method of photosynthesising is 
also found in mesembs, Aloes and a variety of other families e.g. Oxalidaceae and Orchidaceae 
(Rundel et al., 1999). CAM differs from the other methods of photosynthesis, i.e. C3 and C4, in that 
carbon dioxide is fixed into organic acids at night, with deacidification occurring during the day, 
13 
 
rather than the other way around (Lambers et al., 1998). This means that the stomata are open at 
night when temperatures are cooler and less moisture is lost – a direct adaptation to the conditions 
in Namaqualand. 
Great endemism, specialised life and survival strategies and recent divergent evolution means that 
there are many unique plants in Namaqualand, some of which may contain unique secondary 
metabolites. Theses metabolites may be active in traditional medicines and could be a possible 
source of templates for future drug development. This study aims to investigate these secondary 
metabolites in the context of traditional healing systems, with a view to potential drug discovery. 
The aims of this particular section of the study are covered in more detail in the “Aims and 
Objectives” section of this chapter. 
1.2.4 A brief history of the study area 
While plants have evolved different growth forms and life strategies to enable survival in the harsh 
Namaqualand climate, the people of Namaqualand have also needed to adapt as outside influences 
forced lifestyle changes upon them. As previously mentioned, Namaqualand has a long history of 
occupation by small groups of hominins (Deacon & Deacon, 1999). San hunter gatherers lived in 
Namaqualand prior to groups of Nama-speaking Khoekhoen pastoralists moving into the area 
approximately 2000 years ago (Webley, 2007). With the advent of colonialism, Namaqualand and its 
people changed forever, particularly with the creation of the communal reserve areas and the 
restriction of seasonal transhumance practiced by goat and sheep herding pastoralists. Hoffman and 
Rhode (2007) suggest that the development of Namaqualand can be divided into three distinct 
phases - 1) the pastoral ecological revolution: domestic livestock were introduced to the 
Namaqualand region for the first time and there was a general shift to a pastoral society 
(approximately 2000 years ago) 2) the colonial ecological revolution: colonists arrived, mission 
stations were established and cropping was encouraged and 3) the post-agrarian ecological 
revolution: there was a general decline in agriculture and a shift to post-apartheid transformation. 
Medicinal plants were used throughout all of these periods to a greater or lesser extent. 
Key events in the history of the region are summarized in Table 1. With the influx of people in the 
1750’s moving into Namaqualand from the Cape to establish “loan farms”, came conflict. Land 
disputes between the indigenous Namaqua people and the settling farmers became more common 
as the establishment of farms meant that the seasonal movement of pastoralist Namaqua groups 
was hindered (Rhode et al., 2003). In the late 1800’s, the displaced Namaqua people appealed to the 
church to help them reserve grazing land as more and more farms were being staked out. The 
church established a mission station at Leliefontein, under the authority of Reverend Barnabas 
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Shaw, and created six reserve areas - which later became the present day communal reserve areas 
(May & Lahiff, 2007) (Figure 3). Groups of Namaqua people moved in to the reserve areas with their 
herds, and were encouraged by missionaries to become more sedentary and give up their semi-
nomadic pastoralist lifestyle. At the Leliefontein mission station they were taught to plant and 
maintain crops such as wheat, oats, barley and rye (Rhode et al., 2003). This agricultural lifestyle was 
relatively precarious and frequent droughts made cropping difficult. People took their remaining 
livestock and moved away from the mission station to find pasture, abandoning their crops. In an 
attempt to retain his congregation during the severe drought of 1820 for example, Rev. Shaw 
followed them, establishing small mission outposts along the way. The ten outposts thus established 
were the beginnings of what are the present day villages in the Leliefontein communal reserve area - 
Klipfontein, Kharkams, Leliefontein, Nourivier, Paulshoek, Tweerivier, Kiess, Rooifontein and 
Kamassies (Rhode et al., 2003). 
In the mid 1800’s the role of the church become even more entrenched in Namaqua society as, the 
church was issued an official “ticket of occupation” by the colonial government at the Cape for the 
land surrounding the Leliefontein mission station and its outposts. This ticket of occupation 
conferred a form of “land ownership” to the church. This was the first formal step in the process that 
eventually led to the displacement of the people of Namaqualand and their segregation into reserve 
areas under first church, and then state authority (Rhode et al., 2003; May & Lahiff, 2007). It was 
also around this time that copper mines opened in the area, and many Namaqua people who had no 
remaining livestock after the droughts of the mid 1820’s eventually turned to formal wage earning 
on the mines and farms surrounding Leliefontein in the mid-1800s, exchanging their pastoralist 
lifestyle for more a more sedentary one dependant on employers for wages (Scott & Hewett, 2008). 
As with settling at the mission station in the early 1800’s, the change in lifestyle was beneficial, if 
only for a while. In the late 1800’s drought struck again and many people surviving on farm labourers 
wages found themselves without jobs. Production at the once prosperous copper mines slowed and 
people who were dependant on mining wages also found themselves without jobs. Widespread 
destitution followed. Those who were able to do so began farming with small stock as they are 
easier to keep in times of drought. Goats became the most commonly herded animal in the area and 
this remains so today (Rhode et al. 2003; Hoffman & Rhode, 2007). 
The Mission Station and Communal Reserves Act (enacted in 1913), was the final influence on 
Namaqua people that cemented the transition from a pastoralist to a sedentary lifestyle. The Act 
transferred control and governance of communal areas to the state, and in the case of Leliefontein 
this meant that the church was no longer the local authority. The national government declared 
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Leliefontein an official “native reserve”, with Afrikaans the main language. Namaqua people could 
no longer move beyond this area in the traditional ways of transhumance and thus the villages in the 
reserve started to become more established as people settled down (Rhode et al., 2003; May & 
Lahiff, 2007). Traditional healers became associated with certain areas, which meant that they used 
locally available plants and had to share with other healers to obtain plants not found in their 
immediate vicinity. 
Ownership of the land would only begin to be transferred back to the Namaqua people in the late 
1990’s, when the post-apartheid government passed The Transformation of Certain Rural Areas Act 
(TRANCRAA). TRANCRAA allowed the transfer of land held in a trust by the Minister of Agriculture 
and Land Affairs to either a municipality or a Communal Property Association. The people from 
Leliefontein elected for their land to be governed by the local municipalities with elected office 






Figure 3: Map of the Leliefontein communal reserve area showing the location of the ten villages. Paulshoek 




Table 1: Timeline of major events in the history of Namaqualand and, specifically, the Leliefontein reserve (compiled from data from Scott & Hewett, 2008; Hoffman & 
Rhode, 2007; Webley, 2007; May & Lahiff, 2007; Rhode et al., 2003; Petersen, 2004; Price, 1976; Lebert & Rhode, 2007; Cousins et al., 2007 and Penn, 1995. Additional 
specific references given in text). 
Date Event 
2100/2000BP Archaeological evidence at Spoegrivier Cave, on the Namaqualand coast, suggests sheep herding on a small scale. This is the earliest 
evidence of pastoralism in South Africa 
800BP Archaeological evidence at Bethelsklip (in the modern day Leliefontein communal area) of sheep and goat herding 
1600s European colonists arrive at the Cape and the Dutch East India Company (Vereenigde Oost-Indische Compagnie (VOC) in Dutch)  
establishes a supply station for ships sailing east from Europe 
1661 Colonists mount expeditions of exploration northwards from the Cape and encounter several large groups of Khoekhoen pastoralists 
whom they call the “Little Namaqua” in the vicinity of the Kamiesberg 
1685 Simon van der Stel ventures northward in search of copper and encounters groups of pastoralist “Namaqua” with herds of cattle and 
sheep. He also encounters a few hunter/gatherer groups of San/Bushmen 
1720s Smallpox, introduced to the  colony at the Cape in 1713, spreads northwards and decimates both the European and indigenous 
populations, continuing to do so for the next 100 years 
1750s The first European colonists move onto “loan farms” in Namaqualand and begin farming 
1770s Conflict arises between indigenous Namaqua people and settling European farmers. Land disputes become more frequent 
1779 Namaqua leader “Captain Wildschut” centres his group of pastoralists in the Leliefontein region of Namaqualand for summer grazing 
1779 On a trip to Namaqualand, Robert Gordon records the area as inhabited by very few people. He is quoted as saying that “this entire 
nation consisted of about four hundred men and women, as well as children” (Raper & Boucher, 1988) 
late 1780s A new group of people, the “Bastaards”, resulting from the union of loan farmers and Namaqua women, as well as other race groups, 
arises. Many of these mixed race individuals move to the colony at the Cape to associate themselves with Europeans, in preference to 
staying in Namaqualand and assuming the “lower status” of the Namaqua people 
late 1780s “Bastaards” allowed to acquire loan farms in Namaqualand 
1780 The previous popularity of loan farms wanes and the northward expansion into Namaqualand slows nearly to a halt 
1790s “Bastaards” lose their status in colony society and many are turned into bonded labourers at the Cape. Most return to Namaqualand or 
settle further afield in Bushmanland 
1798 The Kamiesberg has so few people (due to the smallpox epidemic) that it is described by settlers as “formerly inhabited by Namaqua 
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Hottentots”.  A company (presumably the Dutch East India Company) builds a rudimentary road across the Kamiesberg making it easier 
for “wandering peasantry” to settle in the area 
Early 1800s Pastoralist Namaqua people living in the Leliefontein area, led by Wildschut, appeal to the church to help protect their traditional 
grazing land from the “wandering peasantry” (settlers, runaway slaves, Bastaards etc.). Missionaries are more than willing to help and 
the six modern day “coloured reserve areas” (CRA’s) are created by formal church protection of land. 
1816 Reverend Barnabas Shaw establishes a mission station at Leliefontein. Drought and continuing disease cause the remaining Nama 
people in the area to seek refuge at the new mission station and Rev. Shaw becomes their leader, governing the area. In an effort to 
shift the Nama people from a nomadic-pastoralist way of life to a more sedentary one, they are encouraged to plough and plant crops 
(mostly wheat, oats, barley and rye). 
Early – mid 1820s Namaqua people abandon their crops and leave the Leliefontein mission station with their remaining animals in the wake of severe 
droughts. Rev. Shaw follows them and establishes mission outposts wherever they go. These outposts eventually became small 
settlements in their own right and today reflect the locations of some of the main villages in the communal reserve area  
1800s With increasing settlement in the area, the seasonal transhumance of the Namaqua people is limited. Eventually many become 
sedentary at the mission outposts and by 1874, 268 families (approximately 2000 people) are living in the Leliefontein reserve 
1850s Copper mines are established in Namaqualand, mostly in the vicinity of Springbok 
1854 Present day CRA’s previously established by the church in the early 1800’s are formally acknowledged by the British Cape Colony 
Government. The Leliefontein mission station is issued a “ticket of occupation” which gives leasehold title to the church. Namaqua 
people living in the area are only given occupational status. 
1855 A large church is built at Leliefontein 
1856 A civil commissioner and resident magistrate are appointed at modern day Springbok, further establishing the authority of the 
colonists and missionaries in the region 
1870s Typhoid breaks out on the copper mines 
Late 1870s Copper production begins to decrease at the mines in Namaqualand 
1878 The Cape Government requires the registration of everyone living in Namaqualand in order to collect a new “house duty” tax 
Late 1888 The global demand for copper plummets and as a result many mine workers are laid off. This causes widespread poverty in the 
previously prosperous Leliefontein area 
1881 – 1883 A series of severe drought years cause crop failures. Labourers on commercial farms are laid off and previously poor farming families 
become destitute. Those families able to switch from keeping cattle to herding smaller livestock do so. 
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1895 More drought hits the already stricken area 
1909 The Mission Station and Communal Reserves Act (enacted in 1913) means that church control and mission station governance of the 
Leliefontein reserve are replaced by direct state authority 
1913 Leliefontein becomes an official “native reserve” under control of the state. Afrikaans becomes the lingua franca, although older 
people still speak Nama. Most people still refer to themselves as “Namaqua” 
1919 After struggling for years, the Cape Copper Company shuts down and closes all its’ mines in Namaqualand. Many miners lose their jobs. 
Early 1920s More farmers, many of them Namaqua, settle in the reserve and start farming with cattle and goats and planting crops. Due to the 
hardship of this way of life, many reserve settlers are convinced at this time to sell all of their possessions and move to Steilhoogte (a 
farm on the southern side of the Olifants River) for a better life, only to return destitute 
1920s Leliefontein (the settlement) becomes overpopulated and people begin leaving as land pressures increase. Some people move to the 
mission station outpost of Paulshoek (which was used at the time to keep rams separate from the rest of the herd in the run up to the 
breeding season) 
1925 Returning residents left destitute after the Steilhoogte debacle work on the Garies/Platbakkies road for basic food rations 
1920s Global economic depression 
1930s Severe drought hits again forcing even more families to move from outside into the reserve and from the overcrowded Leliefontein 
village to Paulshoek 
1920 – 1960 The influx of farmers to the area means widespread ploughing and a rapid expansion of croplands 
1940 The Land Settlement Act gives grazing rights inside the reserve to white farmers. These rights could be converted to ownership rights 
  
1950s Many of the former “Bastaards” and their descendents leave the Leliefontein reserve to settle further north in the Richtersveld 
1950s Many recently created croplands are abandoned as the younger generation move away to find more profitable work on commercial 
farms and diamond mines 
1950s The Group Areas Act confines coloured people (i.e. Namaqua descendants and people of mixed heritage) to the CRA’s and forces white 
farmers living in the area to move outside the reserve. Many people who had moved away returned to settle in the reserve. 
Commercial farms (owned by white famers) bordering on the communal area are fenced with the assistance of government subsidies, 
restricting communal grazing. 
1960s Villagers become fully sedentary for the first time in several of the villages associated with communal areas. Most people are 
dependent on state grants, income generated from farm labour, or money sent home by family members working at the mines or in 
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the major urban centres of Namaqualand 
1963 The Coloured Rural Areas act allows the Minister of Coloured Affairs to review land use and tenure in the CRA’s, dividing up the land 
into “economic units” and allocating these units to selected individual farmers (this act was subsequently amended and then replaced 
by the Rural Areas Act of 1979) 
1970s and 1980s More people settle in the towns associated with the communal areas as they are seen as places where one can survive on a very tight 
budget, thus making it more affordable for the unemployed and poor to live there 
1979 The Rural Areas Act is passed by government which formalised the notion of “economic units” of land (first mentioned in the Coloured 
Rural Areas Act of 1963) which would be privately leased to farmers. This is first implemented in Leliefontein in 1984 
1984 Leliefontein reserve is divided into 47 farming units for private lease. Many people lose access to grazing land and angry residents 
opposing the new policy and force would-be occupants off the new units 
1988 The Rural Areas Act is overturned by the Cape Supreme Court. The policy of “economic units” is set aside and communal land is 
restored to communal farmers 
1990s Land reform policies and the RDP (Reconstruction and Development Programme) bring infrastructure improvements to the village such 
as RDP housing. A land reform programme is stated to increase the commonage area. 
1993 The Land Titles Adjustment Act allows for the updating of land title deeds that had not been maintained (e.g. through non-registration 
of change of ownership upon inheritance of land) and allows investigation by a commissioner into the rightful owners where the legal 
ownership was unclear. 
1994 Transition to democracy in South Africa 
1996 The constitution of South Africa is established, which obliges the government to implement a programme of land reform, restoring 
historical land and redistributing land and resources 
1995 Communities in Namaqualand request a formal district planning project to manage land reform in their areas 
1998 The Transformation of Certain Rural Areas Act (TRANCRAA) allows the transfer of land held in a trust by the Minister of Agriculture and 
Land Affairs to either a local Municipality or a Communal Property Association 
1999 The District Planning and Management Project requested by residents in 1995 is completed and provides a framework for future 
resolution of conflicting land claims as well as an action plan for the acquisition of new communal land 
2000 The local municipalities of Richtersveld, Khai Ma, Kamiesberg and Nama Khoi are established within the greater “Namakwa District”. 
Leliefontein reserve falls under the Kamiesberg municipality and is currently administered by a Commonage Committee 
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1.3 Paulshoek - the study area 
1.3.1 Climate and vegetation 
There are six communal reserve areas in Namaqualand which were previously known as “Coloured 
Reserve Areas” (CRA’s): Richtersveld, Komaggas, Steinkopf, Leliefontein, Concordia and Pella (Figure 3). 
These are the ultimate result of church protection of land during the 1850’s (Table 1). As of 2007, they 
make up 22.6% of the land area in Namaqualand (May & Lahiff, 2007). Specifically, this study was done 
in the village of Paulshoek (30°25’S; 18°15’E) in the communal reserve of Leliefontein. The Leliefontein 
reserve covers approximately 190 000 ha of land in the Kamiesberg region of Namaqualand. A post-
apartheid land distribution programme known as the Municipal Commonage Programme acquired an 
additional 33 000 ha between 1998 and 2000, bringing the total reserve area to 223 000 ha (Lebert & 
Rhode, 2007). 
Paulshoek is the most easterly of ten villages in the reserve and is relatively isolated, being situated 27 
km away from the nearest village and about 50 km along a gravel road from the town of Garies. The 
village lies approximately 1400 m above sea level and receives an average of 180 mm of rain annually 
(unpublished data). This is a slightly higher than the average annual rainfall for Namaqualand but not 
nearly as much precipitation received by some of the wetter parts of the Kamiesberg. There are no 
permanent rivers in the village and people rely on borehole water for their main water supply which is 
augmented by household water storage tanks which collect run-off water from roofs. A small dam fed 
by precipitation run-off from a large granite outcrop behind the village supplements the water supply, 
but water shortages are a common feature of the village life (Petersen, 2004). The climate is generally 
mild, but temperatures can reach up to 37°C in summer, and in winter there may be frost and light snow 
due to the altitude. Temperature extremes may occur in a single 24 hour period, from near freezing at 
night to upper 30’s during the day, especially during October and November (Petersen, 2004). 
The vegetation is typical of the Kamiesberg region and is dominated by species belonging to the families 
Mesembryanthemaceae, Aizoaceae, and Asteraceae. Succulence is common, as are geophytes. Larger 
shrubs and a few trees grow along seasonal river courses and at the base of granite outcrops, where 
runoff accumulates (Le Roux, 2005). The communal grazing land surrounding the village is degraded in 
places. Like other disturbed areas in Namaqualand it has become dominated by Galenia africana, which 
is generally unpalatable to livestock (Simons & Allsop, 2007). Studies suggest that under prolonged 
heavy grazing, the perennial-dominated shrubland becomes replaced by annuals and geophytes and 
that this trend is not easily reversed once grazing pressure has been reduced (Anderson & Hoffman, 
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2007; Todd & Hoffman, 1999). This may be one of the contributing factors to the noticeable difference 
between the quality and composition of the vegetation on the communal rangelands and the adjacent 
commercial farms. Stocking rates on communal lands tend to be higher than the rates recommended by 
the South African Department of Agriculture and in some cases twice the number of recommended 
animals grazes a particular area of the commons (Hoffman & Ashwell, 2001). The impact of this on 
vegetation is most noticeable along fence lines, where glaring differences between communal and 
commercial land often exist (Todd & Hoffman 1999, Todd & Hoffman, 2009). Heavy or overgrazing is one 
of the main causes for vegetation degradation and loss of biodiversity, with an estimated 30% reduction 
in species numbers in the areas immediately surrounding a stock post (Hendricks et al. 2005; Haarmeyer 
et al., 2010). Recent studies suggest that under a heavy grazing regime woody perennial shrubs, many of 
which are medicinal plants, decrease and fast growing annuals and herbaceous species increase 
(Anderson & Hoffman, 2011). Moderate grazing is thought to have only a moderate effect on vegetation 
(Haarmeyer et al., 2010). The study of Goldberg (1998) suggested that there was no significant impact 
on medicinal plants from either grazing or harvesting, but the true effect of grazing on medicinal plants 
is not well documented and deserves further study. 
1.3.2 Creation of the modern village and its infrastructure 
Leliefontein mission station was established in the early 1800’s (Table 1). Later, satellite mission 
outposts were established and these became the ten villages in the reserve, of which Paulshoek is one 
(May & Lahiff, 2007; Petersen, 2004). The reserve was acknowledged by the government at the Cape in 
the mid 1850’s and the Leliefontein reserve was officially established as a “coloured reserve” in 1913, 
but it wasn’t until the 1960’s that the first permanent houses were built in Paulshoek. It is said that 
Paulshoek got its name because rams being kept separate from the rest of the herd prior to breeding 
season were penned in the area by a man named Paul Joseph - hence “Paul se hoek” (“Paul’s corner”) 
(Petersen, 2004). Prior to this, there were few people living in Paulshoek mostly herding goats or 
planting crops. Most of them lived in traditional mat houses (“maatjieshuise”) and built outdoor shelters 
for cooking, but some had more permanent structures. With the advent of the Group Areas Act in the 
1950’s, more people moved into the reserve as a whole. Paulshoek experienced an influx of people as it 
offered a small school, a church and the possibility of grazing land, and was therefore attractive to those 
seeking security in uncertain times (Rhode et al., 2003). This trend continued and there was a fivefold 






Figure 4: Traditional reed mat house “matjieshuis” (left) and typical modern houses (right), with outhouse on 
the premises (photos taken by Timm Hoffman (left) and N. Wheat (right)). 
 
Today there are approximately 100 houses in Paulshoek, housing between 400 and 450 people (99 
houses and 405 individuals were recorded in a survey of the people living in the village in 2010 
(Duijnstee, 2011). 
The number of inhabitants fluctuates as people return to stay with family when out of work, leave to 
search for work or seek opportunities in another village in the reserve or in the nearest large centres e.g. 
Vredendal. Some of the  houses are simple Reconstruction and Development Programme (RDP) style 
houses built by the government as part of the post-apartheid upliftment project aimed at improving the 
quality of life of the poorest South Africans (May & Lahiff, 2007; Petersen, 2004; Rhode et al., 2003). 
However, many houses consist of more than two rooms and some still have a traditional cooking shelter 
built from dried bushes and branches (referred to as a “kookskerm”) in the yard (Figure 4). 
In recent years, since the establishment of a local municipality for the Kamiesberg region and the 
implementation of TRANCRAA, there have been significant improvements. Most houses now have 
electricity (running on a pre-paid meterage system), telephones (also on a pre-paid meterage system) 
and piped water to a tap on the premises. There is still no indoor plumbing.  There is at least one 
household with dial-up internet access and several small shops (run by village inhabitants and a 
neighbouring commercial trader) that sell basic foodstuffs, toiletries and household goods. Despite the 
improvements in living conditions, many people in Paulshoek continue to live in poverty. In an 
assessment of the village conducted in 2003, approximately 30% of people were living on less than $1 a 
day, the United Nations measure for the least developed and poorest countries (Rhode, et al., 2003). In 
a more recent study, it was shown that, due to a large increase in inflation, the mean average total 
income from employment has only increased moderately since then and almost 85% of village 
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inhabitants are unemployed (Duijnstee, 2011). Only 20% of households in the greater Leliefontein 
reserve have a regular income (Berzborn, 2007) and many people rely on state grants. In Paulshoek, 50% 
of the entire village income is from state support, with the most common forms being elderly, child and 
disability grants (Duijnstee, 2011). 
Education levels in the village tend to be low, with the average adult obtaining a total of six years of 
education. Education has been steadily improving over the past years, with more people being 
educated, but the average level has not increased much above grade 6 (Rhode, et al., 2003; Duijnstee, 
2011). This is most likely a result of there being a nursery school as well as a permanent primary school 
in the village, providing education up to grade 7. There is no secondary school in the village and learners 
must attend boarding school in one of the towns outside the village to obtain education beyond grade 7. 
For many families this expense is too great. However, many people now realise the value of education 
and an increasing number of learners are completing their schooling despite the difficulty involved for 
them and their families. 
1.3.3 Healthcare and medicinal plant use in Paulshoek 
Overall, there has been a general decrease in agriculture (fewer crop lands), and an increased 
dependence on state subsidies and wages since the village started expanding in the 1960’s (Hoffman & 
Rhode, 2007). Pastoralism is still important but it is not the main source of income for most households, 
as most practice economic diversification with multiple livelihood strategies (Berzborn, 2007). Keeping 
herds of small livestock such as goats and sheep is often practised as an insurance policy against 
unemployment or to provide meat and milk for family needs (Rhode et al., 2003). A recent study of 
household incomes in Paulshoek indicated that income generated from selling livestock accounts for 
only 5% of the average household income (Duijstee, 2011). 
Many people are entirely or largely dependent on state pensions and grants for their survival, which 
means that there is often very little money to cover basic health care expenses. Although there is no 
permanent medical facility in the village, a mobile clinic with a doctor and a nurse visits once a month. In 
addition to the clinic there is a recently appointed Community Health Worker, whose purpose is to 
educate people in aspects of healthcare, to facilitate access to healthcare and occasionally to treat 
minor illnesses or wounds (Duijstee, 2011). The mobile clinic service provides checkups and vaccinations 
for infants as well as basic medication to those living with HIV or tuberculosis (TB). It also provides 
chronic medication to those with illnesses such as high blood pressure. In a study done on health in 
Paulshoek by the Medical Research Council (MRC), it was found that the most common ailments 
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recorded at the clinic were high blood pressure, and respiratory diseases such as TB and asthma. The 
incidence of these diseases seems elevated due to the majority of adults being regular smokers (Rhode 
et al., 2003). Most services are free of charge, but occasionally a small fee is incurred. Despite the 
minimal cost involved, many people cannot afford to pay either the clinic or the traditional 
“bossiesdoctor” for treatment and thus the most accessible form of health care available to them is 
treatment with basic home remedies. While specific knowledge of how to treat serious illnesses such as 
cancer, strokes and mental illnesses is kept confidential and is only known to specialist healers, many lay 
people have a working knowledge of the plants used to treat everyday illnesses such as colds and 
stomach upsets (Dahlberg & Trygger, 2009; Dold & Cocks, 2000). Even though many people use home 
remedies out of necessity and the inability to make use of other available facilities, many people prefer 
to treat themselves and their families with home remedies as a first line of treatment (Cocks & Dold, 
2000). If home remedies don’t work, then the help of a Western doctor or the services of a traditional 
healer may be sought. 
Traditional veterinary knowledge has also arisen out of necessity. Plants are responsible for a large 
number of animal deaths in South Africa, and herders living on remote stock posts are unable to gain 
the assistance of a Western veterinary doctor, and in many cases cannot afford the service if it is 
available (Kellerman et al., 1998). Thus, most herders have some knowledge of plant remedies to aid 
animal illnesses such as diarrhoea, gallsickness, heartwater, coughing and helminth infestation. It has 
been estimated that 75% of livestock herders in the Eastern Cape use plant-based treatments for animal 
illnesses (Masika et al., 2000; McGaw & Eloff, 2008) and the same may be true for herders in 
Namaqualand. Most herders also have some knowledge of the plants that their animals graze on and 
can prevent unnecessary poisoning, paralysis or liver damage due to ingestion of toxic plants (Bath et al., 
2005). While this is vital knowledge for rural farmers, the topic falls beyond the scope of this study. 
1.4 The importance of this study and its relevance 
Medicinal plants play an integral role in the lives of modern Namaqualand inhabitants, and have done so 
for hundreds of years. Investigating trends in medicinal plant use may provide insight into how 
knowledge systems are created and how traditional use is maintained and may be continued in a 
modern society. It is also important to document traditional plant use so that this knowledge can be 
retained for future generations, particularly now that all of the traditional healers formally recognised in 




Investigating the status of plant use in the community is also important in order to compare it with plant 
use in other parts of South Africa as well as other areas globally. This information may assist government 
in creating policy for traditional health care systems, for those that practice as healers and for traditional 
medicines themselves. Recording and detailing the actual plants used to create remedies may also 
provide a starting point for further investigations into biological activity or the nature of secondary 
metabolites present in those plants. 
1.5 Aims/questions and objectives of this section 
The main aim of this part of the study was to get a general overview of medicinal plant use in the village 
of Paulshoek and the demographics of medicinal plant users. A second aim was to compare this 
information with data from 14 years ago, in an attempt to highlight trends or changes in medicinal plant 
use over time (Goldberg, 1998). Plant choice was also investigated in order to establish if particular 
families are preferred for creating remedies for particular types of illnesses. In addition, methods of 
knowledge acquisition and commonly held perceptions of medicinal plants and their uses were 
investigated. In summary, the aims of this section of research are to: 
1) Investigate the extent of knowledge of medicinal plant use within the village population 
a. Record all plants that are used for medicinal purposes 
b. Investigate the demographics of people who use home remedies and compare this with 
results from 14 years ago 
2) Examine trends in plant choice and establish whether certain families are preferred for treating 
particular types of illnesses 
3) Investigate how medicinal plant knowledge is acquired and transferred between users 
4) Investigate the role of medicinal plants in the community and examine commonly-held 
perceptions of them and their use 





Ethical clearance for this research was obtained from the Faculty of Science Research Ethics Committee 
(based at the University of Cape Town), approval number SFREC 032_2011. Participants were informed 
of the nature of the project and no one was obliged to participate in the study. Personal information 
was kept confidential, with hard copies of interview transcripts stored in a locked desk drawer and 
electronic copies stored in a database on a password protected computer. 
2.1 Interviews with villagers 
Interviews with villagers took place between September 2010 and September 2011. An initial 
questionnaire was created in order to investigate the extent of use of medicinal plants by individuals not 
practicing as traditional healers, and to gain a basic overview of which species were commonly used in 
the preparation of home remedies (See Appendix A: “Question Set One”). Households that responded 
positively to this initial questionnaire were subsequently revisited and asked a series of follow up 
questions designed to investigate the demographics of those respondents in more detail (See Appendix 
A: “Question Set Two”). The second questionnaire also investigated general perceptions of medicinal 
plants and their use in Paulshoek, and allowed interviewees to comment freely on this and to give their 
opinions regarding remedy efficacy in relation to ‘Western’ medicine as well as historical anecdotes and 
anything else they felt was relevant and should be recorded. 
Information gathered during interviews was compiled using Microsoft® Office Excel® 2007 and 
compared to data gathered in Paulshoek in a similar fashion previously (Goldberg, 1998), as well as to 
ethnobotanical data previously gathered for the greater Richtersveld area (Archer, 1994). 
2.2 Interviews with healers 
Interviews with two of the village healers, Oom Jacobus ‘Kooitjie’ Corjeus and Oom Gert ‘Julk’ Dirkse, 
now both deceased, took place in July 2009. These brief interviews, along with additional recorded 
interviews conducted over the past five years with the same people (M.T. Hoffman, unpublished 
recordings and transcripts), allowed comparison of opinions and perceptions of medicinal plants and 
their use between non-specialist villagers and formal traditional healers (“bossiesdoktors” or 
“kruiedoktors”). Interviews also allowed comparison of practices between non-specialist villagers 




2.3 Plant collection and identification 
The questionnaire surveys provided a basic list of the most commonly used plants in the preparation of 
home remedies. Walks were taken through the veld with a local field assistant in order to create a more 
comprehensive list of medicinal plants from the Paulshoek region, which included historical use as well 
as applications that have fallen out of common use. This is a modified version of the “active participant 
observation” method (Martin, 1995). Instead of observing someone who is involved in collecting plants 
for their own medicinal needs (as is done with “active participant observation”), guided walks were 
taken with a field assistant. The field assistant was someone who would usually collect medicinal plant, 
but was not actively involved in the activity at that time. The field assistant, (Ms. Marianna Lot) lives in 
Paulshoek and her father was a traditional healer in the area before his death. Even though she didn’t 
officially train as a kruiedoktor she picked up knowledge of medicinal plants, their common names and 
uses from her father and is very knowledgeable in this area. She regularly makes use of plant-based 
home remedies and has an extensive knowledge of the methods used for preparing remedies. She has 
also been trained as a para-ecologist by BIOTA Southern Africa (see http://www.biota-
africa.org/reg_south_paraecol_ba.php) and has worked on several other research programmes in the 
surrounding areas, making her a capable field researcher and valuable guide for the area. Walks were 
taken in several different areas around the village to encompass a variety of soil and vegetation types 
and to maximise the likelihood of encountering the widest selection of medicinal plants possible. Ms. 
Lot would identify plants of interest and provide common names and uses for each. Samples were taken 
from each plant identified in this manner for the purposes of formal identification and as herbarium 
samples. Species were identified by the author (M.Sc. Botany, UCT) and by Prof. M.T. Hoffman (Director 
of the Plant Conservation Unit at the University of Cape Town), who has extensive experience working in 
Namaqualand, specifically in the Leliefontein Reserve. 
Herbarium samples were placed in a plant press and rotated with fresh paper weekly until they were 
adequately dry. This was done in accordance with standard pressing techniques (Victor et al., 2004). 
Spirit collections were made of succulents and spiky plants not suitable for pressing, according to the 
method outlined in Victor et. al (2004). Spirit collections were preserved in a standard Kew Solution 
containing 5% glycerine, 70% EtOH (70%), and 25% distilled water (www.kew.org). Additional 
photographs were taken of dried herbarium material for reference purposes and inclusion in data 
profiles (See Appendix B). Herbarium samples were submitted to the Bolus Herbarium at the University 
of Cape Town. An exhaustive literature search was performed on all plants collected in order to uncover 
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any additional uses, historical and present, in other areas or by different cultural groups. Additional 
information was included in the resulting plant profiles submitted with this thesis. 
In addition to the system of informal guided walks, a typical south-facing rocky slope with sandy soil was 
selected as a collection site for additional exhaustive species sampling of the area. Paired sample 
squares (quadrats) measuring 2 m x 2 m were marked out along a north-south transect running up the 
slope. All new species were collected from quadrat one. All new species not already collected on veld 
walks or in quadrat one were collected from quadrat two, and so on along the transect, until a negligible 
number of new species was being collected per additional quadrat surveyed. This is in accordance with 
the law of diminishing returns, which says there is a point at which surveying another quadrat or 
interviewing another person will not add any significant or new information to the study and it becomes 
inefficient to continue collecting data (Martin, 1995). 
A total of 10 sample quadrats were investigated in this fashion. Herbarium samples were made for each 
species and additional small samples of leaves, fruit or flowers were collected and placed in bags to be 
taken back to the University of Cape Town for analysis (See Chapter 3). Species collected in this way 
were identified by the author (M.Sc. Botany, UCT) and by Prof. M.T. Hoffman (Director of the Plant 
Conservation Unit at the University of Cape Town). This sampling strategy was a mixture of two 
commonly accepted sampling methods, namely random sampling and ethnopharmacological sampling. 
Random sampling involves collecting any plant in a given area that can be collected in a sufficient 
amount of a given quality for a given purpose. Here the main purpose was to collect non-damaged 
(through insect activity or grazing etc.) species for analysis (see chapter 3). This gives a good indication 
of the plants with potential medicinal application in an area. Random sampling is also the best method if 
any statistical analysis is to be performed on the data (Cunningham, 2001). Ethnopharmacological 
sampling involves sampling only plants that are used medicinally and is most likely to produce positive 
bioactive hits (Martin, 1995). 
2.4 Investigating trends in plant choice 
In order to determine which families are most often used for which types of illness, a series of 
regression analyses were performed at the family level. The number of species used medicinally per 
family (MSPE) was the independent variable, and the number of uses per family for a particular category 
of treatment was the dependant variable (Moerman, 1991). The rationale behind this is that it is a way 
of highlighting which families are favoured (“hot”) for treating particular types of illness. In essence, the 
approach uses least-squares regression analysis to establish an equation that describes the relationship 
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between the two variables under investigation. Assuming the relationship is linear, the equation will 
have the form: 
 
where y is the dependant variable, x the independent variable, B is a coefficient representing the slope 
of the line and A is a constant representing the y axis intercept. The equation can be used to predict the 
expected number of uses per family for a certain category of illness. These predicted values are then 
compared to the actual values per use category. Subtracting the predicted value from the actual count 
gives the residual value for that data category. 
Residuals can be calculated for each family. Families with positive residuals are the ones used more 
often than regression would predict, while those with negative residuals are used less often than would 
be expected. Therefore, families are designated either “hot” or “cold” and the choice to use (or avoid) 
species from certain families to treat certain illnesses is not random. Extreme outliers are of interest as 
they represent families that are either particularly favoured, or particularly avoided for medicinal use 
(Douwes et al. 2008; Moerman, 1991; Treyvaud Amiguet et al., 2006; Molander et al., 2012). This 
method was followed for the medicinal species mentioned in interviews with Paulshoek residents. 
3. Results 
3.1 Extent of use of medicinal plants 
A few people declined to be interviewed, or were not available when the interviews were being 
conducted and were not included in this study. A total of 71 households in Paulshoek, out of 
approximately 99 were interviewed in order to investigate the extent of knowledge of medicinal plants 
and the use of traditional home remedies by villagers. Of the participating households, it was found that 
70.4% had used plant based remedies in the previous year, compared with 70.0% recorded in a similar 
survey of medicinal plant use in Paulshoek in 1998 (Goldberg, 1998). Thus, the number of people using 
medicinal plants had not changed significantly in the time between the two studies, suggesting that 
plant use in the village is not in decline. However, while the percentage of people using plant medicine 
has not changed, the demographics of the group may have. 
Children (minors under the age of 18) made up 27.7% of people using medicinal plants, 57.6% of which 
were under the age of 10. Thus, children under 10 years of age comprised 15.9% of the total population 
y = A + Bx 
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using medicinal plants. Adults over the age of 18 made up 72.3% of the people who used medicinal 
plants. Goldberg (1998) reported that more than 50.0% of people using medicinal plants were children, 
which suggests that there has been a decline in the number of children using plants in the 14 years 
between the two surveys and an overall increase in the number of adults using medicinal plants. Since 
the percentage of the population using medicinal plants has not varied significantly over the past 14 
years, and the total population size has not varied significantly, it must be assumed that there has been 
a general shift in the demographics of people using medicinal plants.  A few of the older people 
recorded in Goldberg’s study (1998) have passed away in the interim years, and many of those recorded 
as minors in the previous study will now be adults. This resulted in an overall increase in the number of 
people in the adult group, and a decrease in percentage of children using plants. However, while some 
of the observed drop in the percentage of minors using medicinal plants can be explained by previously 
recorded children growing up, the rest of the decline implies fewer children are being born in the village 
and that a large number of new minors born in the interim years between studies are not using 
medicinal plants. These indicators of an ageing and declining population were also recorded in a 2010 
survey of the village (Duijnstee, 2011), which indicated that the number of children in the village had 
dropped since 1995. This trend was explained as result of a combination of fewer children being born in 
the village and that mothers with children were more likely to move away from Paulshoek in search of 
work. Both of these events have led to a decrease in the number of children using medicinal plants in 
the village, and will eventually result in declining numbers of adults using medicinal plants in coming 
years. As recorded in this study, Duijnstee (2011) also showed that the number of elderly people had 
increased. 
Each household consisted of an average of four people, ranging between one and eight occupants per 
house, as compared with the average of six people per household, ranging between one and twelve 
occupants per house, reported in a 2003 study of Paulshoek (Rhode et al., 2003). The number of houses 
has not changed significantly, so this does not indicate that people just prefer to live in smaller groups, 
but rather it suggests that there has been an overall decline in the number of people living in Paulshoek 
permanently, as was previously suggested by other recent studies (Duijnstee, 2011). 
Of the 29.6% of respondents that said they did not use medicinal plants, 18.2% had used plant based 
home remedies in the past, but no longer did so. There were various reasons given for the cessation the 
most common being that the respondent was old and unable to collect plants, make medicine or 
remember which plants to use. One respondent said they no longer used medicinal plants as the plants 
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they preferred had died out, and, most interestingly, one person was under the impression that it was 
illegal to collect plants and so did not make home remedies anymore. The remaining 11.4% of 
respondents currently do not use medicinal plants, and have not done so in the past. 
3.2 What is used and for what purpose? 
The aim of this section was to investigate the extent of knowledge of medicinal plants of non-specialist 
villagers in order to identify which species are used and for what purposes as well to establish if there 
are preferences in plant use among non-specialists. 
3.2.1 How many species are used? 
A total of 50 plants in 27 families were described during interviews with villagers and talks with Ms Lot, 
18 of which were mentioned by her alone. The common names and uses of these plants were recorded 
and they were identified to species level (Table 2). In addition to the information about medicinal plants, 
common names and applications of other locally-used, non-medicinal plants were also recorded. Most 
of these non-medicinal species mentioned were used for grazing or firewood, while some had other 
functional uses such as traditional building materials, insect repellents or for food (Table 3). 
In the previous study of Goldberg (1998), it was recorded that 22 plants were used by traditional 
healers, but only 15 were being used regularly for home remedies by villagers in Paulshoek. Other 
studies reported that 45 species were known in the greater Richtersveld area, but only 20 of those were 
being used regularly (Archer, 1994). Thus, the number of plants used in the creation of home remedies 
by village residents in Paulshoek appears to have trebled, but this may be due to a more rigorous 
sampling approach adopted in this study. Comparing these numbers to results from similar studies in 
other regions of South Africa indicates that they are not significantly different. For example, Bhat & 
Jacobs (1995) reported 26 medicinal plants in 21 families used by people in rural Transkei; van Wyk et al. 
(2008) reported the medicinal use of 86 plant species (72 indigenous) in 39 families in a study of the 
South Eastern Karoo; Dahberg & Trygger (2009) reported 49 species in 29 families used in rural KwaZulu-
Natal; and Thring & Weitz (2006) reported 36 species in 19 families in use in the Overberg region of the 
Western Cape. This gives a mean number of 23 families used per region. Paulshoek, with its 27 reported 
families, is comparable with these other South African studies. 
An average of 7 medicinal plants was known per person interviewed, with the majority of people 
naming between 6 and 10 medicinal plants (Figure 5). Less than 5.0% of respondents in the general 
survey could name and give uses for more than 15 species, and a similar number only named a single 
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Table 2: A list of the plants used in Paulshoek for medicinal purposes and a brief description of the uses for which they are intended 
Scientific name Local name Medicinal use 
Aloe microstigma Salm-Dyck 
subsp. microstigma 
(Asphodelaceae) 
Vuurpylalwyn In the past, the leaves were boiled and the liquid reduced to a thick yellow syrup 
which would be given to livestock to treat gall sickness. 
Antizoma miersiana Harv. 
(Menispermaceae) 
Bloubos, Dawids wortel (David’s 
root), inkbos 
A decoction of the root is taken as an emetic and for fever and stomach 
complaints. Dried plant material has veterinary application for the treatment of 
horses with bot fly, a parasitic fly of the family Oestridae that uses horses as a 





Ambeibos A cooled decoction of the leaves is used to treat an unidentified illness “ambei”. 
Old literature (Laidler, 1928) refers to the “ambiaer bush” which was used to 
treat haemorrhoids. It seems that the “ambei” mentioned in this instance also 
refers to haemorrhoids. 
Asparagus aethiopicus L. 
(Asparagaceae) 
Hakiesdoringbos A decoction made from the roots of A. aethiopicus and an unidentified plant, 
“wildekanniedood”, is used to treat tuberculosis. 
 
Asparagus rubicundus P.J. 
Bergius (Asparagaceae) 
Wag-’n-bietjie bos The lower stem and roots are dried and ground into a powder which is used a 
snuff to treat headaches. 
Ballota africana (L.) Benth. 
(Lamiaceae) 
Kattekruie A hot or cold poultice is prepared from fresh leaves and placed on burns or 
wounds to reduce inflammation. A similar poultice can be applied to relieve 
pain. 
Carpobrotus edulis (L.) L. 
Bolus (Aizoaceae) 
Hotnotsvye The juice of the leaf is used to treat fever blisters. 
Chrysocoma ciliata L. 
(Asteraceae) 
Metjiesbos, ouwerfbos A decoction of the leaves is taken to treat stomach pain. 
Colpias mollis E.Mey. ex 
Benth. (Scrophulariaceae) 
Klipblom Ground up then chewed to help heal sores. 
Cotyledon orbiculata L. var. 
orbiculata (Crassulaceae) 
Pêpêbos, skaapiesbos The outer leaf surface is removed and placed directly on the skin to treat 
cracked lips. The leaf juice is used to treat fevers and sores in the mouth. 
Crassula atropurpurea 
(Haw.) Dietr. var. 
watermeyeri (Compton) 
Rooirantjie The outer cuticle of “rooirantjie” is placed on sore lips and fever blisters to help 




Crassula muscosa L. var. 
muscosa (Crassulaceae) 
Hoendervoet, volstruistoon The leaves are stripped off the stems and boiled in water. The resulting 
decoction is used to treat a range of general children’s illnesses. 




A decoction is taken by pregnant women to help expel the placenta and as a 
general tonic after giving birth. A decoction is also drunk for general body pains. 
Crushed fresh or dried leaves are mixed with animal fat or petroleum jelly to 
make an ointment or plaster to treat burns and sores. The plant can also be put 





Bergrenoster is found in the 
mountains and the Witrenoster is 
found in rivers, they are the same 
taxonomic species) 
A cooled decoction of “witrenoster” leaves is used to soak burning, itchy feet. 
The buds of the “witrenoster” are dried and crushed and the powder put into 
wounds to prevent infection.  
A decoction of “bergrenoster” is used to clean the kidneys, urinary tract and 
help expel phlegm from airways and placenta after giving birth. To treat spiritual 
illness or “vuil winde” (lit. “foul winds” meant to describe an evil spirit or an evil 
spell or curse), a decoction of “bergrenoster”,  “kalkoentjiebos” and “balerja” is 
made 
Diospyros austro-africana De 
Winter var. austro-africana 
(Ebenaceae) 
Kraaibos The juice of the unripe berry is swallowed to treat stomach pain and flatulence. 
A decoction of the leaves is drunk as an emetic and to treat intestinal problems. 
Dodonaea viscosa Jacq. var. 
angustifolia (L.f) Benth, 
(Sapindaceae) 
Xhoubie, toubee, wilde olino  A cooled decoction made from the leaves of “wilde olino”, “balerja”, “taaibos”, 
“salie” and “koorsbos” is taken every few hours to treat colds and flu. A 
decoction of the plant by itself is used to break fever. 
Eriocephalus brevifolius (DC.) 
(Asteraceae) 
Roosmaryn A decoction is used to wash skin to treat rashes and pimples. 
Eucalyptus camuldensis 
Dehnh (Myrtaceae) 
Bloekomblare/blue gum General home remedy. Placed on sore areas to relieve pain. Also used 
specifically to treat back pain and headaches. The leaves are boiled and placed 
on the areas that are sore. 
Euryops multifidus (Thunb.) 
DC. (Asteraceae), Othonna 
cylindrica (Lam.) DC 
(Asteraceae) and others 
Rapuis (there are five types of 




The resin of any “rapuisbos” can be dried, crushed and mixed with fat to make 
an ointment which is used to remove thorns or splinters. “Kallataaibosrapuis” 
leaves can be chewed to treat colds. 
Galenia africana L. 
(Aizoaceae) 
Kraalbos, geelbos Leaves may be used dry or fresh. When powdered they are used for toothache. 
A decoction is used to treat several ailments: sores on the head, aching legs, 
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bladder problems (when mixed with ostrich egg shell). 
Gethyllis afra L. 
(Amaryllidaceae) 
Koekemakrank The plant juice is used to treat bald patches as well as spots or blemishes on the 
skin. 
Hermannia amoena Dinter 
ex. Friedr.-Holzh. 
(Malvaceae) 
Jeukbos The leaves are boiled and strained and the decoction drunk for nausea. This 
liquid is also used to treat weakness resulting from long illnesses, especially 
diabetes. The leaves may also be crushed and mixed with petroleum jelly to 
make an ointment for insect stings. Used in treating “vuil winde” (lit. “foul 
winds” but meant to describe an evil spirit or an evil spell or curse). 
Hermannia cuneifolia Jacq. 
var. cuneifolia (Malvaceae) 
Agtdaegeneesbossie A decoction of the plant is used to help build strength in the body (presumably 
after illness) and as a tonic for general body pains and sores. 
Leonotis leonurus (L.) R.Br. 
(Lamiaceae) 
Wilde dagga Inhaled as smoke or snuff for respiratory problems. A tea may also be made 




Seepbos A decoction of the leaves of the “seepbos” combined with “ambeibos” and an 
unidentified plant, “xhoro”, is used to treat flatulence and stomach pain. 
Melianthus pectinatus Harv. 
subsp. pectinatus  
(Melianthaceae) 
Kruidtjie-roer-my-nie                 Dried plant material is ground with animal fat or petroleum jelly to make an 
ointment which is used to treat pain. 
Mentha longifolia (L.) Huds. Kruistement, ballerja A tea made from the leaves is drunk for colds and flu. This plant is also 
mentioned as in ingredient in several other combination medicines for a variety 
of illnesses. 
Microloma sagittatum (L.) R. 
Br. (Apocynaceae) 
Bokhoringbos, bokhoutbos The root is ground to powder and used in treating “vuil winde” (lit. “foul winds” 
but meant to describe an evil spirit or an evil spell or curse). 
Monoculus hyoseriodes (DC.) 
B. Nord. (Asteraceae) 
Dassiepisbos/Dassiegousblom General home remedy and tonic, illness unspecified 
Montinia caryophyllacea 
Thunb. (Montinaceae) 
Peperbos None officially, but the leaves apparently taste peppery, hence the common 
name. Some people believe the sharp taste indicates a good and “healthy” 
plant. 
Nicotiana glauca Graham 
(Solanaceae) 
Twaksboom The leaves are mixed with petroleum jelly or castor oil to make an ointment 
which is applied to treat pain. A bandage is wrapped over the ointment, and the 
ointment is reapplied until the pain subsides. 
Oncosiphon suffruticosum 
(L.) 




Old literature sates that “stink kruid” was used to treat stomach pains and as a 
plaster/poultice for scorpion stings, however this use does not seem prevalent 
in Paulshoek. 
Pelargonium alternans J.C. 
Wendl. (Geraniaceae) 
Skaapbos In the past, people would crush up the leaves with petroleum jelly or animal fat 
to make an ointment which would be applied to sores. 
Pentzia incana (Thunb.) 
Kuntze (Asteraceae) 
Wilde als A decoction of the leaves is used to treat high blood pressure. 
Polymita albiflora (L.Bol.) 
L.Bol. (Aizoaceae) 
Muisoor The leaf juice or a decoction of the leaves is swallowed to relieve stomach pain. 
Ruschia fredericii (L.Bolus) L. 
Bolus (Aizoaceae) 
Vygiebos The leaves are chewed and the juice is swallowed to help relieve stomach ache. 
Ruta graveolens L. 
(Rutaceae) 
Wynruik General home remedy and tonic with multiple uses. 
Salsola kali L. 
(Amaranthaceae) 
Khakiebos   A decoction of the plant is used to treat diabetes. 
Salvia dentata Aiton 
(Lamiaceae) 
Salie, bergsalie The leaves are chewed to treat influenza.  For a stronger medicine for colds and 
flu, the leaves of “salie”, “kalkoentjiebos”, “balerja”, “taaibos” and “koorsbos” 
are made into a decoction to be taken at 4 hour intervals. 
Sceletium tortuosum (L.) 
N.E.Br. 
(Mesembryanthmaceae) 
Kougoed Chewed to relieve hunger and to lift moods. Also a bit of the leaf juice is placed 
on a rag and given to babies to suck on to calm them down, help them to sleep 
and to relieve winds (indigestion). 
Searsia undulata (Jacq.) 
T.S.Yi, A.J.Mill. & J.Wen 
(Anacardiaceae) 
Taaibos Tea made from the leaves, sometimes in combination with leaves of “salie”, 
“balerja” and “koorsbos”, is drunk for colds and flu.  
Crushed leaves mixed with kidney fat are used to make an ointment or plaster 
for boils, ringworm and abscesses. 
Senecio cinerascens Aiton 
(Asteraceae) 
Vuurhoulap, handjiesbos The leaves are used to make a warm poultice which is placed on burns and 
wounds. The poultice is also placed on painful areas to reduce the ache.  
Seriphium plumosum L. 
(Asteraceae) 
Hotnoskooigoed General home remedy, mood enhancer, calmative and recreational material. 
Also used to calm down restless babies and children and for constipation. 
Stachys rugosa Aiton 
(Lamiaceae) 
Koorsbos, TB bos, Hen-met-
kuikens 
A cooled decoction of the leaves is drunk to break fevers. It is also combined 
with “balerja”, “salie”, “xhoubie” and “taaibos” in a decoction used to treat 
colds and flu. This plant is also used to help women to fall pregnant (treat 
infertility) and as a general health tonic during pregnancy. 
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Sutherlandia frutescens (L.) 
R.Br. (Fabaceae) 
Kalkoentjie, kankerbos, (klein) 
Jantjie Bêrend 
A cooled, strained decoction of the root, stalk and leaves is used to treat 
diabetes. A decoction of “kalkoentjie”, “salie” and “balerja” is taken for asthma, 
while a decoction of equal amounts of “kalkoentjie” and “balerja” is taken for 
high blood pressure. In the past, people would use the bush to treat cancer but 
details of the treatment are not known (or were not provided during this 
investigation). 
Termitomyces schimperi 
(Pat.) R. Heim  
(Lyophyllaceae) 
Ajoos (“termite mushroom”) The spores of this fungus are mixed with lard to make an ointment which is used 
to treat allergic reactions and rashes. 
Tetragonia fruticosa L. 
(Aizoaceae) 
Roosmaryn The leaves are mixed with other plants in a range of different medicinal 
preparations. 
Trichodesma africanum (L.) 
Lehm. (Boraginaceae) 
Brandnetel General home remedy and tonic, illness unspecified 
Tulbaghia violacea Harv. 
(Alliaceae) 
Wilde knoffel Made into a tea for colds and flu. The bulbs can be eaten “as is” for the same 
purpose.  
Viscum capense L.f. 
(Viscaceae) 
Voëlent Cooled tea made from the entire dried plant is drunk as a general health tonic 
and a decoction of the plant is used to treat diabetes. The same decoction is 
given to sheep and goats to help expel placenta after giving birth. 
 
Table 3: Additional plants used in Paulshoek for non-medicinal purposes 
Scientific name Local Paulshoek name Non-medicinal use 
Albuca spp. Slymstok The stalk and bulb are eaten by humans and livestock. 
Aloe dichotoma Mass. 
(Asphodelaceae) 
Kokerboom The hollowed out stem is covered with a lid and used to store food. It 
keeps things cool as a fridge would do. 
Antizoma miersiana Harv. 
(Menispermaceae) 
Bloubos, Dawids wortel (David’s 
root) 
Firewood and grazing. 
Antizoma miersiana Harv. 
(Menispermaceae) 
Inkbos The green leaves are grazed and it is used as kindling. 








Asparagus aethiopicus L. 
(Asparagaceae) 
Hakiesdoringbos Grazing. 
Asparagus rubicundus P.J. 
Bergius (Asparagaceae) 
Wag-’n-bietjie bos Grazing for goats. 
Ballota africana (L.) Benth. 
(Lamiaceae) 
Kattekruie Grazing. 
Carpobrotus edulis (L.) L. 
Bolus (Aizoaceae) 
Hotnotsvye The fruit is edible and is used to make traditional jam. 
Cheiridopsis denticulata 
(Haw.) N.E.Br. (Aizoaceae) 
Xhotsiama Grazing. 
Cheiridopsis namaquensis 
(Sond.) Hartmann (Aizoaceae) 
Xhotsiama, type noordepool Grazing. 
Chrysocoma ciliata L. 
(Asteraceae) 
Metjiesbos, ouwerfbos In the past, the entire dried bush was used as a broom to sweep hearths. 
People would also use it as cushioning when carrying firewood on their 
backs. 
Cotyledon orbiculata L. var. 
orbiculata (Crassulaceae) 
Pêpêbos, skaapiesbos In the past people would blow through the broken off flower stems to 
make a noise to draw animals out of hiding in order to hunt them. 




Grazing. It is pointed out that the leaves are believed to be toxic to 
livestock when they are covered with morning dew. 
Cyphia crenata (Thunb.) 
C.Presl. (Lobeliaceae) 
Bouroe/berg bouroe In the past the root/corm was eaten as a source of nutrition and 






is found in the mountains and the 
Witrenoster is found in rivers, but 
are presumably the same species) 
The leaves are put into smelly shoes to remove foot odours. 
Diospyros austro-africana De 
Winter var. austro-africana 
(Ebenaceae) 
Kraaibos Branches are used to make brooms for domestic use. 
Dodonaea viscosa Jacq. var. 
angustifolia (L.f) Benth, 
(Sapindaceae) 
Xhoubie, wilde olino  Firewood and grazing. Farmers at stockposts also use the branches to 
make shelters or screens for themselves and their animals. 
Euphorbia decussata E. Mey. Soetmelkbos Grazing. Provides a sticky “glue” that was used as bubblegum in the past. 
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ex Boiss. (Euphorbiaceae) 
Euphorbia mauritanica L. 
(Euphorbiaceae) 
Bittermelkbos Building shelters and kraals. 
Fockea edulis (Thunb.) 
K.Schum (Apocynaceae) 
Kambroo (two different species 
are called kambroo – berg 
kambroo and stink 
kambroo/bitter kambroo) 
“Berg kambroo” has an edible tuber. In the past, the tuber of the “bitter 
kambroo” was used to make a type of honey beer. 
Galenia africana L. 
(Aizoaceae) 
Kraalbos, geelbos Firewood, building of cooking shelters and grazing (only when green, 
otherwise the leaves cause illness in livestock). 
Gethyllis afra L. 
(Amaryllidaceae) 
Koekemakrank The fruit is eaten by humans and animals. 
Grielum humifusum Thunb. 
(Neuradaceae) 
Pietsnot/duikerwortel The root is eaten by humans and animals. 
Hermannia cuneifolia Jacq. 
(Malvaceae) 
Vet-en-brood bos Grazing. 
Hirpicium alienatum (Thunb.) 
Druce (Asteraceae); Pentzia 
incana (Thunb.) Kuntze 
(Asteraceae); Pteronia incana 
(Burm.) DC. (Asteraceae); 
Eriocephalus microphyllus DC. 
(Asteraceae) and others 
Xhibbie/krakrakie (There are ± 7 
species that are all called 
“xhibbie”) 
Grazing. Cushions were made from the “wool” of xhibbie (presumably E. 
microphyllus). 
Hoodia gordonii (Mass.) 
Sweet ex Decne 
(Apocynaceae) 
Bossielêr In the past, “bossielêr” was used as a veld food and to stop hunger pains 
Hypertelis salsoloides (Burch.) 
Adamson (Molluginaceae) 
Haas suuring Grazing. People can eat it too, but it has a sour taste. 
Larryleachia cactiformis 
(Hook.) Plowes (Apocynaceae) 
Bobbejaanseep  Used as soap for cleaning hands when out in the veld. 
Lebeckia sericea Thunb. 
(Fabaceae) 
Fluitjiesbos Firewood and grazing. 
Leipoldtia schultzei (Schltr. & 
Diels) Friedr. (Aizoaceae) 
Female Xhouroe Firewood and building cooking shelters. 
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Lycium ferocissimum Miers./  
Lycium cinereum Thunb. 
(Solanaceae) 
Large/small kirriedoring bush Firewood and grazing. Berries are eaten by humans. 
Manochlamys albicans (Aiton) 
Aell. (Chenopodiaceae) 
Seepbos Firewood and grazing. 




Soutslaai Grazing. In the past, people would use the plant to remove hair from 
animal skins in the process of making leather. The leaves combined with 
sand were used to scour clean pots and pans.  
Microloma sagittatum (L.) R. 
Br. (Apocynaceae) 
Bokhoringbos, bokhoutbos The flowers and pods are eaten by animals and humans.  
Monoculus hyoseriodes (DC.) 




Pepperbos In the past, the branches were used to make “canes” for administering 
corporal punishment to children. 
Nicotiana glauca Graham 
(Solanaceae) 
Twaksboom NOTE: leaves of N. glauca are used as a substitute for tobacco in many 
parts of South Africa due to their high content of anabasine, a nicotine-
like compound. However this use does not seem to be prevalent in 
Paulshoek. 
Ornithoglossum vulgare B. 
Nord. (Colchicaceae) 
Raap The bulb is fried and eaten. 
Pelargonium alternans J.C. 
Wendl. (Geraniaceae) 
Skaapbos Grazing. 
Polymita albiflora (L.Bol.) 
L.Bol. (Aizoaceae) 
Muisoor Firewood and building shelters (specifically cooking shelters). 




In the past, people would use the ash made by burning the leaves and 
branches in the process of soap making. The ash was also considered a 
good whitener for clothing (i.e. it was used as bleach). 
Quaqua mammillaris (L.) 
Bruyns (Apocynaceae) 
Ouroena/green ouroena/aroena Eaten in the past as a source of nutrition and hydration when out in the 
veld. 
Ruschia fredericii (L.Bolus) L. 
Bolus (Aizoaceae) 
Vygiebos Grazing. Also as a source of water when out in the veld for extended 
periods. 




Salsola kali L. 
(Amaranthaceae) 
Rolbos, donkiebos Grazing for donkeys. 
Salvia dentata Aiton 
(Lamiaceae) 
Salie, bergsalie Grazing. 
Sarcocaulon salmoniflorum 
Moffet (Geraniaceae) 
Kersbos  Firewood. 
Scirpus nodosus Rottb. 
(Cyperaceae) 
Matjies The reeds were cut down, bundled together and sew into mats. The mats 





Besembos (two types are 
recognised: “regular besembos” 
and “jagbesembos”) 
Grazing. Bundles of sticks from the “besembos” are used to make brooms 
and implements for threshing oats, wheat or rye. 
Searsia undulata (Jacq.) T.S.Yi, 
A.J.Mill. & J.Wen 
(Anacardiaceae) 
Taaibos Firewood and grazing. In the past, hot water was poured on crushed bark 




Ajoos (“termite mushroom”) In the past, the ointment was also used as sunscreen and as a substitute 
for makeup. 
Tetragonia fruticosa L. 
(Aizoaceae) 
Roosmaryn Grazing. 
Thesium lineatum L. f. 
(Santalaceae) 
Pennetjiesbos, witstorm Firewood. Sharpened shoots were used to pin out animal skins during 
tanning. 
Ubiquitous daisy plants e.g. 
Arctotis spp 
Gousblom Grazing. 
Unidentified bulbous spp. e.g. 
Babiana 
Uintjies (There are five types of 
uintjies: klipuintjies, 
bobbejaanuintjies, swartuintjies, 
tol uintjies and perdeklou uintjies) 
The bulbs of the different uintjies can be fried or boiled in goat milk and 
eaten. 
Unidentified but presumably 
some sort of Gazania spp. 
Botterblom Grazing. 
Unidentified Salsola spp. Ganabos Firewood. 
Various Oxalis spp. 
(Oxalidaceae) 
Suuring (There are four types of 
suurings: bobbejaan suuring, 
Livestock may eat “suuring” and people sometimes boil the bulbs in goat 
milk to make a type of porridge. 
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haassuuring, langbeen suuring, 
and skilpad suuring) 
Zygophyllum microphyllum 
L.f. 
/ Zygophyllum foetidum 
Schrad. & J.C.Wendl. 
(Zygophyllaceae) 







Figure 5: Average number of plants known to respondents 
 
plant. The exception was Ms. Lot who, during walks and conversations, could name and give uses for 32 
species. This is comparable to similar studies done, for example, in rural KwaZulu-Natal, where the 
average number of medicinal plants known to non-specialists was 8, ranging between 1 and 59 
(Dahlberg & Trygger, 2009). This indicates that the majority of people know a few plants and remedies 
while there are a handful of more knowledgeable non-specialists, most of whom had had some familial 
relationship to a healer e.g. daughter (as in Ms. Lot’s case) or spouse (in the KwaZulu-Natal example). 
Some people mentioned that plants could be used in combination, for example to make a better 
treatment for colds and flu (see entry “salie” in Table 2) and some plants had multiple applications e.g. 
“jeukbos” - Hermannia amoena - which is used to treat nausea, weakness and insect stings. This 
sentiment was echoed by the healers who said that lots of different plants are combined to make their 
medicines. The majority of people regard mixing plants like this to be more specialised knowledge, held 
by more experienced, often older, members of the community and in particular by the healers. 
3.2.2 Most common illnesses treated with plant medicines 
Participants in this study mentioned 27 illnesses that are commonly treated with home remedies. These 
could be grouped into 7 broad categories: 1) “colds and flu” 2) “digestive/bowel problems” (e.g. 
constipation, diarrhoea, excessive flatulence) 3) “aches and pains” (e.g. headache, body ache or 
toothache) 4) “respiratory problems” (e.g. asthma) 5) “women’s problems” (including healthcare during 
pregnancy, childbirth and urinary tract infections) 6) “wound care and sores” and 7) “other”. This last 
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category included a variety of non-specific minor ailments, which could be symptomatic of other 
illnesses, such as itchy feet, insomnia and bald spots. There were also a variety of ailments that only a 
few, or in some cases a single person, treat with medicinal plant home remedies. These include ailments 
such as skin problems and kidney problems, among others. Figure 6 gives a breakdown of all 27 illnesses 
mentioned during interviews. The size of pie slices is representative of the relative frequency with which 
that ailment was mentioned. 
The most common category of illness that people treat with home remedies is “colds and flu”, followed 
by “stomach problems”, and “aches and pains” of different types. Together, these constituted 83.1% of 
all illnesses mentioned. This is consistent with the results of Archer (1994), who found that the most 
common illnesses treated with medicinal plants in the greater Richtersveld area could be grouped into 
“colds and flu”, “aches and pains”, and “stomach ailments”. Other studies of different rural areas of 
South Africa highlight a similar trend. For example, Bhat & Jacobs (1995) found that in rural Transkei the 
most commonly treated illnesses could be grouped into “coughs, colds and fevers”, “stomach 
complaints” (including stomach ache, diarrhoea, and constipation), “wounds”, and other minor ailments 
similar to those mentioned in the Paulshoek survey (i.e. earache, toothache and skin problems). 
Dahberg & Trygger (2009) in rural KwaZulu-Natal also recorded the most common groups of illnesses 
treated with home remedies as “aches and pains”, “coughs and colds”, “stomach problems” and others 






Figure 6: Breakdown of all 27 illnesses mentioned during interviews. Size of pie slices are representative of how often the particular illness was mentioned. 
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However, in other areas of South Africa, illnesses falling into the “other” category in Namaqualand, 
which were the least frequently mentioned illnesses, were some of the most often treated 
complaints. For example, van Wyk et al. (2008) found that problems of the bladder, kidneys, 
stomach and back were the most commonly treated ailments in the south eastern Karoo region. 
Colds and “minor” ailments (similar to those mentioned in Paulshoek - skin problems, insomnia, 
diarrhoea, fever, earache etc.) were also treated with home remedies, but the majority of 
respondents mentioned those four areas (bladder, kidneys, stomach and back) as being the most 
commonly treated at home. Thring & Weitz (2006) found the most common illnesses treated with 
home remedies in the Overberg region of the Western Cape were arthritis, bladder and kidney 
problems, diabetes, fever and stomach problems. Perhaps people in these areas are more prone to 
these types of illnesses, for whatever reason, or perhaps there is simply a higher occurrence of these 
illnesses in this area because of some environmental or external influence not experienced in 
Namaqualand. 
Overall, it seems that the majority of people in Paulshoek, indeed in many rural South African areas, 
make simple home remedies to treat common illnesses that are self-evident and require no 
specialist knowledge to diagnose e.g. diarrhoea. Diagnosis and treatment of more serious or obscure 
illnesses and those with indistinct symptoms remains the domain of the traditional healer. Oom 
‘Kootjie’ Corjeus, one of the healers living in Paulshoek, described his method of diagnosis via 
consultation with the patient, listening to their description of the problem and sometimes involving 
a spiritual aspect such as using a pendulum to divine the diagnosis using his “God-given talent”. 
Once diagnosis is complete, he knows which plants to use to make a medicine to treat the problem 
and makes it by combining plants from the stocks he has on hand. In his experience, the most 
commonly treated illnesses were headaches, stomach problems, general pains, diabetes and more 
general treatment such as making plasters for wounds. He also assists with birthing and treats sick 
animals and pets.  The late Oom Gert ‘Julk’ Dirkse, a second healer living in Paulshoek at the time of 
this study, dealt more with illnesses resulting from spiritual causes. He, and many inhabitants of 
Paulshoek, believed that spiritual problems manifest as physical illnesses. His diagnosis was carried 
out through divining using specific items in an almost ritualistic fashion, and he claimed to be able to 
treat people over a distance, without needing to be near them. His method of diagnosis sometimes 
showed that the patient has a “regular” illness, not caused by spiritual means and, if this was the 
case, he would advise the patient to seek treatment from the clinic. Such illnesses include high blood 
pressure, diabetes, rheumatic pain, colds and sinusitis. 
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In general, surveys and interviews indicated most people would rather make their own medicine at 
home as the first course of treatment. Then, if the condition persists, visit a conventional doctor or 
the clinic. If the doctor or clinic is unable to cure the malady, the herbalist/traditional healer is the 
final resort. This is the same view that was expressed during Goldberg’s investigation (Goldberg, 
1998), but differs from the other areas in which traditional and Western health care systems coexist. 
For example, in a study performed in KwaZulu-Natal, villagers preferred home remedies as the first 
line of treatment, followed by visiting the traditional healer if home remedies didn’t work and then 
finally the Western clinic (Dahberg & Trygger, 2009). This sequence of treatment is also more 
common in areas that have limited access to Western health care e.g. rural Mozambique and other 
parts of Africa (Bruschi et al., 2011; Agyare et al., 2009), but may not represent preference for 
traditional healers over Western doctors as all options are not always available. 
3.2.3 Which species are used? 
The 50 medicinal plants mentioned by people in Paulshoek in the course of this study fell into 27 
different families. However, nearly half of the medicinal plants mentioned during the survey fell into 
four main families. These were (in descending order): Asteraceae, Lamiaceae, 
Mesembryanthemaceae, and Crassulaceae. These families are also some of the most speciose in 
Namaqualand in general. 
The trend of a few families dominating the list of medicinal plants is not limited to this instance in 
Namaqualand and it has been observed in other regions of South Africa as well. For example, in 
studies conducted in the Karoo, Transkei and Overberg regions, the majority of medicinal plants fell 
into the family Asteraceae (van Wyk et al., 2008; Bhat & Jacobs, 1995; Thring & Weitz, 2006), which 
is also the most frequently-cited family in this study in Namaqualand. While Asteraceae is the most 
commonly cited family in all of these areas, the actual genera and species used differ from region to 
region.  Another example of a dominant medicinal plant family is Lamiaceae, which is one of the 
most commonly used families for medicinal purposes across several different regions of South Africa 
(van Wyk et al., 2008; Thring & Weitz, 2006). Some species are used across the country e.g. Leonotis 
leonuris as they have wide distributions, while other species, and sometimes families, are region 
specific such as species of Solanaceae and Apocynaceae resulting in heavy weighting of these 
families in particular areas. Despite regional biases, Asteraceae and Lamiaceae seem to be among 
the most commonly used families for medicinal purposes generally across all regions.  
In Paulshoek, at first glance the particular species that are used seems to have changed over time 
suggesting a general shift in the pharmacopeia. Of the species mentioned in Archer’s study (1994), 
Goldberg’s study (1998) and this study, the only medicinally used species common to all lists were 
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Ballota africana, Sutherlandia frutescens, Mentha longifolia and Salvia dentata. If one only considers 
the study done by Goldberg (as this was done in Paulshoek and is more specific to the area than the 
broader study conducted by Archer) almost all plants were common to both lists. However, on closer 
examination it becomes apparent that in some instances the same genera were mentioned in both 
studies, but different species of those genera were listed e.g.  Pentzia, Pteronia, Rhus, Chrysocoma 
and Sceletium. This may indicate that species were not correctly identified during the previous study 
(some species are very similar in appearance and can’t be easily told apart when not in flower or 
without a microscopic investigation of certain features), or that very closely related species are 
interchangeable in home remedies. This is the practice in other areas e.g. KwaZulu-Natal where 
people said they had other species they could substitute into remedies if one was not available 
(Dahlberg & Trygger, 2009).  The most popular plants recorded during this study, i.e. those 
mentioned most frequently in interviews, were Sutherlandia frutescens, Dodonaea viscosa var. 
angustifolia, Searsia undulata and Salvia dentata. Interestingly, S. frutescens is not common around 
the village and grows predominantly in the mountain fynbos region of the Kamiesberg, and neither is 
D. viscosa. This suggests that people go out of their way to acquire these plants and share them 
amongst themselves. 
In contrast to local villagers, the healers possessed large dedicated sheds or huts to store lots of 
plant material sourced from all over the countryside, particularly from the fynbos region of the 
Kamiesberg. People often bring plants from other areas, and healers will share what they have 
amongst themselves. Most non-specialist villagers, however, do not stockpile in this fashion and 
collect only when needed. 
3.2.4 Are certain families preferred for making home remedies? 
The null hypothesis, H0, was that plants from different families have the same probability to be 
chosen to treat a particular illness. Illnesses mentioned in interviews varied broadly and for the 
purposes of this analysis, recorded medical conditions were classified into 11 broad categories 
termed “use categories”. A similar approach has been adopted in previous studies and these were 
used to guide the selection of use categories in an attempt to standardise the process (Salis-
Lagoudakis et al. 2011; Moerman & Estabrook, 2003; Douwes et al., 2008). The 11 categories were: 
cardiovascular  and blood related disorders e.g. high blood pressure (CAR), dermatological 
conditions (DER), gastro-intestinal conditions (GIT), General (including remedies described as “health 
tonics”) (GEN), gynaecological conditions and fertility treatment (GYN), neurological conditions 
(NEU), musculo-skeletal conditions (MUS), Oto-rhino-laryngology (ear nose and throat, including 
mouth ailments) (ENT), respiratory and pulmonary ailments (PUL), urinary, bladder and kidney 
conditions (URI), other e.g. diabetes (OTH). Table 4 lists the types of illnesses encompassed by each  
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Table 4: Indications and therapeutic categories used in regression analysis 
Use category Abbreviation Medical conditions included in this category 
Cardiovascular  and blood 
related conditions 
CAR Hypotension 
Dermatological conditions DER Burn ointment, allergy treatment (dermatological 
antihistamine), sooth rashes, insect stings, boils, 
abscesses, wound and “sores” treatment, ringworm 
cure, spots and pimple cream, fever blisters, treat 
bald patches, itchy feet 
Oto-rhino-laryngology 
conditions 
ENT Toothache, oral sores 
General conditions, not 
specifically identified 
GEN General tonic, building strength after illness, tonic for 
children, general post partum tonic 
Gastro-intestinal conditions GIT Emetic, sore or aching stomach, nausea (antiemetic), 
hunger pains, flatulence, diarrhoea, constipation 
(laxative)   
Gynaecological conditions and 
fertility treatment 
GYN Help expel placenta after giving birth, infertility, tonic 
during pregnancy, alleviate excessive menstrual 
bleeding 
Musculo-skeletal conditions MUS Body pains and aches, back ache, general muscular 
pain relief 
neurological conditions NEU Mood enhancer, fever (febrifuge), headaches 
(analgesic), sedative, narcotic 
Other, miscellaneous conditions 
not fitting the other categories 
OTH Hair treatment, diabetes, infant calmative agent, 
splinter removal, veterinary application, treatment of 
spiritual illness, cancer, haemorrhoids 
Respiratory and pulmonary 
ailments 
PUL TB, colds and flu, asthma, expectorant 
Urinary, bladder and kidney 
conditions 
URI Bladder problems, kidney and urinary tract infections 
 
category. It stands to reason that there is a causal correlation between the medical application and 
the bioactivity (as determined by underlying phytochemistry) which should be revealed by this 
analysis (Weckerle et al., 2011). As medicinal plant species were allocated to 11 use categories, 
regression analysis was performed for each of the 11 categories. For the sake of brevity, one case 
example is described in full and a summary of the remaining 10 is presented. 
3.2.4.1 Case example: use category “respiratory and pulmonary ailments” (PUL) 
 A regression analysis for the use category “respiratory and pulmonary ailments”, which includes TB, 
asthma and respiratory infections, was performed at the family level. The number of species used 
for this illness category was plotted against the total number of medicinal uses per family (Figure 7). 
From this we can see that the data point referring to the family “Lamiaceae” is an outlier, far off the 
regression line described by the equation y = 0.2993x - 0.1209. This indicates that species from this 
49 
 
family are utilised much more often to treat respiratory ailments than if species were selected at 
random for this purpose. This suggests that Lamiaceae is a family of interest for respiratory and 
pulmonary illnesses and species in this family may yield compounds related to the treatment of 
these types of illnesses. 
Residuals were calculated for all data points plotted in regression analysis (Figure 8). This confirms 
what was visually apparent from the regression plot - that Lamiaceae has a much larger residual 
value for this category of illness than any other family. Residual values also indicate that four 
families are tied for second position - Sapindaceae, Fabaceae, Anacardiaceae and Alliaceae. These 
families have slightly lower positive residuals than Lamiaceae and do not lie as far off the regression 
line. Hence, they are used marginally more than if plant use was random, but are not as preferred as 
species in the family Lamiaceae. Mesembryanthemaceae has the largest negative residual, indicating 
that species in this family are avoided when selecting plants to treat respiratory ailments. 
 
 
Figure 7: Regression analysis for Pulmonary medicines: the number of medicinally used species (MUSPE) vs. 





Figure 8: Residual values for the category PUL indicating that species of Lamiaceae are most preferred in this 
category. 
 
A summary of the largest positive and largest negative residual values is given for each of the use 
categories investigated (Table 5). From this summary we can see that species in the family 
Mesembryanthemaceae are consistently avoided, having the largest negative residual for four of the 
11 use categories. Families that have the highest positive residual in more than one use category are 
Fabaceae, Aizoaceae, Lamiaceae and Myrtaceae. This implies that species in these families are most 
often selected for the use categories in question. When the second largest positive residual is also 
considered other families also appear to be popular.  Asteraceae and Viscaceae are also selected 
more than once for different use categories. However, a seemingly contradictory pattern also 
emerges, with Lamiaceae being one of the most avoided families as well as one of the most 
selected. This may mean that species in this family are particularly active, and that that activity is 
suitable for treating certain illnesses but not others. The activity may in fact be contraindicative in 






Table 5: Summary of the major results for residual analysis performed on each use category. In some 
instances, two (or more) families were equally favoured for a single application. 
Use 
category 
Highest +ve residual 2nd highest +ve residual Lowest -ve residual 
CAR Fabaceae Asteraceae Lamiaceae 
DER Amaryllidaceae 
Anacardiaceae 
-  Lamiaceae 
ENT Aizoaceae Crassulaceae Asteraceae 






GIT Ebenaceae Menispermaceae Lamiaceae 








-  Scrophulariaceae 
OTH Fabaceae 
Viscaceae 
-  Lamiaceae 





URI Aizoaceae Asteraceae Lamiaceae 
 
 
Table 6: Comparison of growth types of medicinal plants (1998 vs. present study) 
Growth form Goldberg (1998) (%) This study (%) 
Large tree or shrub 26.7 28.0 
Small shrub 26.7 38.0 
Perennial herb 26.7 14.0 
Annual herb 6.6 4.0 
Succulents 13.3 12.0 







3.2.5 Which growth forms are most used? 
A wide variety of plant functional types or growth forms is used, as indicated by the diverse array of 
families recorded (Table 2). People do not limit themselves to using only shrubs or only succulents, 
for example, as a source of raw materials for making medicines. Despite the fact that the majority of 
plants fell into one of four main families (see section 3.2.3), there was still a diversity of growth 
forms within these families. Of the 50 medicinal plant species identified during this study, small 
shrubs were the most utilised growth form (38.0), followed by large trees and large shrubs (28.0%) 
(Table 6). This is consistent with other studies in other rural areas of South Africa. For example, 
Dahlberg & Trygger (2009) reported that trees and shrubs were the most commonly used growth 
forms in rural KwaZulu-Natal, with 34.0% of the plants used by local people and 47.0% of plants used 
by healers falling into this group. 
In Goldberg’s study (1998), it was reported that large trees, large and small shrubs and perennial 
herbs were equally the most frequently utilised for plant medicines in Paulshoek. While large trees, 
large and small shrubs and perennial herbs remained the most frequently used categories of growth 
form, there appears to have been a general shift to using more trees and shrubs and fewer perennial 
herbs. Perennial herbs dropped from 26.7% of the plants used (1998) to 14.0% (current study), while 
the use of both large trees and shrubs and small shrubs increased slightly (from 26.7% (1998) to 
28.0% (current study) for large trees and shrubs and from 26.7% (1998) to 38.0% (current study) for 
small shrubs). A decline in use was also evident in annual herbs, which dropped from 6.6% (1998) to 
4.0% (this study). Succulents made up approximately the same percentage of plants used in both 
studies (13.3% in 1998 vs. 12.0% current study). No geophyte use was recorded in 1998, but this 
study shows that 4.0% of the total number of medicinally used plants was comprised of geophytes. 
3.3     Plant use in practice 
During the survey, interviewees were asked about methods of plant collection and remedy creation 
in order to get a better idea of medicinal plant uses and practices. Of the people that said they use 
plant based home remedies, 30.3% said they only use medicine when it is prepared by someone 
other than themselves (friends or family, rather than a formal traditional healer). Therefore, 69.7% 
of people responding positively in the survey actually collect plants (are “collectors”) and know how 
to make medicine (are “preparers”). This is an increase from 14 years ago when Goldberg (1998) 
reported that 70.0% of people in Paulshoek used plant medicine, but only 36.0% of people actually 





Figure 9: Trends in ages of people collecting plants and preparing medicine, by age group 
 
substantial increase in the number of people who can identify plants, collect them and make 
medicine from them, suggesting that knowledge is being shared and new people are being shown 
how to collect and prepare medicine. 
The average age of collectors was 60 years (ranging between 35 and 80 years), while the average age 
of preparers was 62 years (ranging between 39 and 96 years). Goldberg (1998) reported that more 
than 80.0% of collectors were over 50 years old, and none were younger than 40 years old. Of the 
people in the current study that collected and prepared medicine, 78.8% of collectors and 81.8% of 
preparers were over the age of 50 (Figure 9). This does not represent a significant difference from 
the previously reported number. 
The majority of people that collect and prepare medicine fall into the 60-69 year old category. While 
the percentage of people over 50 is virtually unchanged since Goldberg, there has been a dynamic 
shift in the composition of this group i.e. the group does not only consist of the same individuals 
from 14 years ago. Even the youngest person recorded in the Goldberg survey would now be at least 
64 (assuming the youngest to be 40 years old in 1998) and the majority of the respondents from that 
study would now fall into the 60-69 year old and the 70-79 year old categories.  
There are still a substantial number of people in the 70-79 year old and 80+ age categories that 
prepare medicine (24.2% of the total), and it is often the case that a single older person makes 
medicine for more than one house. There are still some people (18.2%) in the 70-79 year old 
category that collect plants, but the number drops to only 3.0% for over 80’s, suggesting that people 
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are just physically unable to do it any longer. This feeling of being “too old” to collect plants was 
echoed by the healers. Gert Dirkse stated that he felt a bit too old to climb mountains to collect 
plants, and had enlisted the help of a younger man to do the job for him.  Oom Kootjie also said that 
he was too old and unwell to collect plants anymore, and that his personal health and inability to go 
into the veld had affected the number of people who wanted to be treated by him. 
The youngest person to be recorded in the previous study would now be at least 63. Thus, the fact 
that during this survey collectors and preparers were recorded in the 30-39 and the 40-49 age 
brackets means that younger people are starting to collect medicinal plants and to prepare the 
medicine themselves (rather than relying on the older generations). Even though there are only a 
very few younger people learning to collect and/or prepare plant remedies (6.1% of collectors and 
3.0% of preparers in this survey were under 40), it is a positive sign as there were no collectors or 
preparers in this category 12 years ago (Figure 9). Despite this positive trend, there were still no 
people in the 20-29 year old category that either collected or prepared medicine. 
3.4 How is knowledge acquired and transferred? 
In order to investigate how knowledge regarding medicinal plant use is acquired and transferred, 
people were asked where they had learnt about medicinal plants and, if they had learnt from 
another person, the gender of that person.  We already know that there has been an increase in the 
number of people with knowledge about medicinal plants over the past decade (see part 3 of the 
Results section of this chapter), and this section investigates how these people acquired their 
knowledge. 
3.4.1 How did they learn? 
Three quarters of respondents (75.6%) had acquired their knowledge from family members (mostly 
a parent or grandparent, rather than from a member of the extended family), 17.8% had learnt from 
other knowledgeable (non-family) members of the community and only 6.6% had learnt what they 
know from a traditional healer. One respondent said he was self-taught, through trial and error, 
although for lay people this was the exception rather than the rule and the majority of people were 
taught what they know.  
The opposite seems true for healers though, with both healers saying that they tasted plants and 
experimented on themselves to learn about plant properties. While Oom ‘Kootjie’ Corjeus said that 
he had been taught the basics by his father-in-law, he had expanded his knowledge through tasting 
plants from the veld and selecting them according to certain criteria e.g. bitter tasting plants could 
be used for stomach ailments and “harsh” tasting plants were good for treating headaches. As 
mentioned before, traditional healing involves a spiritual side, and this is evident as even though he 
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tastes and tests plants, he attributes the ability to correctly identify new plants as a “God-given 
talent”. Oom Gert ‘Julk’ Dirkse says that he taught himself but was also guided by God as he mainly 
treats illnesses with a spiritual cause. His method of selecting new plants for making medicine is, 
appropriately, more abstract. Once again, he says if he notices a new plant, he will taste the plant 
himself, and then he can tell if the plant will be good for medicine by drying it, crushing it to a 
powder and using a pendulum to divine its potential. Independent verification of such approaches to 
medicinal plant identification has not as yet been undertaken. 
Some people who use medicinal plants have no knowledge of them and this may be quite common 
(or an emerging trend). 30.3% of people only take medicine that other people make, and can’t 
identify plants or make medicines. 
3.4.2 Gender roles 
Gender does not appear to be as big a determining factor in the level or type of medicinal plant 
knowledge in Namaqualand as it does in other areas of South Africa. In Paulshoek, 28.9% of 
respondents learnt what they know about medicinal plants exclusively from men, and 17.8% learnt 
exclusively from women. The majority of people, 53.3%, gained knowledge from multiple sources, 
both male and female, suggesting that there is no gender bias one way or another when it comes to 
knowledge of plant-based, home remedies. This is in contrast to results from similar studies in other 
rural areas where women (mothers and grandmothers) were found to hold the majority of home 
remedy knowledge (Thring & Weitz, 2006; Gedif & Hahn, 2003; Hernández et al., 2003, 
Karunamoorthi & Tsehaye, 2012). While this was the case for knowledge of home remedies, formal 
traditional healers tended in most instances to be men (Dahlberg & Trygger, 2009; Dold & Cocks, 
2000). 
3.5     Perceptions of plant use and their role in the community 
An important aspect of this study was to investigate the role of medicinal plants in the community, 
and to evaluate commonly-held perceptions of them and their use. To this end, interviewees were 
asked a few set questions and then asked to comment freely on any aspect of medicinal plant use, 
healers, and “Western” medicine and to add anything else they felt was important. 
3.5.1 Clinic vs. veld - what is the relative role of each in healthcare? 
Many people perceive plants as a better treatment than medicine obtained from the clinic. 22.0% of 
people said plants were better medicine and it is “healthier” to use plants, mostly due to the belief 
that they don’t leave side effects. There is also the idea that plants collected from the veld provide 
the “best” (i.e. most effective) medicine. Despite this belief, many people are planting plants they 
use the most often in their gardens. 61.4% of people using medicinal plants collect the plants they 
56 
 
use from both the veld and from a cultivated garden on the homestead. 29.6% of people only collect 
plants from the veld, and a small amount (4.6%) only use plants grown in the garden (Figure 10). 
The traditional healers mostly use plants collected from the veld, and are aware of using this 
resource sustainably. Oom Gert ‘Julk’ Dirkse, for example, stressed that one should only break off 
pieces to use and not pull the whole plant out of the ground when collecting. He has also planted a 
few species in his garden, but the vast majority of the plants he uses are collected from far afield. 
Despite the prevalence of using plant medicine, 77.2% of people had also visited the clinic in the 
previous year, with the main reasons cited as “for the baby”, “for chronic medication”, “for 
diabetes”, or “for high blood pressure”. There appears to be a large number of people being treated 
for high blood pressure and diabetes in the village. No one in the survey had visited a traditional 
healer in the previous year. 22.8% of people had not visited the clinic either and relied entirely on 
home remedies for their health care. These people tended to be older people. 
100.0% of the people using medicinal plants said they would be interested in a workshop or learning 
more, especially about what other people had to say. Many also thought that it would be a good 









3.5.2 Widely held perceptions of medicine and medicinal plants 
Other comments made during the interviews could be grouped into four broad categories: 
3.5.2.1 Concern with the loss of traditional knowledge 
Many people were concerned that there has been a loss of knowledge about plants and 
traditional plant medicine as the most knowledgeable people have died and not passed on 
what they know. It was felt that “the researchers” came too late to preserve most of what 
was known, and now only a fraction of what was known in the past has been recorded. 
There was a general feeling that more was known in the past by grandparents and that the 
most knowledgeable people still alive are the older generations, but they often can’t 
remember everything as the memory is not too good as age progresses, and so their 
knowledge has also been lost. 
3.5.2.2 Concern that the traditional ways are no longer relevant in the modern day 
It was suggested that the tradition of using medicinal plants is dying out and just isn’t as 
important in modern life as they were to people in the past. One person said that in the past 
they used plants because they didn’t know about germs, disease and vaccinations. Now that 
more people have at least some understanding of basic healthcare (due to an improvement 
in education) there is little need for people to use plants when there is the clinic. There was 
also the perception that it is more difficult to work with plants nowadays as people think you 
need to register to work with plants and it’s just easier to avoid medicinal plants altogether. 
This belief is incorrect - while there may be a drive to formalise and regulate traditional 
medicine practice in South Africa, there is no such rule governing the use of home remedies 
using your own garden plants. 
3.5.2.3 Perceptions that plant medicine is better than Western medicine 
Several people felt that local plants make better medicine than that prescribe by the 
“Western” doctor. There was a variety of reasons given to support this idea - mostly that 
they are “safer”, cheaper and have no side effects. Different people said that plants are the 
secret to a long life; and plants work better than the medication from the clinic for illnesses 
like diabetes and high blood pressure. One person said that the doctor’s pills “calcify” his 
body, but plant medicine does not do this.  
3.5.2.4 Perception that plants and plant knowledge is valuable - should it be shared? 
Many of those people that use medicinal plants felt that other people don’t know the value 
of plants and the knowledge of how to make medicine. Most people were of the opinion 
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that the knowledge should be shared, particularly that “the researchers” need to share what 
information has been collated with everyone in the village, especially the youth. They were 
interested in learning what their neighbours use plants for and possibly discovering new 
uses for plants. People were, for the most part, happy that research is being done on the 
topic, but there was one exception. One person refused to share any information on the 
topic and insisted on being paid. He said it was his secret. However, people were more than 
willing to share and get involved as they see it as an opportunity for the youth and 
themselves to learn something about their traditions which they feel are dying out with the 
older generation. 
3.5.3 Will the youth learn traditional ways? 
People were divided on this topic. Half of the respondents felt that the youth will learn and continue 
the tradition while half suggested that they would not and that they have no interest. 100.0% of 
respondents said they felt there was benefit to having a workshop about medicinal plants and most 
were of the opinion that youth might use plants if they were told how to use them and were given 
more information at such a workshop. It seems that over the years more people have started 
thinking that the youth won’t learn, as the general perception during the Goldberg study in 1998 
was that knowledge would be passed on and the youth would be keen to learn. This belief may stem 
from the fact that both traditional healers have passed away recently, neither having trained an 
apprentice. 
4. Discussion 
4.1. The role and importance of plants in the lives of Paulshoek residents 
Plants play an integral role in the lives of Paulshoek residents, particularly for the purpose of 
healthcare. Many people view plants and knowledge of plant use as valuable, and wish to preserve 
their traditional healthcare system. So much so that a few residents were unwilling to share their 
knowledge of medicinal plants and believe that it should be kept secret from “outsiders”. This view 
however seems to be the exception rather than the rule in Paulshoek, but is often encountered in 
other rural areas. For example, in the Transkei it is believed that herbal preparations will lose their 
potency if the secret of how to make them is revealed to anyone from “outside the village” (Bhat & 
Jacobs, 1995). Plant use is so widespread in the Paulshoek community that 70.0% of residents use 
medicinal plants, and 22.8% of those use plant-based home remedies exclusively. This is in line with 
the World Health Organisation’s estimate that between 60 and 75% of the global population relies 
primarily on plants to fulfil their healthcare needs (World Health Organization, 2002), and slightly 
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more than 70% of South Africans living in rural areas do the same (Van Staden, 2008). Despite there 
being virtually no change in the percentage of people in Paulshoek using medicinal plants since 
Goldberg’s (1998) survey, subtle changes in the demographics of medicinal plant users have 
occurred over time. These changes hint at an underlying shift in attitude to, and use of, traditional 
methods of healthcare. For example, 18.2% of people interviewed in this study had used plant-based 
home remedies in the past, but no longer did so, suggesting that there are other forces at work 
influencing the use of medicinal plants in Paulshoek and it is a more complicated and delicate health 
care system than appears on first glance. 
While many people who use plant-based remedies view them as being “better than Western 
medicine”, there are a number of people who feel that plant medicine is old fashioned and 
outdated. This disparity in attitudes may be linked to age, with older generations preferring the 
“traditional ways”, and the younger generations, who have had more exposure to a Western lifestyle 
and culture, rejecting what they perceive as “the old ways” (Gedif & Hahn, 2003; Satimia et al. 1998; 
Karunamoorthi & Tsehaye, 2012). 
The average age of collectors and preparers recorded in this study was 60 and 62 years respectively. 
Also the majority of people collecting and preparing were over the age of 50, and none were in their 
20’s. This creates the impression that it is only the older generations involved in medicinal plant use. 
This, in turn, may be the reason that many children are not using medicinal plants as their young 
parents do not have the knowledge required to gather plants and prepare medicine. They are left 
with the situation where a few older people prepare medicine for several others. In fact, this study 
shows that 30% of people using plant medicine are only able to access medicine via a third party i.e. 
when it is made by someone else. It would seem, at least on first investigation, that the majority of 
plant knowledge is held by older people. 
Despite this, there are a handful of younger people learning to collect and/or prepare plant 
remedies. Once again there are some interesting dynamics at work. While not many young people 
(defined here as being under the age of 30) are learning about the medicinal value of plants, there 
has been a 100% increase in the number of people who can identify plants, collect them and make 
medicine from them since the 1998 study by Goldberg. This indicates that the older generations who 
hold the knowledge are sharing and teaching others, but mostly with other people who are at least 
50 years old, rather than with the younger generation in their 20’s. The reason for this may be that 
only those older than 50 are seen as responsible and mature enough to be taught the ways of plant 
use. Or it may just be that as people get older, health becomes more of a concern and this prompts 
them to learn how to make medicine for themselves, or at the very least how to treat a nagging 
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personal pain or illness (Dalhberg & Trygger, 2009). This demographic pattern of plant use seems to 
be common in some areas (Gedif & Hahn, 2003; Satimia et al. 1998; Karunamoorthi & Tsehaye, 
2012), while in other rural areas the situation is reversed. In some areas it is the “middle aged” 
people (30 – 50 years) who know the most about medicinal plants and their uses, while the older 
generations report that they have forgotten most of what they once knew (Dalhberg & Trygger, 
2009). There are also villages, for example in Kenya, where children pick up plant knowledge and 
treat their own ailments without adult supervision (Geissler et al., 2000). Neither of these situations 
seemed to be the case in Paulshoek. In future, the demographics of plant users in Paulshoek may 
shift to either one of these models, but there are currently no indicators that this is imminent. 
Gender does not seem to play as a big a role in the traditional medicinal systems present in 
Paulshoek as it does in other areas of South Africa, and globally. Both men and women are involved 
in plant collection and the preparation of medicines, which is different to other areas where it is 
mainly the women involved in preparing home remedies while the role of formal healer is often 
reserved for a man (Thring & Weitz, 2006; Gedif & Hahn, 2003; Hernández et. al, 2003; 
Karunamoorthi & Tsehaye, 2012). Dahlberg & Trygger (2000) suggest the reason for this distinction 
could be due to the traditional roles assigned to young adults, particularly in rural environments. 
Daughters tend to stay at home with their older female relatives to help with cooking, household 
duties and looking after the younger children. Male children are sent to tend fields or livestock. 
Therefore, women have a more immediate need to treat ill children at home and have the 
opportunity to learn home remedies while spending time with female relatives who pass on their 
personal experiences and knowledge. Tending livestock and fields tends to be a more individual 
activity, where the males would not have the opportunity to learn about the medicinal value of 
plants, unless they are apprenticed to a formal traditional healer.  
In the past in Namaqualand, women seemed to have had a better economic standing than they did 
in the late 20th century, particularly with regard to stock farming and land ownership. But the loss of 
land and changes to society that occurred in the 19th and early  20th centuries lead to increasing 
marginalisation of women to reproductive and domestic roles (Archer & Meer, 1997). In theory, all 
community members residing in the communal areas are entitled to residential and arable land plots 
if they wish to farm. In practice it was not that simple. Research undertaken between 2003 and 2005 
suggested that women who wanted to farm faced difficulties in obtaining land as land was 
traditionally passed along family lines from father to son or to another suitable male family member. 
There was a general reluctance to bequeath land to daughters. Commonly held opinions given in 
different villages in Namaqualand were that “fathers focus on their sons when it comes to farming 
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with the understanding that they will become farmers and household heads one day” and “a 
woman’s function is to support the husband, take care of the house, rear the children and do the 
washing and cook while livestock remain the men’s domain” (Kleinbooi & Lahiff, 2007). This echoes 
the findings of Dahlberg & Trygger (2000) and suggests that we should expect to see a similar 
pattern of female dominance in plant collection and medicine preparation, which is not what was 
observed. 
Despite these commonly held perceptions of gender roles, a study conducted in the communal areas 
of Namaqualand, including Leliefontein, indicated that many women played a vital role in the 
functioning of farms (Kleinbooi & Lahiff, 2007). Some women interviewed during the study consider 
them and their husbands as partners in a joint farming enterprise, despite the fact that the land was 
registered in the husbands’ name. A minority of women had been able to get land in their own 
names and engaged in small individual farming activities such as vegetable production. It may be this 
longstanding blurring of the “traditional roles” that lead to the observed pattern of relative equality 
between the sexes (at least in regard to medicinal plant knowledge) in Paulshoek. 
Over the last 15 years in Paulshoek there has been an increase in the number of female-headed 
households from 30% in 1995 to 44% in 2010 (Duijnstee, 2011). Since the head of a household is also 
the property owner, 44% of the property in 2010 was in the hands of women. In 1995 this situation 
wasn’t as prevalent. This may be because strong social convention dictated that land ownership was 
transferred through inheritance along male familial lines. Today, women have rights to land and it is 
easier for them to obtain land ownership. More women are informed of their rights to own land in 
the communal reserves and do so without having to rely on male family members. Women can apply 
directly to the municipality for access to land on which to farm. Even though this was legally allowed 
in the past, social conventions and tradition dictated that it was nearly always a man who acquired 
land in his name. Even if a wife acted as part owner, sharing all duties and responsibilities it was still 
the husband whose name was on the title deed (Kleinbooi & Lahiff, 2007). They also participate in 
community meetings and are involved in decisions that affect the village. Despite the fact that many 
women do accept the traditional role of home maker and child rearer, they are not resigned to these 
roles, and they have not been enforced. Not all men believe in the patriarchal system that, until 
recently, has dominated communal societies and this may have resulted in the observed pattern of 
gender in plant use (Kleinbooi & Lahiff, 2007). 
Paulshoek residents had different attitudes towards traditional healers and the use of home 
remedies which are viewed as very different practices despite both being part of the “traditional 
healthcare system”. Residents are confident in preparing simple plant remedies for day to day 
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ailments, but healers are considered as having specialist knowledge that the average person does 
not possess. This is most likely a reflection of the spiritual link that healers use in diagnosis and 
patient treatment. Still, home remedies are the first choice for most people, despite there being 
reasonably priced alternative healthcare options available. This preference is seen in other areas of 
South Africa, as well as globally. Healers are visited as a last resort, or for obscure ailments, and 
sometimes as the third option after Western medicine has been considered. (Dahlberg & Trygger, 
2009; Giovannini et. al, 2011). With home remedies, people have the power to manage their own 
healthcare, which is important to a society which has been historically displaced, dispossessed and 
excluded from decision-making processes regarding their own future. 
4.2    The influence of ethnobotany, education, and government policy on the use of 
medicinal plants 
Many people in Paulshoek are concerned about the effect that “modernisation” and “the West” are 
having on traditional methods of healthcare. Now that there are widespread campaigns aimed at 
educating people about health and hygiene and which promote Western medicine and healthcare 
services, people may be less inclined to use traditional plant medicines. It was mentioned during 
interviews that people had little knowledge about vaccinations and the ways in which various 
diseases are transferred between people before health education came along, and now that they do, 
they take their babies to the clinic and are more aware of unsanitary practices. In some parts of 
Africa there has been confusion once a village receives health education, particularly those areas 
where the belief in witchcraft persists. For example, in a study performed in the Kilombero District of 
south eastern Tanzania it was found that information given to the community regarding mosquitoes, 
malaria prevention and treatment had merged with local knowledge. Some people were under the 
impression that a witch could cause the symptoms of malaria without the person actually 
contracting the disease. So people did not always go to the clinic for treatment, despite the 
extensive education they received regarding malaria (Meula et al., 2002). This type of confusion does 
not seem to have happened in Paulshoek. People have assimilated health education and not 
misinterpreted the information. For example, people have been told about diabetes and what it is. 
The local name for the illness is “suiker siekte” (lit. “sugar sickness”) indicating an understanding of 
the disease and its causes. 
While the majority of parents with infants and young children do take their children to the clinic for 
vaccinations, it does not mean that they neglect the traditional plant medicines in favour of the 
clinic. While there is a definite and noticeable effect of health education and modernisation on the 
inhabitants of the village, it is not necessarily a negative one. It also does not necessarily mean that 
traditional ways will be abandoned. The introduction of pharmaceuticals does not have to displace 
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traditional healthcare systems and a complementary system may evolve. This was the case in rural 
India where Western medical information and treatment have been incorporated alongside 
traditional Indian plant medicine (Lambert, 1996; Minoncha, 1980). Sometimes the preference for 
traditional medicines is so strong that it survives long distance migration. For example, Bolivian and 
Peruvian immigrants in London purchased traditional Andean plant medicines from “Latino shops” 
that import dried plants from South America. Roughly 50% of the traditional medicines used in 
Andean countries is available in the UK through these shops. People still prefer the remedies of their 
home villages over the free Western healthcare available through the National Health Service 
(Ceuterick et al., 2011). Similarly Chinese migrants in the UK also prefer traditional Chinese 
medicines and visit the increasing number of traditional Chinese herbalists, acupuncturists and 
doctors practicing in Britain (Green et al., 2006). In South Africa, an increase in the use of traditional 
medicines, particularly dried plant materials, has been documented in some urban centres. 
Pietermaritzburg in KwaZulu-Natal is one such city where there is enough demand for medicinal 
plant materials to necessitate a large informal market (Ndhlala et al., 2010). The use of traditional 
medicine is not restricted to rural areas, and studies suggest that rural residents who migrate to 
urban centres continue to use traditional remedies (Marsland, 2007). However, the incidence of this 
trend in migrants from rural Namaqualand to urban centres in the Western Cape has not been 
investigated.  
In many instances, as in other areas of the world where Western medicine and traditional healthcare 
systems co-exist, people use a mixture of home remedies and Western pharmaceuticals (Etkin et al., 
1990; Meula et al., 2002; Giovannini et al., 2011; Giovannini & Heinrich, 2009; Calvet-Mir et al., 
2008; Scrimshaw & Cosminsky, 1980). In Paulshoek, 75% of people had visited the clinic for 
treatment in the year preceding this study, indicating that the majority of residents practice medical 
pluralism3. 
The extent of medical pluralism in South Africa is not well understood, but in other African countries, 
such as Kenya, studies suggest that it is a widespread practice (Nagata et al., 2011; Janzen, 1978). 
This is a cause for concern amongst medical practitioners as there may be unknown pharmacokinetic 
and pharmacodynamic interactions between medicines dispensed from the clinic and traditional 
plant remedies (Langlois-Klassen et al., 2008). In some cases, patients do not disclose their use of 
plant medicines and the interactions between pharmaceuticals, particularly antiretroviral agents 
(ARVs), and plants are of particular concern. Of the commercially available plant medicines, “African 
potato” (Hypoxis spp.) and “Cancer bush” (Sutherlandia frutescens) have been tested and in some 
                                                          
3
 Medical pluralism refers to the practice of drawing on both traditional and Western health care systems for 
personal wellbeing and treatment of illness 
64 
 
instances appear to inhibit ARVs (Mills et al., 2005; Nyika, 2007). In the case of nevirapine these 
traditional treatments cause increased uptake of the drug into the blood, resulting in incorrect 
dosage and possible toxicity (Brown et al., 2008). Most of the plants being used in Namaqualand, 
and in South Africa, have not been tested for drug interactions or safety (Nagata et al., 2011; Street 
et al., 2008). In Paulshoek in particular, there are a number of people who mentioned that they 
receive chronic medication for high blood pressure and diabetes, among other illnesses. The 
interactions between medicinal plants and these drugs have not been studied and could be a cause 
for concern as the village relies increasingly on pharmaceutical products delivered by the mobile 
clinic (Ernst, 2000). The danger of plant-drug interaction is not limited to rural villages. The use of 
Complementary and Alternative Medicines (CAM, which covers a range of treatments includes 
aromatherapy, herbal medicines etc.) is on the rise in developed nations such as the UK. Products 
remain largely unregulated, non-standardised and untested for interactions with each other or with 
pharmaceuticals. Such products are available to the public without supervision or assistance from a 
health care professional and people similarly do not disclose their use (Wahlberg, 2007). In some 
areas where medical pluralism exists, for example, in Thailand, traditional treatments have been 
adopted by Western practitioners. Hospitals offer treatment with traditional remedies, and a 
combination of traditional and “modern” hospital staff provide treatment. This combination of the 
two healthcare systems supposedly allows the “safer” concomitant administration of herbal and 
pharmaceutical preparations. At the very least it ensures that doctors are aware of the exact 
treatment a patient has received (Chotchoungchatchai et al., 2012). A similar system might be 
successful in South Africa, but would take many resources, much careful management and careful 
integration to achieve.  There is still the view that the isolated active compounds from traditionally 
used plants have a weaker ability to heal than extracts created from whole plants, or plant parts 
(Rodriguez-Fragoso et al., 2008). So, perhaps this is not feasible considering the current state of 
South Africa’s public health system infrastructure, but it is something that might be an appropriate 
goal.  
Another effect of increasing Western influence on traditional medicinal plant use was investigated in 
a previously isolated village in rural Mexico (Giovannini et al., 2011). The study determined that 
there is a negative association between increasing levels of schooling and the use of medicinal 
plants. A similar trend has also been observed in African villages (Satimia et al 1998; Gedif & Hahn, 
2003; Karunamoorthi & Tsehaye, 2012). This may also be true in Paulshoek. Education levels rise as 
education facilities become incorporated into the national system. Young adults in Paulshoek are the 
most educated (having on average twice the number of years of schooling that their parents have), 
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and are also the age group least involved in collecting, preparing and using plant medicine. The long-
term of effects of this remain to be seen. 
In addition to increased levels of education, is an increased level in the standard of living, as a result 
of government projects to uplift the poorest communities by building houses and roads and 
introducing services such as sanitation and electricity. Better sanitation and clean water means that 
fewer water-borne diseases such as diarrhoea and bacterial infections are likely to occur. This means 
that there may be less of a demand for home remedies to treat these ailments, which in turn may, in 
coming years, lead to a decreased reliance on medicinal plants and a loss of traditional knowledge of 
these treatments. In addition, now that many houses have electricity people can use electrical or 
gas-powered cookers instead of having to rely solely on wood-fuelled fires in outdoor cooking 
shelters. This means that there is less smoke inhalation and possibly in the future we will see fewer 
incidences of asthma and other respiratory illnesses. Many people still use fires, and the damage 
caused by years of smoke inhalation cannot be undone in a few years. Perhaps the younger 
generations will see a decline in respiratory problems in the coming years. 
The presence of the clinic, increased levels of education and better amenities are not the only 
influences that may affect traditional healthcare systems. Government policy is also a factor. The 
government has proposed the regulation of medicinal plants, healers and the trade in medicinal 
plants mostly in response to concerns regarding the safety of traditional medicines and the 
overexploitation of raw resources. Many cases of poisoning are caused by the incorrect use or 
preparation of plant medicines, and usually involve self-administration or administration to children. 
Between 1991 and 1995, 43% of traditional medicine poisoning cases treated in Johannesburg 
hospitals were caused by plants (Stewart et al., 1999). Similar trends are observed elsewhere and 
are not limited to developing or rural areas. For example, poison control centres in the United States 
of America reported that for the period 2000 – 2007 “dietary supplements, herbs and homeopathic 
products” was the highest group of products associated with poisoning requiring hospitalisation 
(Vassilev et al., 2009). 
Other concerns regarding traditional medicines which may influence government policy and the use 
of plants are incorrect plant identification, heavy metal contamination and microbial contamination. 
In a test of dried plants sold in various African markets for the purpose of treating various illnesses 
with herbal teas, it was found that many of them contained large microbial concentrations at levels 
that would be unacceptable to commercial food supplement manufacturers (Street et al., 2008). In 
the USA, herbal preparations and traditional medicines are regulated as dietary supplements. The 
United States Federal Drug Administration (FDA) requires that proper controls are in place to ensure 
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these products are processed in a consistent manner and meet certain quality standards. However, 
manufacturers do not have to register their products with the FDA and so many remain unregulated 
(Jordan et al., 2010).  
Heavy metal toxicity is also a concern in South African medicinal plants, some of which are known to 
accumulate certain metals (Street et al., 2008). For example, Senecio coronatus (Thunb.) Harv. 
(Asteraceae) accumulates nickel which can cause allergies, lung fibrosis and cancer (Przybylowicz et 
al., 1995; Kasprzak et al., 2003). There is also the problem of adulterated or counterfeit products 
reaching the market. South Africa needs government regulation of traditional medicines to ensure 
quality, safety and authenticity. Particularly if traditional medicines are in future to be incorporated 
into treatment plans offered by hospitals, as is the case in Thailand (Politi et al., 2009; Heyman & 
Meyer, 2012). Unfortunately, comprehensive safety and efficacy data on traditional medicines are 
lacking, and will take time and money to obtain (Springfield et al., 2005). 
However, the testing and standardising of traditional medicines is difficult and could have a 
significant impact on the current traditional healthcare system and the way it is often practiced. Yet 
one cannot ignore the poisonings caused by misinformation and the possible microbial or heavy 
metal contamination of products intended to heal. There must be a way to provide safe and 
efficacious traditional medicines without changing the system so radically that it loses its identity 
and the characteristics that define it. In this spirit, the government has begun attempting to regulate 
the system with the proposed Traditional Health Practitioners Bill of 2003 (Government Gazette No. 
24704, 2003). The proposed legislation would require all persons involved in treating patients with 
traditional medicines to register. It also promotes a regulatory framework which will ensure the 
efficacy, safety and quality of traditional health care services. As yet this has not been passed. A 
subsequent Draft National Policy on African Traditional Medicine in South Africa appeared in 2008, 
which aimed to provide a framework for the institutionalizing of African Traditional Medicine in the 
South African healthcare system, but this too has yet to be passed into legislation (Draft National 
Policy on ATMSA, 2008). Registration would provide practitioners with credibility, provide a forum 
for healers to talk to one another and would also allow only those with the necessary skill to prepare 
medicines. This sounds like a good idea when faced with child deaths and poisonings, but it would 
make home remedies illegal and would effectively halt the use of traditional medicines in villages 
such as Paulshoek. It may also have the negative effect of creating a black market in traditional 
medicinal plants for those practicing without a license, effectively criminalizing those people it 
aimed to protect. Even though the WHO has called for the integration of traditional medicines into 
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mainstream national health systems, this may be difficult to achieve in practice. At the very least it 
will take a long time and more research is needed before a suitable solution is reached. 
4.3 Conservation, bioprospecting and the value of medicinal plants  
The value of medicinal plants to the people of Paulshoek is unquestionable. However this resource 
may be under threat in several different ways, including threats caused by the very same people for 
whom the plants are so important. In Paulshoek, as in many areas of South Africa and the world, the 
most common practice is to prepare remedies using plants collected from wild populations 
(Zschocke et al., 2000). A large number of these are non-renewable resources i.e. when material is 
collected for the purpose of medicine preparation, the entire plant (or a part vital to its survival e.g. 
roots, bulbs or bark) is collected (Fennell et al., 2004a). This practice puts pressure on wild 
populations and as the demand for plant medicine grows, becomes largely unsustainable. In 
Paulshoek, many medicines are created using leaves alone, and harvesting does not kill the plant or 
remove it entirely. However, alternatives to wild harvesting may still need to be provided if the 
practice is to continue or to increase. 
In Paulshoek, people are becoming aware of the need to preserve plants. During an interview with 
one of the healers, the point of not damaging the plant and only taking what is necessary was 
repeatedly stressed. People also plant gardens near to their houses to provide them with some of 
the more commonly known medicinal plants rather than collect from the wild. 61.4% of people said 
that they collect plants from both the veld and from a cultivated garden, which reduces the pressure 
on wild populations. In a similar study conducted in the Overberg region of the Western Cape 
province of South Africa, 70.0% of participants said they get their plant materials from their own 
gardens (or from roadside verges) thereby greatly decreasing the pressure on wild populations 
(Thring & Weitz, 2006). In some areas stricter, more conservative healers only use wild-grown plants 
as they consider that wild plants “have more power” or are more potent than their cultivated 
counterparts (Vermeylen, 2008). But people in Paulshoek don’t seem to be too concerned that they 
are essentially cultivating the plants in their gardens to make medicine, and still use them in the 
same way regardless of whether wild or garden grown. However, this cultivation for individual 
personal use is very different to commercial cultivation, which has been proposed as an alternative 
source of medicinal plants. Under cultivation situations, environmental conditions can be different 
to those that would normally be experienced by a plant in the wild. These changes affect the 
biochemistry of cultivated plants, which is of great importance when the plants are being grown for 
medicinal purposes (Crozier et al., 2006). Studies done by Fennell et al. (2004b) showed that plants 
under small-scale cultivation had lowered antihelmintic and antibacterial activity when compared to 
wild harvest plants. In other instances, however, cultivated species that had been irrigated actually 
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showed increased antihelmintic activity, making it more potent. Secondary metabolite production 
can also be significantly altered with the addition of fertilisers containing nitrogen and phosphorus. 
Genetic, ecological and environmental conditions all need to be consistent and regulated (Bopana & 
Saxena, 2007). All of these factors make it difficult to prepare plant medicines in any standard way 
without strict quality control and chemical composition determination at multiple points in the 
growth phase of those plants.  
The cultivation of medicinal plants as an alternative to wild harvesting also faces other challenges 
besides the biochemistry changes caused by cultivation. For example, strict legal requirements will 
be needed. Recently, the South African government passed a law requiring anyone developing a 
commercial product using natural resources (defined to include plants, animals and genetic 
resources4), to obtain a bioprospecting permit (Government Gazette No. 26436, NEMBA, 2004). 
Essentially, this piece of legislation was intended to prevent unconstrained access to bioresources, to 
protect the intellectual property rights of indigenous communities and to enforce the need to use 
South Africa’s local bioresources sustainably. Unfortunately, it also had the knock-on effect of 
preventing would-be farmers from cultivating medicinal plants, among other effects. By shifting to a 
cultivated alternative the conservation and protection of medicinal plants is still possible, but it is a 
lengthy process to obtain a permit, and in some cases nearly impossible. This remains a contentious 
issue, with many strong opinions on all sides (Crouch et al., 2008). 
Another alternative to wild harvesting with its potential population-threatening methods of 
harvesting is to use substitute plant parts or where feasible, substitute plants. However, 
experiments done by Zscocke et al. (2000) showed that plant part substitution is species-dependent. 
In some instances roots and twigs of the same plant contain very different chemicals. In other plants 
chemicals from different parts of the plant may be nearly identical and parts can be used 
interchangeably in medicine preparation. More common than part substitution is substitution with a 
different species, usually a closely related member of the same species or family as the traditionally 
used plant (Dahlberg & Trygger, 2009). For example, a similar smelling plant may be substituted for a 
species with a particular aromatic bark. This adaptation to what is available is evidence of the 
“dynamic pharmacopeia” in action, which is essential for the continued survival of these traditions. 
These substitutions may also occur unwittingly when a very similar looking species is misidentified as 
a medicinal plant.  There is no evidence for a similar plant substitution occurring in Paulshoek, 
although it is not impossible that this has happened or will happen in the future. 
                                                          
4
 Commercial products based on natural products are not limited to the pharmaceutical industry, but also 




The medicinal plants of the Leliefontein region are also exposed to the threat of landscape 
degradation due to factors such as overgrazing.  Overstocking on communal rangelands has led, in 
many areas, to the loss of vegetation cover, the increase in woody species such as Acacia karoo and 
Prosopis spp., and conversion of previously diverse vegetation to areas of limited biodiversity 
dominated by stands of Galenia africana and other pioneer species (Hahn et al., 2005; Hoffman & 
Rhode, 2007). This potential reduction is species, particularly those palatable species of Lamiaceae 
and Geraniaceae, could in future affect the ability of people to practice traditional healing. Goldberg 
(1998) found that grazing had no significant impact on the abundance of medicinal plants, but the 
study did not indicate the impact on diversity of medicinal plants. The impacts of grazing on plant 
diversity and soil productivity in general have been studied (Allsopp, 1999; Anderson & Hoffmann, 
2011; Anderson & Hoffmann, 2007; Simons & Allsopp, 2007), but the impact on medicinal species 
specifically is not known. While changing land use practices that have been in place for hundreds of 
years may not be feasible, at least without major social restructuring, if at all, individual cultivation, 
plant substitution and care when harvesting wild populations may be necessary to ensure a future 
for traditional medicine in the Paulshoek area. 
4.4 The changing pharmacopeia and the illnesses it treats 
Over the centuries the pharmacopeia of Namaqualand has changed to accommodate the needs of a 
changing populace (Grenier, 1998; Dold & Cocks, 2000, Berkes & Turner, 2006). In order to remain a 
contemporary alternative or addition to Western medical healthcare systems, the healers and the 
pharmacopeia must remain adaptable to the requirements of the people. This means adapting to 
treat new diseases, as well as adapting to changing environmental conditions (such as the effects of 
land degradation and climate change). For example, studies show that the Namaqualand area will 
experience a general shift to wetter summers and dryer winters over the next 100 years, more 
typical of the rainfall regime of the Nama-Karoo (MacKellar et al., 2007). Adaption has happened in 
the past. For example the integration of Nama and Dutch plant remedies to treat new diseases such 
as TB and when some of the new plants naturalised at the Cape were included into the local 
pharmacopeia. These are vital steps in maintaining the adaptability of the traditional medicinal 
system. In Paulshoek, we see evidence of this adaptability not only in the healers, but also in the lay 
people. 
A wide variety of plants is used, but many are used infrequently, with only a handful being the most 
commonly used. Most people use an average of seven medicinal plants to meet their basic 
healthcare needs. Despite this rather limited use, this study suggested that the total number of 
plants known to be useful as home remedies in Paulshoek had increased in recent years. While some 
of the increase may be explained by a more robust investigation technique uncovering more plants 
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and more uses, but it is doubtful that this could explain the large increase in the number of plants 
used. This could be indicative of a pharmacopeia in flux - that new plants are being added, but they 
are not yet as widely used as the reliable staples people have come to trust. We know that in other 
areas plants may be substituted if the preferred ones are not available, and there is documented use 
of alien and weed species for medicinal purposes (Dold & Cocks 2000; van Wyk, et al., 1997). This is 
common in other areas of South Africa, and there is limited evidence of this in Paulshoek. For 
example, Nicotiana glauca is used in Paulshoek to treat pain and as a bandage. But not only is it not 
indigenous to the area, it is not indigenous to South Africa at all, having been introduced from South 
America (Dold & Cocks, 2000). Adopting new plant species into the pharmacopeia seems to be 
largely the domain of formal traditional healers (McMillan, 2004). During interviews, the healers 
described how a new plant would be chosen. This ability to determine whether a plant has potential 
healing power is still seen as a “talent” with spiritual associations and it is not likely that non-
specialists who only prepare home remedies would be able to do this. This is a concern, since all of 
the resident healers in the village have died and there may be no one left to add new material to the 
pharmacopeia which is likely to remain relatively static under such circumstances.  
Despite the variety of plants used, nearly half of them fell into one of four families. Asteraceae, 
Mesembryanthemaceae, Lamiaceae and Crassulaceae. These families are also some of the most 
speciose in Namaqualand in general, and it is apparent that they would be the most commonly 
represented. While different species are used in different areas (mostly due to species distribution) 
the fact that the majority of medicinal plants fall into the same families could indicate that there is 
some common biological activity or chemical property at a family or genus level that makes them so 
popular for treating illness (Harborne, 1998).  
Plant selection is not random, and it is not just the most common plants that are used - plants are 
actively sought out. Certain families and species are specifically chosen for certain remedies. 
Regression analyses for traditionally used medicinal species in the Paulshoek area showed that 
Fabaceae, Aizoaceae, Lamiaceae and Myrtaceae were preferentially selected for more than one use 
caterogy, while Amaryllidaceae, Anacardiaceae, Malvaceae, Ebenaceae, Melianthaceae, Solanceae, 
Menispermacae and Sapindacea were preferred over other families for one of the 11 use categories 
investigated. When the second most preferred families are also included, Asteraceae and Viscaceae 
emerge as second best in more than one use category. This implies that species in these families 
should be good candidates for screening as they are most likely to contain bioactive molecules. 
Similar results have been found in studies performed in other areas of the world. Seeing as some of 
the families in this study are largely endemic to the region, they may not appear in lists of “hot 
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families” from other regions. Nonetheless, some families are consistently preferred for traditional 
medicinal treatment. Asteraceae and Lamiaceae are usually among the top medicinal families used 
(Belize - Treyvaud Amiguet et al., 2006; Mexico - Leonti et al., 2003; India - Kapur et al., 1992, 
Ecuador - Bennet & Husby, 2008). 
Lamiaceae, Asteraceae, Poaceae, Fabaceae, Malvaceae, Rutaceae, Apiaceae, Brassicaceae and 
Rosaceae dominate the list of most used medicinal species in South America (Bennett & Prance, 
2000). Weedy families such as Lamiaceae, Solanceae, Malvaceae and Urticaceae were most 
preferred in the medicinal flora of Campania, Italy. (Weckerle et al., 2011) and similar results were 
found for the flora of Sicily and Sardinia (Leonti et al., 2009). 
Kapur (Kapur et al., 1992) did a similar analysis of the medicinally used flora of India to see which 
families were preferred in general, rather than for any specific use category. The top family was 
Asteraceae, then Lamiaceae and Solanaceae; which is consistent with previous studies. However, 
they also found that Malvaceae, Scrophulariaceae, Menispermaceae, Geraniaceae, Crassulacae and 
Rutaceae were marginally preferred - similar results to those found in this study. Zygophyllaceae, 
Iridaceae, Chenopodiaceae, Oxalidaceae, Apocynaceae, Sapindaceae, Brassicaceae, and 
Anacardiaceae were least preferred (Kapur et al., 1992). In a study on medicinal species performed 
on in South Africa medicinal species in general “hot” orders were identified as Malpigiales, Fabales, 
Gentianales, Asterales, Solanales, Malvales and Sapindales (Douwes et al., 2008). 
In this study, Mesembryanthemaceae was consistently avoided for traditional use. At first this seems 
anomalous, as the MIC assays showed that mesemb species were the most active in two of the three 
assays performed. In addition they are largely succulent species, which was linked to certain types of 
activity e.g. protease inhibition. But avoidance may be explained by the fact that species of 
Mesembryanthemaceae have strong activity, but the activity causes negative side effects for the 
illness being treated and are thus avoided for certain types of illness. The same may be true for 
species in the family Lamiaceae. These species are preferred for some types of illness e.g. pulmonary 
ailments, but avoided for others e.g. dermatological conditions. 
Even though the species are mostly from the same families, a wide variety of plant growth forms 
was recorded. Comparison with Goldberg’s (1998) survey also suggests that there has been a 
general shift to using more trees and shrubs, and fewer perennial herbs. The shift may directly 
reflect a change in the composition of the vegetation surrounding Paulshoek, or could indicate 
subtle changes in attitudes towards medicinal plants. As noted earlier, there has been a general 
decrease in vegetation cover in communal areas due to overgrazing, and an increase in annuals and 
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invasive species, particularly along river courses (Hoffman & Rhode, 2007). With large areas 
becoming covered in Galenia africana, previously abundant perennial and annual herbaceous 
medicinal plants may become scarcer, forcing people to use alternatives. As stated previously, while 
grazing has not seemed to impact on medicinal plant abundance in the past (Goldberg, 1998), the 
effect of grazing on medicinal plant biodiversity has not been fully investigated. People may have 
also just simply shifted to a more reliable source of medicinal plant parts i.e. shrubs rather than the 
rainfall-dependant annual and perennial herbs. Even if rainfall is sufficient for a good yield of 
annuals, they are not available year round and have to be located every year. While this is not a 
problem for formal traditional healers, who stockpile dried plants for later use, it may be a problem 
for the non-specialist user as they don’t tend to store plants and have to collect as required. Longer 
lived, larger bushes and succulents, which one can return to year after year without fail, become a 
much more attractive and reliable option. The ease of use and reliability may also have resulted in 
the large percentage of people (61.4%) using plants grown in their gardens. The use of geophytes is 
mostly described by healers only and most home remedies do not usually make use of bulbs or 
corms. During interviews some people seemed wary of bulbs as there have been poisonings in the 
village related to ingestion of toxic geophytes. Locating and identifying geophytes is also much more 
of a specialised skill than locating shrubs, and remains largely the domain of the traditional healers. 
Despite this, this study recorded a 4% increase in the use of geophytes, indicating that non-
specialists are becoming more comfortable identifying these species. This could imply that what was 
once the preserve of a few formal healers is now becoming more common knowledge. 
4.5 Transfer of knowledge (within the community and between the community and 
outsiders) 
The transfer of knowledge of medicinal plants is vital if traditions are to continue. The transfer of 
knowledge may be within communities, between generations, or to outside entities, such as 
researchers and ethnobotanists. The results of this study indicate that knowledge is being shared 
among generations, and that new people are being shown how to collect and prepare medicine. 
However, few being taught are under 40 years old. It would seem that the general concern in the 
village that the “youth” will not adopt the traditional ways is one to seriously consider. People are 
divided on whether the younger people want to learn methods of traditional plant use at all. The 
younger generation have had the importance of education instilled in them, so much so that most 
complete their schooling, at least up to Grade 10 (the minimum compulsory level of schooling) 
which was not the case a generation ago (Duijnstee, 2011; Rhode et al., 2003). However, as 
mentioned previously, increasing levels of education appear to correspond to a decrease in use of 
traditional medicines (Giovannini et al. 2011; Satimia et al 1998; Gedif & Hahn, 2003; Karunamoorthi 
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& Tsehaye, 2012). In other instances the preference for traditional medicines survives thousands of 
kilometres after immigration. It would seem that the choice to use traditional medicines is 
influenced by more subtle factors beyond the reach of this study. Plant use is influenced by a range 
of social and cultural factors that change over time. Education, treatment availability, history of 
family use and personal knowledge of plants all play a role, but it seems to be more of a personal 
choice of which system to use rather than any one factor being a direct indicator of future 
preference.  
Knowledge also flows from formal traditional healers to lay people in the village. While there are 
many secrets not revealed to non-healers, some are passed on and become common place. Of the 
people interviewed for this study, only 6.6% said they had been instructed by a traditional healer. 
However, none of the lay people using medicinal plants had unique remedies that they themselves 
had created.  
Knowledge doesn’t only transfer within the village. Researchers are welcomed into the village to 
record traditional knowledge and interview healers, as people value their traditions and believe 
researchers are able to assist in preserving what they know. This is seen as important as many 
believe the traditions are dying out - especially since the formal healers living in the village have 
recently passed away, neither leaving behind a trained apprentice to replace them. With no formal 
healers in the village, the traditional knowledge of medicinal plants is entirely in the hands of the 
people and this can easily be lost as people move away or they themselves pass away. But in the 
process of recording, collating and documenting knowledge, something is transferred back. People 
are reviving old uses that had been “forgotten” but have been “rediscovered” by researchers 
investigating historical usage, and subsequently shared amongst villagers. An emerging trend is that 
people in other rural villages similar to Paulshoek are using published reference books of medicinal 
plant information, such as those of Gericke or Van Wyk (van Wyk et al., 1997; van Wyk & Gericke, 
2000), to create home remedies that may not have been used in those areas for many years or, in 
some cases ever, before. This may be beneficial to those people using traditional remedies, but it 
does create a situation where plant use becomes less regional, traditional and culture specific, and 
more generic across all regions of South Africa, and thus loses it unique, place-specific identity. 
Transfer of knowledge is also not unidirectional. Some information has been assimilated into the 
community “from outsiders” e.g. regarding germs and vaccinations. In other instances knowledge of 
medicinal plants is accepted by researchers, which could be the start of the commercialisation 
process e.g. Mesembryanthemum tortuosum (kougoed/sceletium), Agathosma betulina (buchu), 
Aspalathus linearis (rooibos tea) and Aloe ferox (Cape aloe) (van Wyk, 2008b). Information seems to 
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go back and forth, from healers to villagers, to researchers and vice versa. This allows new 
understandings and interpretations of illness and health care for all involved, which could eventually 
result in a new integrated system. 
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Chapter 3: Evaluation of the Bioactivity 
of Plant Extracts from Namaqualand 
1. Introduction 
1.1. What use are bioactive plant extracts to people? 
Humans have relied on plants to provide food, shelter, clothing and medicine for thousands of years. 
With the advent of the modern age, synthetic alternatives have taken the place of plants in many 
roles. However, this is not the case for medicines. While there are a great deal of chemically 
synthesised pharmaceuticals available, plants still play a large role in the drug discovery and drug 
manufacturing processes. An estimated 80% of medicinal products developed up to the year 1996 
had their origins in plants, and between 2000 and 2010 plant-derived natural products were 
involved in producing 50% of all new small molecule pharmaceuticals (Harvey, 2007; Newman & 
Cragg, 2012). 
The detection of bioactive plant extracts and the novel bioactive plant compounds therein is the 
starting point for their use as medicines (Ghisalberti, 2008). Determination of activity is done using a 
variety of assays, and is followed by isolation of active compounds. Some plant compounds are used 
unmodified in the form that they appear in nature e.g. morphine, artemesinin and vincristine (Pan et 
al., 2009). Other bioactive plant compounds are “lead compounds”. They are modified and 
developed into versions of the original that are more suitable or more effective for human 
treatment. Certain types of illness have benefitted more from the identification and isolation of 
natural plant compounds than others. In particular, treatment of infectious diseases and cancer have 
benefitted from focussed “natural products research” (Baker et al., 2007). Of the 155 anticancer 
drugs developed between 1940 and 2006, only 27% could not be traced back to a natural product, 
with 47% being either a naturally occurring compound, or a direct derivation thereof (Schmidt et al., 
2008; Newman & Cragg, 2006). 
The primary healthcare system available to many people living in rural or developing areas is 
traditional medicine, which often makes use of whole-plant crude extracts for treatment of illness 
(World Health Organization, 2002). The drawback to using whole plant extracts is that the dose of 
the active compound present in the plant cannot be quantified. Additionally, as all compounds in the 
plant are ingested, not just the relevant ones, there may be unexpected side effects and toxicity. It is 
therefore desirable to identify the compounds responsible for activity in a crude plant extract and 
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develop them into reliable, safe and efficacious pharmaceutical preparations which can be 
administered in reproducible doses (Macías et al., 2007; Colegate & Molyneux, 2008), although the 
synergistic effect of compounds in a complex mixture cannot be discounted. 
Using a combination of assays, plant extracts can be screened for activity and toxicity. This process 
often validates historical traditional use and provides a scientific basis for continued use of 
traditional medicines where pharmaceuticals are not available (Taylor et al., 2001). Such validation 
has, for example, been done on herbal concoctions sold in markets and “muthi” stores in Kwa-Zulu 
Natal, where claims to a variety of healing effects have been made. Testing revealed that some 
products were active in antibacterial, antifungal and antioxidant assays while some had no activity in 
these tests (Ndhlala et al., 2009). Testing of similar preparations in a separate study revealed that 
they all had varying levels of toxicity, making safety a concern for those using these and similar 
products (Ndhlala et al., 2010). The origins and composition of manufactured pharmaceuticals is 
regulated, whereas those of traditional medicines are not. This highlights the importance knowing 
the origins and composition of any substance intended for use as a medicine - whether of traditional 
or pharmaceutical origin. 
In the classical approach to natural products chemistry, the screening of plant extracts is followed by 
bioassay-guided fractionation, and the subsequent isolation and structure determination of pure, 
bioactive compounds in the active fractions. In rare instances this may produce a compound that is 
useful as a drug, in which case an evaluation would be carried out on whether the compound could 
be harvested on a large scale from the plants, or be more efficiently prepared by chemical synthesis. 
Large scale harvesting of wild stocks can endanger species (Macías et al., 2007), and cultivation of 
the plants may or may not be viable. Semi-synthetic approaches are a possible alternative, whereby 
similar compounds to the unavailable bioactive one may be found in other plant species which are 
more easily cultivated or exist in wild populations not under threat. These may then be harvested 
and chemically transformed into the compound from the endangered plant (Colegate & Molyneux, 
2008). 
Natural products are not just a source of drugs for treating human illness. Food production and 
agriculture also benefit from natural products. Active compounds in plants may be developed into 
herbicides, pesticides and microbicides (against bacteria and fungi). Some of these isolated 
compounds are already commercially available: for example cinnamaldehyde, originally isolated 
from natural sources such as cinnamon (Cinnamonum zeylanicum), is synthesised chemically for use 
as an agricultural fungicide (Dayan et al., 2009). Use of natural microbicides in the food industry is 
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also possible. For example, research has shown that essential oil of oreganum (Origanum vulgare) 
containing thymol, carvacrol, γ-terpinene and p-cymene is active against Escherichia coli at 
concentrations of 0.5 - 1.2 μl  per ml (Burt & Reinder, 2003). Consumer tests showed that oregano 
oil applied to beef fillets at 0.8% v/w (Tsigarida et al., 2000) and beef mince at 1% v/w (Skandamis & 
Nychas, 2001) had no perceptible changes to flavour, odour or colour of the packaged meat. Thus, 
switching to this natural microbicide would not have a negative effect on consumer’s perceptions of 
the final product. 
Performing simple bioassays can lead to the development of more sensitive analytical assays for 
particular compounds or for classes of compounds for agricultural and industrial use. One 
application of these analytical assays is for quality control and screening of toxicity in foods 
(Colegate & Molyneux, 2008). Bioassays can also be used to isolate and characterise compounds for 
commercial or industrial use, for example in food production, cosmetics, paint and dye production. 
Natural alternatives to synthetics have become popular over the past decade, with the move 
towards “green industry” and “green consumerism” (Burt, 2004). Consumers want fewer synthetic 
additives in their food and require products with a smaller chemical impact on the environment 
(Marienhagen & Bott, 2012). This means that more and better assays are needed to identify natural 
compounds for this purpose and a better method of selecting screening targets, so as to maximise 
potential positive hits, needs to be in place. 
1.2. What is the purpose of bioactive metabolites in plants? 
As noted above, it is of great benefit to humans that plants produce bioactive compounds. However, 
plants do not produce them for our benefit. Bioactive compounds are secondary metabolites, and 
their production diverts nutrients and energy away from primary metabolism. Their synthesis is 
costly and the biosynthetic pathways used to produce them are conserved. This implies that they 
must confer some evolutionary advantage for them to be produced at all (Macías et al., 2007; Wink, 
2010). It is currently thought that secondary metabolites play major roles in defence against 
herbivores, insects and microbes, as signal compounds, in self-regulation and in protection, for 
example, from UV light-induced damage  (Wink, 2010). 
Plants are immobile and must defend themselves against attack by herbivores, fungi, bacteria, 
viruses and other competitive plant species. They do this in different ways, one of which is through 
producing chemicals that interact with the attacking organism. These chemicals may mimic 
compounds present in an attacker. For example, some plant-derived alkaloids mimic animal 
neurotransmitters. They can act as agonists or antagonists in the animal brain resulting in an 
78 
 
undesired effect causing it to stop attacking the plant (Wink, 2000). Humans can use these 
compounds as medicines precisely because of their effect on the animal brain and physiology 
(Moerman & Estabrook, 2003). It has been suggested that “the only difference between a medicine 
and a poison is often just the dose” (Patrick, 2005). So if some of these defence compounds are 
taken in small doses, they may be beneficial. For example, morphine may depress respiration and 
cause death in high doses, but is an effective painkiller at lower doses. In fact, some of the best 
known pharmaceuticals, stimulants, narcotics and poisons are alkaloids. There are approximately 12 
000 known alkaloids and many more undiscovered alkaloids of potential medicinal value (Zulak et 
al., 2006). 
Plants can also mimic insect compounds to prevent predation. For example, the phytoecdysteroids 
are structurally similar to key compounds involved in the maturation phase of the insect life cycle. 
Larvae feeding on the plant ingest these compounds and are trapped in a never-ending immature 
larval stage (Dinan, 2001). They do not reproduce and insect predation of the plant is reduced. Some 
insects and animals make use of these secondary metabolites, sequestering them for their own use, 
e.g. cyanogenic butterflies (Engler-Chaouet & Gilbert, 2007). So the race continues, with adaptations 
on both sides - plants have evolved to defend against microbes and insects and microbes and insects 
have evolved to try to overcome the new defences (Macías et al., 2007). This may explain the vast 
chemical diversity of secondary metabolites. 
Bioactive metabolites also serve to attract animals and insects by, for example, producing fragrant 
monoterpenes or coloured anthocyanins and carotenoids in flowers (Crozier et al., 2006). Some 
secondary plant metabolites function for self-regulation as phytohormones or for communication 
between individuals of the same species (pheromones) (Macías et al., 2007). Some secondary 
metabolites fulfil multiple roles, such as the monoterpenes which attract insects but are also 
insecticidal and antimicrobial. Some secondary metabolites also carry out physiological functions e.g. 
alkaloids can transport and store nitrogen, but are also toxic (Wink, 2003). It appears that certain 
classes of compounds are generally associated with certain activity. It is this that we try to exploit 
when doing streamlined targeted extraction and testing. If we know that a specific class of 
compound is most likely to exhibit the desired bioactivity, then extraction methods and assays can 




1.3. The use of assays to test bioactivity 
Biological assays test crude plant extracts for activity. They may also be used on fractions of crude 
extracts and on pure compounds to test activity. Plants produce a vast number of secondary 
compounds (for example over 8000 phenolic structures alone have been identified) any of which 
could yield a breakthrough in medical treatment. Testing every plant for all types of chemicals is 
laborious and not economically feasible (Firn, 2003). So in order to streamline the process the most 
likely plant candidates must be chosen, and the appropriate extraction technique for the type of 
compounds expected (Salis-Lagoudakis et al., 2011). There are different methods of choosing which 
plants to test, including random selection, ecology based selection and ethnopharmacology 
informed selection. Ethnopharmacology based selection, where a selection of test plants is chosen 
using traditional medicine as a guide may provide the best success rate (Martin, 1995). However, it 
requires extensive inter-disciplinary collaboration which includes biologists, anthropologists, 
pharmacologists, biochemists, microbiologists and chemists as well as careful negotiation with 
indigenous people. 
Once plant targets are chosen, assays are selected. Simple bioassays can be done on the bench top 
using test organisms or cells, but need to be accurate, reproducible, unambiguous, simple and 
inexpensive. (Pieters & Vlietnik, 2005). Larger volumes of extracts can be processed using automated 
high-throughput screening (HTS), as is practiced by pharmaceutical companies in an attempt to 
increase the discovery rate for new natural products with drug potential (Littleton et al., 2005). 
Additional methods are included to increase hit rate, genomics studies for example (Iskar et al., 
2012; Feng et al., 2009). However, HTS has been criticized for poor results as analyses have shown 
that leads originating from HTS methods are the cause of over 60% of clinical failures (Zhang et al., 
2012). 
1.4. Extent of bioactivity testing 
Investigation into the bioactivity of plants has increased over the years as interest in natural 
products gathers momentum (see Baker et al. 2007 for an overview). This wealth of research has 
generated numerous textbooks and entire journals are dedicated to research in this field. The 
Journal of Ethnopharmacology is notable among many similar journals for documentation of 
research into plant bioactivity. Common approaches to investigating bioactivity include focusing on 
specific groups of plants e.g. certain families, entire pharmacopeia e.g. of a certain area or group of 
people or specific traditionally-used preparations e.g. certain traditional Chinese medicines. Testing 
has been done for a wide variety of activities among them antibacterial, antioxidant, antimalarial, 
anti-inflammatory, antiviral, antifertility, and antifungal to name a few. 
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In South Africa, the most commonly performed assays have been antibacterial, antifungal, 
antihelmintic, antiamoebic, antischistosomal, antimalarial, anti-inflammatory and antioxidant assays 
(Light et al., 2005). The most common method for testing employed by South African researchers, as 
reported in the literature, is serial microdilution (Eloff, 1998), but other methods such as the agar 
disc diffusion method and bioautography (Begue & Kline, 1972; Hamburg & Cordell, 1987) have been 
used (see Marston, 2011 for an overview of these techniques). Several South African studies have 
also been done to investigate the neurological effects of bioactive metabolites e.g. the effect of 
plant compounds on the central nervous system and this forms a significant area of South African 
research (see Stafford et al., 2008 for an overview). These tests are more difficult to perform and 
often require live animal test subjects (Stafford et al., 2005; Stafford et al., 2008). Mulholland & 
Drewes (2004) provide a good overview of research done in South Africa up to 2003. Many more 
studies have been done since then and entire research units, such as the Ethnobotany Unit of the 
National Botanical Institute and research groups based at the University of Kwa-Zulu Natal, the 
University of Johannesburg and at the Council for Scientific and Industrial Research (CSIR), have been 
established with the aim to discover new bioactive molecules and to validate traditionally used 
preparations. 
In South Africa there has also been a specific focus on testing safety and toxicity of traditionally used 
preparations (Ndhlala et al., 2010; Elgorashi et al., 2003; Steenkamp & Gouws, 2006; Verschaeve & 
van Staden, 2008). As the majority of people make use of traditional preparations, it is important to 
validate them and test their toxicity. There is also the possibility of integrating their use into main 
stream western healthcare systems (Fennel et al., 2004b). With this in mind, a few indigenous plants 
have been developed for distribution through health shops and pharmacies. They are available as 
processed and standardised materials in the form of teas, tinctures, tablets, capsules and ointments. 
16 major products1 have been developed, among them Aloe ferox burn gel and laxatives, 
Aspalanthus linearis (rooibos tea), antispasmodics and skin treatment for allergies and eczema and 
Sutherlandia frutescens (Sutherlandia) (van Wyk et al., 2008; van Wyk, 2011). Veterinary applications 
have not been neglected, and studies have been done to investigate plant based veterinary 
treatments (McGaw & Eloff 2008 for an overview of SA research and testing in this area; Bagla et al., 
2012) as well as to better understand livestock poisonings by plants (Botha & Penrith, 2008; 
Kellerman et al., 2005). 
                                                          
1
 “Major products” refers to those plants which have been developed as commercial crops i.e. cultivated and 




1.5. The importance of this study and its relevance 
While some plants have been investigated for bioactive compounds, the vast majority have not. This 
is particularly true of the South African flora. Traditional use is common, but very few of the species 
have been tested for activity or phytochemically evaluated. It is important to test for bioactivity in 
such plants as there is the possibility that novel, highly active compounds may be discovered. In this 
part of the study, some of the traditionally used plants mentioned during interviews with Paulshoek 
residents (see chapter 2) were tested in several assays for activity. Some of the other plants not 
mentioned in interviews were also evaluated for bioactivity in order to test a representative variety 
of species, growth types etc. from the Namaqualand flora. The types of assays that could be 
performed are numerous, and for the purposes of this study only a few could be performed. Here 
follows a short rationale for the choice of assays and their relevance and application in an African 
context. 
1.5.1. Rationale for using an antibacterial assay 
As more and more strains of bacteria develop resistance to antibiotics, so the need for novel 
antibiotics increases. Diarrhoeal diseases, mostly caused by bacterial pathogens, have been 
recognised as the greatest killer of infants and young children in the developing world. Many 
diarrhoeal diseases are caused by bacteria in the gastro-intestinal tract, some of which are becoming 
resistant to drugs (Fawole et al., 2008). Thus, the need for new antibacterials to combat this is great. 
“Stomach complaints”, including diarrhoea, are among the most commonly treated illnesses in 
Paulshoek. So it follows that there is the potential for discovering good antibacterial activity in the 
plants of Namaqualand. 
Diarrhoeal diseases are not the only diseases of concern in third world countries. Infection with HIV 
is rampant. While there have been some studies into the use of traditionally used medicinal plants 
for the treatment of HIV (Tshikalange et al., 2008; Klos et al., 2009), this is not the focus of this study. 
Rather than treating the HI virus, antibacterials play a large role in the treatment of sexually 
transmitted infections (STI’s). A high HIV infection rate has been directly correlated with a high STI’s 
infection rate. Infection with HIV makes co- infection with STI’s more likely. STI’s are a serious cause 
for concern, as left untreated they may result in infertility and even death (Van Vuuren & Naidoo, 
2010; De Wet et al., 2012). 26% of deaths in southern Africa in 2000 were as a result of STI’s 
(Johnson, 2008) caused by microorganisms such as Neisseria gonorrhoea (gonorrhoea) and 
Chlamydia trachomatis (chlamydia). Van Vuuren & Naidoo (2010) found that 90% of the solvent 
extracts of ethnomedicinally used plants from South Africa had activity against 6 pathogenic 
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microorganisms associated with STI. Thus it follows that the plant extracts from Namaqualand may 
have antibacterial activity relevant to the treatment of STI’s. 
In addition to these diseases, there is also the concern about tuberculosis (TB) caused by 
Mycobacterium tuberculosis. Multiple drug resistant (those strains resistant to at least two of the 
major anti-TB drugs) and extremely drug resistant strains (resistant to two of the major drugs, an 
injectible second line drug, as well as a fluoroquinolone) of TB have emerged (Jones et al., 2008). 
These strains are prevalent in Africa, and in particular South Africa, where there is an extremely high 
infection rate (more than 600 cases per 100 000 annually) (McGaw et al., 2008; Green et al., 2010; 
Eldeen & van Staden, 2007). One in ten cases is resistant to some of the available drugs (Lall & 
Meyer, 1999). Plants have been recognised as a useful source of highly active antimycobacterial 
metabolites (Pauli et al., 2005). In South Africa, many studies have focused on developing anti-TB 
drugs (see McGaw et al., 2008 for a review of research done in South Africa on South African plants, 
Eldeen & van Staden, 2007). 
Antibacterials also have an important veterinary application in South Africa. It has been estimated 
that 75% of rural livestock owners in the Eastern Cape province of South Africa use plant based 
remedies to treat their animals (Masika et al., 2000). While many large-scale commercial farmers 
make use of pharmaceutical preparations, the smaller farmers cannot afford these. Thus, it is 
important to develop new affordable alternative treatments based on plant compounds. 
Ethnoveterinary applications are commonly used to treat diarrhoea and gastro-intestinal problems 
associated with bacterial infection as well as other illness such as eye inflammations, and coughing 
which may also have a bacterial element (Mcgaw & Eloff, 2008).  
1.5.2. Rationale for using an antifungal assay 
One of the most common pathogenic fungi is the yeast Candida albicans. It is one of the most 
common opportunistic infections that causes candidosis (thrush) (Motsei et al., 2003). Up to two 
thirds of HIV infected patients are also infected with Candida albicans which causes oral candidosis 
(McCarthy et al., 1991). Vaginal candidosis affects an estimated 75% of non-HIV infected women at 
least once in their lifetime (Richardson & Warnock, 1993). Currently used treatments are becoming 
less effective as the fungus becomes resistant. Thus finding cheap, effective and readily available 
alternatives is important. Some studies have been done on crude plant extracts using bioautography 
and MIC to detect compounds with MIC values as low as 0.02 mg/ml (Shai et al., 2008). This suggests 
that plants are a good source of antifungal agents, and testing the plants of Namaqualand for such 
activity may yield new antifungal compounds. 
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Treatment of fungal infections in humans is not the only application for plant sourced antifungal 
agents. They can also be used to treat fungal infection of crops. For example, fungi are a major cause 
of seed deterioration of stored seeds (Krishnamurthy et al., 2008). If the seed survives storage 
without infection, there is still the chance for fungal attack on plants once the seed is sown. Fungal 
attack of crops is a major cause of losses in agricultural production. Aspergillus species cause fruit 
spoilage and produce toxic compounds that contaminate cotton, corn, peanuts and tree nuts. 
Fusarium blight is the most common fungal disease responsible for wheat and barley loss, and 
Fusarium oxysporum causes wilt disease in tomatoes (Mahlo et al., 2010).  Penicillium species are 
also responsible for post-harvest produce deterioration of fruit such as apples, peaches and cherries. 
Table grapes may also be infected with the fungus Botrytis cincerea, which causes gray mould 
disease. While the wine industry has turned this into a profitable situation (with the production of 
sweet “desert wines”), fresh produce farmers suffer heavy losses. Fungal diseases in plants can be 
controlled by using fungicides. However, some fungi have become resistant to the major antifungal 
agents employed by farmers (Stuardo & San Martín, 2008). Increasingly toxic fungicides are not an 
alternative as there are adverse health effects to humans and animals consuming the produce 
(Mahlo et al., 2010). Hence, finding new antifungal agents that are not as toxic yet still effective is 
imperative for food production as well as human health. 
1.5.3. Rationale for using an antioxidant assay 
Antioxidants are compounds that prevent other compounds or biological targets from being 
oxidised. Oxidative damage to cell membranes and DNA by reactive oxygen and nitrogen species 
(ROS/RNS) has been linked to the development of cancer (Collins, 2005), heart disease (Palace et al., 
1999; Kaul et al., 1993), Alzheimer’s disease (Mariani et al., 2005) and Parkinson’s disease (Joseph, 
2008). Natural antioxidants may provide protection against ROS/RNS and prevent oxidative damage 
associated with these and other diseases (Prior et al., 2005). 
For example, Alzheimer’s disease is characterised by extracellular deposited amyloid-beta peptide 
and intracellular hyper-phosphorylated and tangled tau-protein (Choi et al., 2012). Elevated levels of 
oxidative stress often precede amyloid deposition and neurofibrillary tangles, suggesting that 
oxidative stress is an early event which leads to development of Alzheimer’s disease (Smith et al., 
1991; Lovell & Markesberry, 2007; Resende et al., 2008). 
Natural antioxidant compounds, such as polyphenols, are able to quench free radical species, 
removing potentially damaging ROS/RNS. They may also be able to promote cellular pathways that 
allow cells to produce antioxidant molecules thereby increasing total antioxidant capacity. This can 
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be done, for example by stimulating the Nuclear factor-erythroid 2-related factor (Nrf)/ antioxidant 
response element (ARE) pathway (Dumont & Beal, 2011; Choi et al., 2012) Thus there is the 
possibility that preventing free radical generation, increasing antioxidant capacity and reducing the 
oxidative stress that often precedes development of the disease may intervene and prevent amyloid 
deposition and associated cognitive impairment (Ramassamy, 2006). Studies using vitamin E have 
shown that a dose of 2000 IU per day was effective in improving the cognitive ability of Alzheimer’s 
patients (Sano et al., 1997). Natural extracts containing high levels of flavonoids, such as those from 
Ginkgo biloba are also thought to confer similar protection (Viña et al., 2004; Mecocci & Polidori, 
2012). Extract of Ginkgo biloba, containing 24% flavonoids and 6% terpenes, is able to scavenge free 
radicals including NO, hydroxyl radical, superoxide anion and peroxyl radical (Choi et al., 2012). 
Ginkgo extract also up-regulates several genes that encode antioxidant enzymes, such as haeme 
oxidase-1 thereby increasing total cellular antioxidant production (Defeudis, 2002). 
This is of particular relevance to Africa. While the incidence of Alzheimer’s disease in African 
populations has not been explicitly investigated, studies conducted on groups of African-Americans 
showed that antioxidant concentrations and levels of oxidative DNA damage differ significantly 
between adults of African-American ethnicity and adults of white ethnicity (Watters et al., 2008). In 
addition, African-Americans have a higher mortality rate from cardiovascular disease than whites in 
America (American Heart Association, 2005; Qian et al., 2007), and they also have a higher risk factor 
for developing other diseases related to oxidative stress such as cancer (American Cancer Society, 
2006).  Whether this is true of people of African ethnicity has not been established, but there has 
been a changing lifestyle profile among South Africans which may suggest that oxidative stress 
related disorders could be of greater concern in the future. As more South Africans become 
urbanised, more meat and refined carbohydrates become included in the daily diet. Tobacco and 
alcohol consumption also increase and these lifestyle and dietary changes lead to higher levels of 
oxidative stress, which can lead to disease (Reddy et al., 2003). For this reason, identifying natural 
sources of antioxidants and the development of antioxidant treatment for diseases such as cancer 
and heart disease is of great importance. 
1.5.4. Rationale for using protease and protease inhibition assays 
Proteases are enzymes that cleave proteins into amino acids and smaller peptides. They participate 
in many physiological processes including digestion and blood clotting. Proteases and protease 
inhibitors may have medicinal use - protease inhibitors are already widely used to treat HIV infection 
and hypertension (Joseph, 2008). In Africa, traditional medicinal plants are often the only available 
treatment for many infected with HIV. Investigation into the bioactivity of traditionally used 
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medicinal plants from around the world has shown that several posses some degree of anti-HIV 
activity (Tshikalange et al., 2008). Plants can act at different stages of the viral life cycle to halt its 
progression. For example, by preventing viral attachment (thereby stopping the virus from sticking 
to host cells) to inhibition of reverse transcriptase (which allows the virus’s RNA to be replicated by 
the host DNA) (Harnett et al., 2005). An important class of drugs targeted at inhibition of HIV 
protease may arrest the development and proliferation of HIV in infected patients (Tomasselli & 
Heinrikson, 2000). HIV protease is a virus-specific dimeric enzyme required for cleavage of viral 
polyprotein precursors into functioning proteins. Intervening in this process prevents the formation 
of active and infectious virus, which essentially blocks the replication cycle of the virus (Markowitz et 
al., 1995). 
Protease inhibitors (PI) are often synthetic and are quickly metabolised by human cytochrome P450 
enzymes, particularly CYP3A. Thus they need to be taken often and at high doses in order to 
maintain an effective plasma concentration (Treijtel et al., 2009). They are also used in combination 
therapy with other HIV drugs, as in Highly Active AntiRetroviral Therapy (HAART) (Pawar et al., 
2012). Alternatives from natural origins may provide a better solution. A variety of natural products, 
including alkaloids, flavonoids and lignans, have been found to inhibit HIV specific enzymes and 
proteins essential for the completion of the virus’s life cycle (Cos et al., 2004). For example, 
Stauntonia obovatifoliola subsp. intermedia, a plant used in Traditional Chinese Medicine (TCM), 
contains several active compounds, most notably a triterpenoid that inhibits HIV-1 protease with an 
IC50 value of 8.7 μg/ml (at a concentration of 100 μg/ml) (Wei et al., 2008). Such natural compounds 
may allow development of improved drugs with better pharmacokinetic profiles. Other natural 
protease inhibitors may be present in plants from Namaqualand, and thus it is important to test for 
this bioactivity. 
1.5.5. Rationale for using an antihelmintic assay 
Helminth infestation is a common and serious problem largely affecting the developing world where 
people are impoverished and marginalised (Aktar et al., 2000). There has been relatively little 
research focusing specifically on helminth infestation and helminth infections such as hookworm and 
schistosomiasis (Jäger, 2005), which are among the core neglected tropical diseases (Hotez et al. 
2007; Hotez et al., 2009).  There is currently no data on the prevalence of helminth related disease in 
South Africa. However, high rates of infection have been reported at the provincial level, particularly 
in Mpumalanga, the Western Cape, and Kwa-Zulu Natal (Aremu et al., 2012). 
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Currently there are only four basic types of antihelmintics available with four modes of action 
(Aremu et al., 2012). The first three types are older drugs developed many years ago to which 
helminths have had time to develop resistance to. They are not always completely effective in 
severe infestations. The fourth class of drugs has been developed much more recently than the 
other three classes. However, certain soil dwelling parasitic helminths are already resistant to these 
drugs (Tritten et al., 2011). Furthermore, drugs of this type often caused complications with hepatitis 
patients and pregnant women (Savioli et al., 2003). The number of isolated plant bioactive 
compounds demonstrating antihelmintic activity is low (Aremu et al., 2012) and this route needs to 
be explored further. Thus, screening the plants from Namaqualand was thought to be of benefit. 
Schistosomiasis, also known as bilharzia, is one of the most common helminth diseases. It is 
estimated that more than 207 million people have been infected worldwide (Steinmann et al., 2006; 
De Moraes et al., 2010). Plant molluscides have been the focus of investigation with the emphasis on 
creating cheap, effective and environmentally acceptable alternatives to often unavailable and 
expensive Western medicines (Clark et al., 1997). Some screening of South African plants, 
particularly traditionally used medicinal species from Kwa-Zulu Natal has yielded positive results 
(Sparg et al., 2000; Aremu et al., 2010). Thus it seemed likely that Namaqualand plants may produce 
similar compounds. 
One of the side effects of intestinal helminth infection is chronic diarrhoea (Lewis & Elvin-Lewis, 
1977). While this can be deadly to the elderly and the very young, it is rarely associated with 
mortality in adults. However, a heavy helminth infestation can cause morbidity such as impaired 
mental and physical development in children, and wasting in adults (Taylor et al., 1995). Another 
serious implication of helminth infestation is a decline in host immune status, which can increase 
susceptibility to secondary infections (Borkow & Bentwich, 2006). This can be a serious problem in a 
person co-infected with HIV or TB. Helminth infection lowers the already lowered immune response 
and can increase the progression of HIV or TB (Elias et. al, 2006; Wolday et al., 2002; Aremu et al., 
2012). In Africa with its high HIV and TB infection rates, reducing helminth infection seems vitally 
important. 
Treating helminth infections is not only of great importance to humans, but also to animals. 
Antihelmintics dominate the animal pharmaceutical industry and this area of research is probably 
the only one where efforts and success in animal health exceed those in human health (Hoste & 
Torres-Acosta, 2011; McKellar & Jackson, 2004; Aremu et al., 2012). The wealth of plants in South 
Africa means that there is the possibility for development of animal helminth vaccines from plants 
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(Smith, 1999). Such research is being performed at various institutes in South Africa with some 
success, and additional plant species from Namaqualand may be useful in this regard. 
1.6. Aims/questions and objectives of this section 
The main aim of this part of the study was to perform a range of simple biological assays on a sample 
of plants from the study area in order to assess their biological activity. A selection of medicinal and 
non-medicinal plant species were collected from the communal area surrounding the village of 
Paulshoek in Namaqualand for this purpose. A second aim was to use various statistical methods to 
investigate trends in bioactivity across family lines and various plant features. In summary, the aims 
of this section of research are to: 
1) Assess the biological activity of plants in a series of simple assays 
2) Test the validity of the simple assays with more robust minimum inhibitory concentration 
(MIC) assays 
3) Examine trends in activity  
a) across family lines in order to establish the extent to which  bioactivity is associated 
with plant families 
b) among various growth forms, in order to establish whether bioactivity is related to 
growth form 
c) across seasonality and degree of succulence, to establish whether either of these 
have a strong relationship with bioactivity 
4) Identify potential candidates from the tested species for further phytochemical and 
metabolomic analysis (see chapter 4) 
2. Methods 
2.1 Plant collection and extraction 
The method for plant collection and sampling was outlined in chapter 2 in the section “Plant 
collection and identification”. 
Collection took place on several field trips interspersed over a five month period, starting in July 
(winter) and progressing through to November (start of summer). This was done to ensure that the 
greatest range of plant species were included in the study as some species have a strong seasonal 
growth pattern, particularly geophytes and ephemerals (Cowling et al., 1999). Plant sampling yielded 
a total collection of 124 individual plant species, 91 of which were used to create 102 ethanolic plant 
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extracts. Some plant species were not extracted due to discovery of insect or fungal damage being 
discovered upon closer inspection of plant material on return to the laboratory. Some plant species 
were used to create multiple extracts in order to account for the possibility of different activity in 
different plant organs e.g. between roots and leaves, or stems and flowers. For example, extracts of 
both the berries and the leaves of Solanum burchelii were created. Plant samples were separated 
into different plant parts (where necessary) and washed and air dried to remove dirt before 
extraction in ethanol. Plant extraction followed a slightly modified version of the protocol outlined in 
the Global Institute for Biological Exploration (GIBEX) “Screens-to Nature” (STN) manual (Joseph, 
2008). 2g of each sample was weighed out and macerated by hand in a mortar and pestle with 4ml 
of 70% EtOH. Ethanolic plant slurry was then filtered through Whatman No. 1 filter paper and stored 
as liquid ethanolic extracts at 4°C until biological testing was performed. 2ml’s of each extract were 
stored as reference samples, and the remainder used in biological testing. 
2.2. GIBEX assays 
A range of biological assays developed by The Global Institute for Biological Exploration (GIBEX) were 
performed on all extracts. These qualitative “Screens-to Nature” (STN) bioassays were developed to 
be field deployable, simple to perform and requiring little specialised equipment. The idea being that 
the assays would be available to scientists in the developing world for use in the field, removing the 
need for a fully equipped laboratory and making it possible to test plants for bioactivity in the areas 
where they are medicinally used (Andrae-Marobela et al., 2012). The STN bioassays focus on testing 
for bioactivity relevant to treating diseases prevalent in developing countries. For example 
antibacterial and antifungal assays indicate potential treatment of infection, an antihelmintic assay 
indicates potential treatment of parasitic diseases and an assay that tests for enzyme activity and 
enzyme inhibition indicates potential treatment for certain metabolic diseases and HIV (Joseph, 
2008). 
A pilot run of the biological assays gave no results as the extracts were too concentrated to allow 
accurate assessment of results as several of the assays are colorimetric in nature. For example, it 
could not be determined whether the worms used in the antihelmintic assay were dead or alive 
after the incubation time had elapsed as the liquid in the wells was too dark to see through. After 
consultation with Prof. D.W. Gammon (Department of Chemistry, University of Cape Town), it was 
decided that plant extracts should be diluted 1:3 with 95% EtOH and that these dilutions be used in 
assays. This was adopted as the protocol for all subsequent samples. Bioassays were performed 
according to the instructions outlined in the GIBEX manual (and described below) and results 
recorded. All reagents were obtained from Sigma-Aldrich, unless otherwise specified. 
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2.2.1. Antibacterial assay 
To test the antibacterial activity of the plant extracts under investigation, 300µl of agar solution 
(containing 1g agar in 30ml water) was placed in each well of a sterile 48 well plate and allowed to 
solidify. 10μl of human saliva (obtained from the author at least 1 hour after consumption of food or 
beverages) was placed in each well as a source of bacteria. Human saliva was chosen for this assay as 
it provides a wealth of bacteria on which to test plant extracts and is easily obtainable in a field 
situation. Ethanolic plant extracts were tested in duplicate, placing 10μl into each test well.  10μl of 
penicillin G solution (containing 4mg lyophilised penicillin G powder (Sigma ) and 1ml sterile water) 
was used as the positive control, while the two negative control wells contained only 10μl saliva on 
agar each. Plates were covered and incubated at 37°C for 24 hours. Bacterial growth was recorded 
as the percentage of agar covered with bacterial colonies after the incubation time had elapsed. 
100% cover indicated no antibacterial activity for that extract, more than 50% cover indicted slight 
antibacterial activity, less than 50% cover indicated moderate antibacterial activity and no bacterial 
growth indicated strong antibacterial activity (Joseph, 2008). 
2.2.2. Antifungal assay 
To test the antifungal activity of the plant extracts under investigation, 200μl of yeast solution, 
containing 50mg dried yeast and 50mg sucrose in 5ml of warm distilled water, was placed in each 
well of a sterile 24 well plate. Common baker’s yeast - Saccharomyces cerevisiae - was used in this 
assay as a model organism for other fungi in the yeast family and as a proxy for general antifungal 
activity in the plant extracts under investigation. Ethanolic plant extracts were tested in duplicate, 
placing 50μl into each test well. 50μl of an econozole nitrate solution (containing 300mg econozole 
nitrate salt dissolved in 1ml dimethyl sulfoxide (DMSO)) was placed into two positive control wells, 
while 50μl 70% EtOH was placed in each of the two negative control wells. Plates were covered and 
incubated at 30°C for 24 hours. After 24 hours had elapsed, 20μl of MTT solution (containing 5mg 3-
(4,5-dimethylthiazole-3-yl)-2,5-diphenyltetrazolium bromide (MTT) in 1ml sterile water) was added 
to each well and the plates were incubated for a further 22 hours. Yellow MTT is metabolised by live 
yeast cells to purple formazan and is widely used to assess cytotoxicity and cell viability (Mosmann, 
1983; Van Meerloo et al., 2011). Thus wells containing live yeast cells will turn purple, while those 
containing yeast cells killed by plant extracts will remain yellow. Extracts in wells remaining yellow 
after the incubation period were recorded as having strong antifungal activity. Extracts in wells that 
changed to a yellow-lilac were recorded as having moderate antifungal activity. Similarly light purple 
indicated mild activity while dark purple was taken to indicate no antifungal activity for that 
particular extract (Joseph, 2008). 
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2.2.3. Antioxidant assay 
In this assay, ABTS (2,2’-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)) was used as an indicator of 
antioxidant activity of plant extracts. The ABTS˙+ radical is generated directly in a stable form prior to 
reaction with any antioxidants present in ethanolic plant extracts. The blue/green ABTS˙+ 
chromophore is generated through the reaction of ABTS and potassium persulfate. The coloured 
radical cation is reduced to colourless ABTS through interaction with antioxidants. Thus the extent of 
discolouration can be used as an indicator of antioxidant activity. The reaction is fast and is usually 
complete within one minute (Re et al., 1999). 
In order to generate the ABTS˙+ chromophore, 20μl of potassium persulfate solution (containing 
50mg potassium persulfate in 1ml distilled water) was added to 1ml ABTS stock solution (containing 
7mg ABTS powder in 1ml distilled water). ABTS stock solution was protected from light and left for 6 
hours at 4°C, after which it was diluted to a working concentration with 20ml distilled water. 
To test the antioxidant activity of the plant extracts under investigation, 200μl of diluted ABTS 
solution was added to each well in a sterile 96 well plate. Ethanolic plant extracts were tested in 
duplicate, placing 10μl into each test well. 10μl of ascorbic acid (containing 17.6mg ascorbic acid 
powder in 1ml distilled water) was used as the positive control, while 10μl 70% EtOH was used as 
the negative control. Antioxidant activity was recorded according to colour change. No change in 
colour from dark blue/black indicated no antioxidant activity in that extract. A change to green 
indicated mild antioxidant activity, and similarly a change to pale green was taken to indicate 
moderate antioxidant activity. A change to completely clear indicated strong antioxidant activity 
(Joseph, 2008). 
2.2.4. Protease activity and protease inhibition activity 
In this assay, strips of radiograph film coated with gelatine were used to test the protease activity 
and protease inhibition activity of plant extracts. If protease activity is present, the plant extract will 
eat away the green top layer of the film exposing the blue layer below (Konarev, 1986). 
To test for protease activity in the plant extracts under investigation, 10μl drops of the extracts 
under investigation were placed at regular intervals along a strip of radiograph film. 10μl of digestive 
enzyme solution (consisting of 2.5mg trypsin powder dissolved in 1ml sterile distilled water) was 
used as a positive control. The negative control was a 10μl drop of sterile water. The film was left on 
a flat surface for 10 minutes and then washed with running water to remove any dried-on remnants 
of the test extracts. Extracts that had removed the top layer to reveal the blue layer below were 
recorded as having protease activity. 
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To test for protease inhibitor activity in the plant extracts under investigation, 10μl drops of extracts 
under investigation were placed at regular intervals along a strip of radiograph film. The positive 
control consisted of a 10μl drop of digestive enzyme solution (consisting of 2.5mg trypsin powder 
dissolved in 1ml sterile water) combined with a 10μl drop of inhibitor solution (containing 3mg 
trypsin inhibitor powder dissolved in 30μl sterile water). The negative control was a 10μl drop of 
sterile water. 10μl of trypsin solution was added to each drop of test extract, the film was left on a 
flat surface for 10 minutes and then washed with running water. Extracts that did not show the blue 
layer below the surface were recorded as having protease inhibition activity (Joseph, 2008). 
2.2.5. Antihelmintic assay 
In this assay, a free-living nematode - Panagrellus redivivus - was used as a model organism to test 
antihelmintic activity of plant extracts. Activity against the model organism may indicate lethality to 
other parasitic species of roundworm e.g. hook worms and pin worms. Worms were cultured in a 
liquid mixture of oatmeal, and re-cultured once every 10 days. New cultures were left for at least 3 
days before use in an assay to allow time for the parasites to multiply. 
To test the antihelmintic activity of the plant extracts under investigation, 100μl of worm suspension 
(consisting of a small spatula scraping of worms from the oatmeal solution in 10ml sterile water) was 
placed in each well of a sterile 96 well round bottom plate. Roughly an even number of worms were 
placed in each well. Ethanolic plant extracts were tested in duplicate, placing 5μl into each test well. 
5μl copper sulphate solution (containing 160mg CuSO4 salt in 1ml sterile water) was placed in two 
positive control wells, while 5μl 70% EtOH solution was placed in two negative control wells. Plates 
were left for four hours at room temperature before evaluating lethality activity. After four hours, 
wells were examined under 10 x magnification. Those wells containing dead worms were recorded 
as having extracts with antihelmintic activity. 
2.3. Minimum Inhibitory Concentration (MIC) assays 
One of the aims of this section of work was to validate the use of GIBEX assays to test for bioactivity. 
While the assays were developed and thoroughly tested by GIBEX, in collaboration with Rutgers 
University and the University of Illinois (Andrae-Marobela et al. 2012), it was deemed useful to 
validate the assays for use with plants from Namaqualand. Namaqualand is a unique bioregion and 
contains many endemic species, some of which were included in this study (Desmet, 2007; Desmet 
& Cowling, 1999). Validation studies were done on the basis that these regionally isolated plants 
may contain unique chemical compounds which may have unforeseen effects on certain assays. 
Hence, serial microdilution assays (Eloff, 1998) were performed on a subset of the ethanolic extracts 
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subjected to the GIBEX assays to determine their minimum inhibitory concentration (MIC) values. 
The original serial microdilution method was intended for use with bacteria only, and slight 
modifications were made for use with yeast cells in order to test the antifungal activity of plant 
extracts (Masoko et al., 2005). Results from the MIC assays were then compared to the results for 
the same extracts obtained in the GIBEX assays. Extracts were selected at random and blind tested. 
 
In addition to determining assay validity, MIC assays allowed quantification of the qualitative results 
obtained from the GIBEX assays. This meant that the actual levels of bioactivity could be evaluated 
and the range of efficacious concentrations of the crude ethanolic extracts could be determined. 
2.3.1. Organism stock maintenance: bacteria 
A stock culture of gram negative (Escherichia coli) and gram positive (Staphylococcus aureus) 
organisms was obtained from the American Type Culture Collection (ATCC). The organisms were 
inoculated into 5ml of Tryptic Soy Broth (TSB), obtained from Sigma-Aldrich in Germany, and 
incubated at 37°C for 24 hours. Gram and Ziehl-Neelson stains were performed on these cultures to 
ensure culture purity. 20% sterile glycerol was added to each culture and 500μl aliquots were placed 
into sterile 1.5ml Eppendorf tubes using plugged 1ml pipette tips. These stocks represent the ‘G0’ 
stocks and were stored at -70°C. One of these ‘G0’ stocks was used to inoculate two further medium 
cultures, and glycerol stocks were prepared from these cultures by the same method described 
above. These stocks, designated ‘G1’, were stored at -20°C and used for all experimentation 
purposes. 
2.3.2. Organism stock maintenance: fungus/yeast 
A stock culture of the organism Candida albicans was obtained from ATCC. The organism was 
inoculated into 5ml of Roswell Park Memorial Institute (RPMI) 1640 medium, obtained from Sigma-
Aldrich in Germany, and incubated at 30°C for 48 hours. Gram stains were performed on these 
cultures to ensure culture purity. 20% sterile glycerol was added to each culture and 500μl aliquots 
were placed into sterile 1.5ml Eppendorf tubes using plugged 1ml pipette tips. These stocks 
represent the ‘G0’ stocks and were stored at -70°C. One of these ‘G0’ stocks was used to inoculate 
two further medium cultures, and glycerol stocks were prepared from these cultures by the same 




2.3.3. MIC assay method 
Bacteria (Escherichia  coli and Staphylococcus aureus) from frozen G1 stocks described above were 
inoculated into 5ml of Tryptic Soy Broth (TSB) medium (consisting of an autoclaved solution of 30g 
TSB powder in 1L sterile water) each and grown for 24 hours before use. Assays were performed in 
duplicate in sterile 96 well plates. 100µl of sterile water was placed into all wells. 50µl of each 
ethanolic extract was tested in duplicate and serial two-fold dilutions were made from the first well 
down to the desired minimum concentration (Langfield et al., 2004). A 1:200 dilution was made from 
the day-old bacterial culture using TSB. Plates were inoculated with the diluted bacterial suspension 
(50µl per well), covered and incubated at 37°C for 24 hours. Ciprofloxacin (concentration 10 μg/ml) 
was used as the positive control, and appropriate solvent blanks were included as negative controls. 
 
After the incubation period, 10µl Alamar Blue (consisting of 5mg resazurin dissolved in 1ml sterile 
water, 0.5% (w/v)) was used as an indicator of growth. Alamar Blue is a blue, non-fluorescent, non-
toxic indicator dye that is reduced to resorufin, a pink fluorescent molecule, by enzymes present in 
living cells. It is used as an indicator of cell growth, particularly in assays involving a bacterium or 
yeast as the test organism (Sarker et al., 2007). A fresh solution of Alamar Blue was made up for 
each batch of MIC assays. The minimum inhibitory concentration was determined as the lowest 
sample concentration at which no pink colour, signifying live organisms, appeared after leaving the 
plate to stand for 1 hour. Plates were returned to the incubator and checked again after another 24 
hours incubation to confirm the previously recorded MIC values. 
A similar method was followed for testing for antifungal activity. Yeast cells (Candida albicans) from 
similarly prepared and frozen G1 stocks were inoculated into 5ml of RPMI 1640 medium and grown 
for 48 hours before use. Assays were performed in sterile 96 well plates. 100µl of sterile water was 
placed into all wells. 50µl of each ethanolic extract was tested in duplicate and serial two-fold 
dilutions were made from the first well down to the desired minimum concentration (Langfield et 
al., 2004). A 1:50 dilution was made from the 48 hour old yeast culture using RPMI 1640. Plates were 
inoculated with the diluted yeast suspension (50µl per well), covered and incubated at 37°C for 24 
hours. Nystatin (concentration 50 μg/ml) was used as the positive control, and appropriate solvent 
blanks were included as the negative controls. 
After the incubation period, 10 µl Alamar Blue (consisting of 5mg resazurin dissolved in 1ml sterile 
water, 0.5% (w/v)) was used as an indicator of growth. A fresh solution of Alamar Blue was made up 
for each batch of MIC assays. The minimum inhibitory concentration was determined as the lowest 
sample concentration at which no pink colour, signifying live organisms, appeared after leaving the 
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plate to stand for 1 hour. Plates were returned to the incubator and checked again after another 24 
hours incubation to confirm the previously recorded MIC values. 
2.4. Statistical comparison of GIBEX vs. MIC 
The results from the GIBEX assays were compared to the results from the MIC assays and statistically 
evaluated to determine the level of agreement between them. This was done using an attribute 
agreement analysis in Statistica version 11 (Statsoft Inc., 2012). The null hypothesis is that there is 
no significant difference between two sets of data. The program calculates Cohen’s kappa statistic 
for the data and gives a p-value indicating whether to accept or reject the null hypothesis. Individual 
agreements analyses were performed to test agreement between the GIBEX antibacterial assay and 
the MIC assay that used E. coli as the test organism, between the GIBEX antibacterial assay and the 
MIC that used S. aureus as the test organism and the GIBEX antifungal assay and the MIC that used 
C. albicans as the test organism. 
2.5. Trends in activity across family, growth form, seasonality and succulence 
Many investigations into bioactivity have been performed on various floras from around the world. 
For example, screening of plant extracts traditionally used for medicine in the Peruvian Andes (Neto 
et al., 2002), and screening of traditionally used medicinal plant extracts from India (Ahmad & Beg, 
2001). However, not all of these investigations are successful (Firn, 2003). Plants must be very 
carefully chosen in order to increase the success rate and number of positive hits resulting from 
screening efforts (Salis-Lagoudakis et al., 2011). In South Africa, with its varied flora, there are so 
many potential candidates for screening that selection must be based upon a predetermined set of 
criteria if maximum positive hit rate is to be achieved. 
One way of doing this is to use traditional medicine as a guide. The chance of discovering bioactive 
compounds of interest is increased if ethnomedicine is used as a guide, particularly if disparate 
pharmacopoeias use the same, or similar, plants (Upretty et al., 2010).  If plants have been 
independently selected by different cultures for medicinal use, then their case for efficacy is stronger 
and they become preferred candidates (Salis-Lagoudakis et al., 2011). Using traditional medicine as a 
guide could be useful for further investigation into bioactivity of Namaqualand plants. However, a 
large percentage of Namaqualand species are endemic, so the method of selecting the species with 
cross-cultural use cannot be applied here. A slightly different approach could be used though, where 
trends in bioactivity across family lines, growth forms and seasonality are used as a guide to plant 
selection for future screening efforts. 
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Certain types of compounds responsible for specific bioactivity may be associated with growth 
strategy, family or life cycle. Uncovering trends in bioactivity, along family lines for example, may 
indicate which species to focus on when screening for novel compounds with specific activity. The 
success of future screening endeavours may be enhanced if species are selected on the basis of 
these trends. In order to establish the trends in bioactivity for species in Namaqualand, the 
relationships between bioactivity and growth form, seasonality, family and succulence were 
examined using correspondence analysis and regression analysis. 
2.5.1. General method of correspondence analysis 
Commonly used multivariate techniques for reducing data complexity and visualising relationships 
among sets of data include principle components analysis (PCA) and factor analysis (FA). However, 
these techniques are only applicable to data sets of continuous variables, and cannot be used with 
categorical data such as the results from the bioassays (Sourial et al., 2010). Correspondence 
analysis (CA) is an alternative multivariate technique specifically designed for use with categorical 
data stored in contingency tables (Greenacre, 2007). 
CA calculates the chi-square statistic to determine if there is a significant relationship between 
variables in a contingency table. CA, as with PCA, aims to graphically display any relationship existing 
between the variables in question and describes the inertia present in the data set. Inertia is a 
measure of the variance in the data set contained in the contingency table. Thus the larger the 
inertia, the greater the differences between data points. CA reduces inertia to a small set of 
orthogonal dimensions. Dimension 1 describes the greatest amount of inertia, Dimension 2 the next 
largest amount and so on. PCA performs a similar task, but uses principle components to describe 
the variance between samples. Each dimension has an associated eigenvalue, which describes how 
much of the inertia it explains. Most analyses retain three dimensions and generally it is accepted to 
retain the number of dimensions that accounts for >70% of the total inertia i.e. the cumulative 
percentage eigenvalues must be 70% or more for the retained dimensions (Sourial et al., 2010).  
CA generates a 2D correspondence map with Dimension 1 as the horizontal axis and Dimension 2 as 
the vertical axis. The degree of clustering or closeness of points in the same areas of the map can be 
used to interpret relationships between variables. Points that are positioned close to one another 
along the first dimension can be said to be highly related. Similarly, those lying close together along 
the second dimension may also be said to be related, only slightly less so than those clustered along 
dimension one. Points that are close together on both dimensions may be said to be very highly 
related. In general, points that lie between -0.2 and 0.2 along a dimension cannot be said to have 
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any significant association with that dimension and are usually disregarded when interpreting the 
correspondence map (Heir, et al.). 
2.5.2. Definitions of growth form and classification 
For the purposes of this study, plant growth form data were extracted from the Plants of South 
Africa (POSA) website - an online checklist of current taxonomic data maintained by the South 
African National Botanical Institute (POSA, 2012). Using the data extracted from POSA, species were 
grouped into nominal categories following the suggestion of de Almeida et al. (2005) and Douwes et 
al. (2008): trees, bushes/shrubs, herbs, climbers and geophytes. “Trees” were defined as perennial, 
woody plants generally with a single stem axis. “Bushes/shrubs” were defined as perennial, woody 
plants that are shorter than trees and generally have several branches rather than a single stem. 
“Herbs” were defined as are non-woody plants that are relatively shorter than plants in the “trees” 
and “bushes/shrubs” categories. “Herbs” grow from seed and have roots. “Geophytes” were defined 
as herbaceous species growing from an underground rhizome, tuber, bulb or corm. “Climbers” were 
defined as vine-like creepers that use other plants to support their trailing stems. 
In addition to taxonomic data, life strategy data for each species under investigation was also 
extracted from POSA. “Annuals” were defined as short lived (only persisting for a single growing 
season) species. Annuals follow an r life strategy i.e. they have a high rate of reproduction and 
growth. “Perennials” were defined as longer lived species. Perennials usually follow a K type life 
strategy i.e. lower reproduction potential but greater ability to survive competitively (de Almeida et 
al., 2005). 
Information regarding the succulence of each of the species under investigation was also extracted 
from POSA. Plants may be stem or leaf succulents, and some show a combination of woody stems 
and succulent leaves. Hence, “succulent” was not treated as a distinct growth type, as has been 
done in other studies, but rather as an attribute related to overall habitat adaptation and choice of 
photosynthetic pathway. In this study, plants were classified as either “succulent” or “non-
succulent”. All species under investigation were classified according to these groupings and a 
contingency table was created for the purpose of performing correspondence analysis on the data. 
2.5.3. Analysis of trends in activity  
Correspondence analysis was performed in Statistica version 11 (Statsoft Inc., 2012) using a 
contingency table containing family data extracted from POSA, and bioactivity data from GIBEX test 
results. A chi-square test was performed as part of the analysis in order to investigate whether there 
was a significant association between family and bioactivity.  Correspondence maps were generated 
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to visualise the association. For the purposes of this investigation, assay 4 - the test for protease 
activity - was excluded from the analysis on the basis that only a single species was recorded as 
having this activity. This was thought to lend unnecessary bias to the data and was therefore 
excluded. 
Similarly, the relationship between growth form and bioactivity was examined using correspondence 
analysis in Statistica version 11 (Statsoft Inc., 2012). The analysis made use of a contingency table 
containing growth form data extracted from POSA, and bioactivity data from GIBEX test results. The 
chi-square statistic was used to investigate whether there was a significant association between 
growth form and bioactivity. Correspondence maps were generated to visualise the association. 
Assay 4 was omitted from this analysis for the same reason given in the previous test. 
In order to examine the relationship between seasonality and bioactivity, seasonality data extracted 
from POSA was summed for each assay type. These figures were then plotted in a bar chart and 
trends extrapolated. Similarly, in order to investigate the relationship between succulence and 
bioactivity, succulence data extracted from POSA was summed for each assay type. These figures 
were also plotted in a bar chart and trends extrapolated. 
2.6. Choosing candidates for further phytochemical analysis 
Of the 102 extracts created and tested for this section of the study, ten were selected for further 
phytochemical analysis. Species were evaluated on the basis of several criteria - how easy it would 
be to collect a large sample (plants must be of a suitable size e.g. a species that only grows to a 
maximum of 5cm would not be a good candidate as hundreds, if not thousands of plants would have 
to be collected) and how abundant the species is in the Paulshoek area (species must be locally 
abundant so as a large scale collection would not have a negative impact on populations). Medicinal 
use was taken into consideration (a good selection of both species with recorded medicinal uses and 
those with no medicinal uses should be considered). When choosing species of interest, bioactivity 
was evaluated in two different ways. First, the number of assays a particular extract was active in 
was considered - activity in four or more assays was taken to indicate a species that merits further 
investigation. A second evaluation of activity was how strong the activity was in individual assays. 
This was done so as not to exclude an extract with a single very strong result for one assay, and 
negative results in other assays. Finally, the literature was reviewed to see if other research groups 
were working on the same or a closely related species. Those species with no existing literature were 
deemed more important for investigation.  Species were evaluated on all of these criteria and ten 




3.1. Results of the GIBEX assays 
The aim of this section was to assess the biological activity of 102 Namaqualand plant extracts using 
a range of assays. Some of the tested extracts are from plants used traditionally in Paulshoek, and 
others are from plants with no recorded medicinal use. Results of the selected GIBEX assays that 
were performed on all 102 extracts are summarised in Table 2. The key to codes used to record 
results is given in Table 1. 
 
Table 1: Key codes used to record GIBEX assay results 
Assay type Key 
antibacterial 0 = no activity, 1 = slight activity, 2 = moderate activity, 3 = strong activity 
yeast inhibition 0 = yeast practically unaffected, 1 = some yeast alive, 2 = yeast slightly alive, 3 = 
yeast dead 
antioxidant 0 = no activity, 1 = mild activity, 2 = moderate activity, 3 = high activity 
protease activity 0 = no activity, 3 = activity 
protease inhibition 0 = no inhibition, 3 = inhibitor activity 




Table 2: A summary of the results of GIBEX assays performed on plant extracts under investigation  













1. Aizoon canariense (leaves) Aizoaceae 3 0 1 0 0 0 
2. Aizoon canariense (roots) Aizoaceae 2 0 0 0 0 0 
3. Adromischus spp. (leaves) Mesembryanthemaceae 2 0 3 0 3 0 
4. Antizoma miersiana (leaves) Menispermaceae 0 0 3 0 0 0 
5. Aptosimum indivisum (leaves) Scrophulariaceae 1 0 2 0 0 0 
6. Aptosimum indivisum (rootstock) Scrophulariaceae 2 0 2 0 0 0 
7. Aptosimum spinescens (leaves) Scrophulariaceae 1 0 3 0 0 0 
8. Arctotis fastuosa (leaves) Asteraceae 1 2 1 0 0 0 
9. Aridaria noctiflora (leaves) Mesembryanthemaceae 0 0 0 0 0 0 
10. Asparagus rubicundus (leaves, stems 
& flowers) 
Asparagaceae 0 3 2 0 0 0 
11. Ballota africana (leaves) Lamiaceae 2 3 1 0 0 0 
12. Berkheya spinosissima (leaves) Asteraceae 1 0 2 0 0 0 
13. Bulbine abyssinica (leaves) Asphodelaceae 2 0 3 0 0 0 
14. Bulbine abyssinica (rootstock) Asphodelaceae 1 1 3 0 0 0 
15. Bulbine praemorsa (leaves) Asphodelaceae 1 0 0 0 0 0 
16. Calobota sericea (leaves) Fabaceae 2 0 2 0 0 0 
17. Carpobrotus edulis (leaves) Mesembryanthemaceae 2 3 2 0 3 0 
18. Cheiridopsis denticulata (leaves) Mesembryanthemaceae 2 0 3 0 3 0 
19. Cheiridopsis namaquensis (leaves) Mesembryanthemaceae 2 0 1 0 0 0 
20. Chrysocoma ciliata (leaves & stems) Asteraceae 3 3 3 0 0 0 
21. Conicosa elongata (leaves) Mesembryanthemaceae 0 0 0 0 0 0 
22. Cotyledon cuneata (leaves) Crassulaceae 2 3 3 0 2 0 
23. Cotyledon orbiculata var. orbiculata 
(leaves) 
Crassulaceae 1 0 3 3 0 0 
24. Crassula atropurpurea var. 
watermeyeri (leaves) 
Crassulaceae 3 0 3 0 3 0 
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25. Crassula brevifolia ssp. brevifolia 
(leaves) 
Crassulaceae 2 0 3 0 3 3 
26. Crassula muscosa var.muscosa 
(leaves & stems) 
Crassulaceae 3 0 3 0 3 0 
27. Cyphia crenata (entire plant) Lobeliaceae 3 0 3 0 0 0 
28. Diascia namaquensis (leaves & stem) Scrophulariaceae 0 0 1 0 0 0 
29. Dodonaea viscosa var angustifolia 
(leaves) 
Sapindaceae 3 3 3 0 0 0 
30. Drosanthemum hispidum (leaves & 
stems) 
Mesembryanthemaceae 2 2 1 0 0 0 
31. Drosanthemum spp. (leaves) Mesembryanthemaceae 0 0 1 0 0 0 
32. Eriocephalus microphyllus (leaves) Asteraceae 1 3 3 0 0 0 
33. Erodium cicutarium (leaves) Geraniaceae 0 0 3 0 0 0 
34. Euphorbia decussata (leaves & 
stems) 
Euphorbiaceae 0 0 3 0 3 2 
35. Euphorbia mauritanica (leaves & 
stems) 
Euphorbiaceae 1 0 2 0 0 0 
36. Euryops multifidus (leaves) Asteraceae 2 3 2 0 0 0 
37. Foveolina dichotoma (leaves) Asteraceae 2 2 1 0 0 0 
38. Galenia africana (leaves) Aizoaceae 3 3 3 0 0 3 
39. Gazania heterochaeta (leaves) Asteraceae 0 0 1 0 0 0 
40. Grielum humifusum (leaves) Neuradaceae 1 0 3 0 0 0 
41. Heliophila variabilis (leaves) Brassicaceae 1 0 2 0 0 0 
42. Hermannia amoena (leaves) Malvaceae 1 1 3 0 0 0 
43. Hermannia cuneifolia (leaves) Malvaceae 2 0 3 0 0 0 
44. Hirpicium alienatum (leaves & buds) Asteraceae 0 0 3 0 0 0 
45. Hypertelis salsoloides (leaves) Molluginaceae 1 0 0 0 0 0 
46. Lachenalia anguinea (leaves) Hyacinthaceae 0 0 1 0 0 0 
47. Larryleachia cactiformis (succulent 
stem) 
Apocynaceae 2 0 0 0 0 0 
48. Leipoldtia schultzei (leaves) Mesembryanthemaceae 2 1 3 0 3 0 
101 
 
49. Lessertia diffusa (leaves & stems) Fabaceae 2 2 1 0 0 0 
50. Leysera tenella (leaves) Asteraceae 1 0 3 0 0 0 
51. Lycium ferocissimum (leaves) Solanaceae 1 0 1 0 0 0 
52. Manochlamys albicans (leaves) Chenopodiaceae 1 0 0 0 0 0 
53. Mesembryanthemaceae 
guerichianum (leaves) 
Mesembryanthemaceae 2 0 0 0 0 0 
54. Microloma sagittatum (leaves) Apocynaceae 0 3 1 0 0 0 
55. Microloma sagittatum (flowers) Apocynaceae 0 3 2 0 0 0 
56. Monoculus hyoseroides (leaves) Apocynaceae 0 1 0 0 0 0 
57. Moraea pallida (leaves) Iridaceae 2 0 3 0 0 0 
58. Moraea serpentina (leaves) Iridaceae 1 3 2 0 0 0 
59. Nicotiana glauca (leaves) Solanaceae 1 0 3 0 0 0 
60. Ornithogalum pruinosum (bulb) Hyacinthaceae 1 0 2 0 0 1 
61. Ornithogalum pruinosum (leaves) Hyacinthaceae 0 0 3 0 0 0 
62. Ornithogalum secundum (leaves) Hyacinthaceae 1 0 1 0 0 0 
63. Ornithoglossum vulgare (leaves) Colchicaceae 1 0 3 0 0 0 
64. Othonna abrotanifolia (leaves) Asteraceae 1 3 3 0 0 0 
65. Othonna cylindrica (leaves) Asteraceae 2 0 2 0 0 0 
66. Othonna floribunda (flowers) Asteraceae 1 0 1 0 0 0 
67. Othonna floribunda (leaves) Asteraceae 0 0 1 0 0 0 
68. Oxalis obtusa (leaves & stem) Oxalidaceae 1 2 3 0 0 0 
69. Oxalis pes-caprae (bulb) Oxalidaceae 2 0 2 0 0 0 
70. Oxalis pes-caprae (leaves) Oxalidaceae 2 0 1 0 0 0 
71. Oxalis pes-caprae (lower stem) Oxalidaceae 1 0 0 0 0 0 
72. Pelargonium alternans (leaves) Geraniaceae 2 0 3 0 0 0 
73. Pelargonium crithmifolium (leaves) Geraniaceae 0 0 3 0 3 0 
74. Pelargonium pulchellum (leaves) Geraniaceae 0 0 3 0 0 0 
75. Pentzia incana (leaves & stems) Asteraceae 0 0 2 0 0 0 
76. Polymita albiflora (leaves) Mesembryanthemaceae 3 0 3 0 3 0 
77. Pteronia divaricata (leaves) Asteraceae 0 3 3 0 0 0 
78. Pteronia incana (leaves) Asteraceae 1 3 3 0 0 0 
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79. Quaqua mammillaris (stem) Apocynaceae 2 0 3 0 3 0 
80. Ruschia fredericii (leaves) Mesembryanthemaceae 2 0 3 0 3 0 
81. Ruschia fredericii (stems) Mesembryanthemaceae 1 0 2 0 0 0 
82. Ruschia robusta (leaves) Mesembryanthemaceae 2 1 3 0 3 0 
83. Salvia dentata (leaves) Lamiaceae 3 0 3 0 0 0 
84. Sceletium tortuosum (leaves & stem) Mesembryanthemaceae 1 0 0 0 0 2 
85. Searsia undulata (leaves & shoots) Anacardiaceae 3 3 2 0 3 0 
86. Senecio cardaminifolius (flower 
stalks) 
Asteraceae 2 0 1 0 0 0 
87. Senecio cardaminifolius (leaves) Asteraceae 0 2 1 0 0 0 
88. Senecio cinerascens (leaves) Asteraceae 1 0 1 0 0 0 
89. Senecio radicans (leaves) Asteraceae 0 0 0 0 0 0 
90. Solanum burchellii (leaves) Solanceae 1 2 2 0 0 0 
91. Solanum burchellii (ripe berries) Solanceae 1 0 3 0 0 0 
92. Spiloxene ovata (leaves & bulb) Hypoxidaceae 1 0 3 0 0 1 
93. Tetragonia fruticosa (leaves) Aizoaceae 0 1 1 0 0 0 
94. Thesium lineatum (leaves & 
flowering stems) 
Santalaceae 0 0 3 0 0 0 
95. Trachyandra tortilis (bulb & leaves) Asphodelaceae 1 0 1 0 0 0 
96. Trichogyne polycnemoides (leaves) Asteraceae 0 1 3 0 1 0 
97. Tripteris sinuata (leaves) Asteraceae 1 0 1 0 0 0 
98. Tylecodon wallichii ssp. wallichii 
(leaves) 
Crassulaceae 2 0 0 0 0 0 
99. Unidentified spp. -  2 0 1 0 0 0 
100. Viscum capense (stems & leaves) Viscaceae 1 1 3 0 0 0 
101. Zaluzianskya benthamiana (entire 
plant) 
Scrophulariaceae 0 0 2 0 0 0 






Figure 1: The percentage of tested samples active in each assay type. Additional bars in the antibacterial, 
antifungal and antioxidant assays indicate the percentage of positives that were strongly, moderately and 
weakly active (in decreasing order left to right). 
 
 
Figure 2: The number of plants that were active in no, single and multiple assays. The majority of screened 
species were active in two assays. 
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On examining the results of the assays it is evident that the majority of plants exhibited antioxidant 
activity (86.3%) and antibacterial activity (73.5%) when tested (Figure 1). Over half of those with 
antioxidant activity were strongly active (51.1%), while those with antibacterial activity were mostly 
moderately (38.7%) or weakly active (48.0%) (Figure 1). Very few of the tested extracts were positive for 
protease activity (0.98%) or antihelmintic activity (3.92%). The majority of extracts were positive in two 
assays, while very few (2.94%) displayed no activity in any of the assays utilised for this study (Figure 2). 
3.2. How do MIC assays compare with GIBEX assays? 
The aim of this section was to evaluate how well the simplified GIBEX assays approximate results from 
more scientifically rigorous assays. A random selection of extracts from the pool of 102 was tested using 
a more robust serial microdilution MIC assay method. The results of the MIC assays and the results from 
the GIBEX assays were compared. Extracts having activities with MIC values below 8mg/ml are  
Table 3: Minimum inhibitory concentration (MIC) values for all tested crude ethanolic extracts with positive 
results against various organisms. EC = Escherichia coli, SA = Staphylococcus aureus and CA = Candida albicans. 
“NT” indicates “not tested” against a particular organism, while “-” indicates a negative result in a particular 
assay. 
Extracted species MIC CA (mg/ml) MIC SA (mg/ml) MIC EC (mg/ml) 
Aizoon canariense (leaves) NT - 166.7 
Arctotis fastuosa (leaves) NT 166.7 20.8 
Berkheya spinosissima (leaves) NT 166.7 - 
Bulbine abyssinica (leaves) NT 83.3 83.3 
Carpobrotus edulis (leaves) 83.3 - - 
Crassula brevifolia ssp. brevifolia (leaves) NT 20.8 166.7 
Galenia africana (leaves) 10.4 NT NT 
Hermannia cuneifolia (leaves) 166.7 NT NT 
Calobota sericea (leaves) NT 83.3 83.3 
Leipoldtia schultzei (leaves) NT 5.2 83.3 
Microloma sagittatum (flowers) 10.4 NT NT 
Microloma sagittatum (leaves) 41.7 NT NT 
Monoculus hyoseroides (leaves) 41.7 NT NT 
Moraea pallida (leaves) NT 83.3 83.3 
Othonna floribunda (flowers) 166.7 NT NT 
Othonna cylindrica (leaves) 10.4 NT NT 
Pentzia incana (leaves & stems) NT 166.7 166.7 
Quaqua mammillaris (stem) NT 166.7 166.7 
Ruschia fredericii (leaves) 2.6 NT NT 




Table 4: Results of the attribute agreement analysis performed to assess whether there was a significant 
difference between the results of the GIBEX assays and microdilution MIC assays. 
Comparison between assay: Result Conclusion 
Antibacterial GIBEX and MIC (using E. coli) p = 0.2910 Accept H0 
Antibacterial GIBEX and MIC (using S. aureus) p = 0.0029 Reject H0, accept H1 
Antifungal GIBEX and MIC (using C. albicans) p = 0.5759 Accept H0 
 
considered to posses some activity of interest (Fabry et al., 1998) and those with MIC values below 
1mg/ml are considered of particular interest (Rios & Recio, 2005). Pure compounds with activity of 
10μg/ml or less are considered good candidates for development into pharmaceuticals (van Vuuren, 
2008). MIC values ranged between 166.7 mg/ml to 2.6 mg/ml for the assay using C. albicans as a test 
organism, 166.7 mg/ml to 5.2 mg/ml for the assay using S. aureus as a test organism and between 166.7 
mg/ml and 20.8 mg/ml for the assay using E. coli as the test organism (Table 3). Ruschia fredericii with 
an MIC value of 2.6 mg/ml, Leipoldtia schultzei with an MIC value of 5.2 mg/ml, and Arctotis fastuosa 
with an MIC value of 20.8 mg/ml were the most active in each of the assays. While none of these crude 
plant extracts showed exceptional MIC values, the values are low enough to merit further investigation 
into the active compounds present in these plants. 
Any activity against the test organisms was recorded a positive result for comparison against results 
from GIBEX assays for the same extracts. Attribute agreement analysis performed on each set of results 
- the GIBEX results and the MIC results - gave p-values for each of the tests ( 
Table 4). In this case, we want to have a non-significant value of p at the 5% level i.e. a p-value greater 
than 0.05 in order to accept the null hypothesis (H0) that the two sets of data are not significantly 
different. From the results, we can see that H0 can be accepted for the attribute agreement analyses 
performed between MIC (using E. coli) and the GIBEX antibacterial assay (p = 0.2910) as well as for MIC 
(using C. albicans) and the GIBEX antifungal assay (p = 0.5759) (Table 4). This is not true for the analysis 
between MIC using (S. aureus) and the GIBEX antibacterial assay (p = 0.0029) and the alternative 
hypothesis, H1 that there is a significant difference between the results from the two assays, must be 
accepted. Thus, GIBEX assays may be used as suitable indicators of both antibacterial and antifungal 
activity. However GIBEX assays may not be equally sensitive to all strains of bacteria resulting in false 
negatives i.e. extracts may have broad antibacterial activity but are not active against a specific test 
organism and are recorded as non-active. 
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3.3. What trends in bioactivity are apparent? 
The aim of this section was to examine bioactivity across family, growth form, seasonality and 
succulence in order to determine if any trends were apparent. Patterns in underlying chemistry have 
been investigated previously. It has been suggested that plants have two major anti-herbivory strategies 
and that these are linked to their life strategy and growth form. Plants may either display metabolically 
inactive defences such as tannins and lignans which reduce digestibility, or chemically active defences 
such as alkaloids, cardiac glycosides and terpenoids which negatively affect the attacker (Coley et al., 
1985). These low molecular weight defence compounds are the ones that most likely to be bioactive. 
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Figure 3: Correspondence analysis map of bioactivity and plant family. Codes used for bioactivity data point 
labels (represented by open circles) are: AB = antibacterial, AF = antifungal, AH = antihelmintic, AO = 
antioxidant, PI = protease inhibition. Codes used for family data point labels (represented by filled squares) are: 
AIZ = Aizoaceae, ANA = Anacardiaceae, APO = Apocynaceae, ASC = Asclepiadaceae, ASPA = Asparagaceae, ASPH 
= Asphodelaceae, AST = Asteraceae, BRA = Brassicaceae, CHE = Chenopodiaceae COL = Colchicaceae, CRA = 
Crassulaceae, EUP = Euphorbiaceae, FAB = Fabaceae, GER = Geraniaceae, HYA = Hyacinthaceae, HYP = 
Hypoxidaceae, IRI = iridaceae, LAM = Lamiaceae, LOB = Lobeliaceae, MAL = Malvaceae, MEN = Menispermaceae 
MES = Mesembryanthemaceae, MOL = Molluginacceae, NEU = Neuradaceae, OXA = Oxalidaceae, SAN = 
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Figure 4: Correspondence analysis map of bioactivity and plant family with non-significant data point labels 
removed for clarity. Codes for labels for activity and family data points are the same as those used in Figure 3.  
 
Ephemeral or r-selected species, which tend to be opportunistic colonisers and weedy species, seem to 
rely more on chemical defence (Rhoades & Cates, 1976). Thus, annuals, weeds and herbs are expected 
to be more bioactive than longer lived shrub and tree species and therefore better targets for screening 
endeavours (Stepp & Moerman, 2001).  Furthermore, studies have shown that alkaloids are twice as 
likely to be present in annual species as in perennial species (Levin, 1976). Additionally, leaf life may be a 
predictor of underlying anti-herbivory defence strategy. Plants with long lived leaves rely mainly on 
more physical defence mechanisms of tannins and lignans. Plants with short lived leaves tend to invest 
in chemical defence mechanisms (Stepp, 2004). These trends are expected in the species from 
Namaqualand. 
3.3.1. The relationship between bioactivity and family 
The chi-square test performed on the data as part of correspondence analysis revealed that there is no 
significant relationship between family and activity at the 5% level (p = 0.9798). The cumulative 
percentage of inertia explained by the first two dimensions resulting from correspondence analysis is 
68.14%. The correspondence map of these two dimensions clearly shows a lack of relationship between 
bioactivity and family, as indicated by the chi-square test (Figure 3). The map becomes even clearer 
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when data points that fall in the range -0.2 to 0.2 on both dimensions (which is the threshold for a 
significant association with a particular dimension) are removed (Figure 4). 
The only relationships are the very weak associations between Zygophyllaceae (ZYG) and antifungal 
activity (AF), and Hypoxidaceae (HYP) and antihelmintic activity (AH). But as these are extremely weak 
associations, they may be disregarded. This confirms the lack of strong associations between families 
and activities. The lack of any significant relationship or clustering on the correspondence map suggests 
that bioactivity is not limited to specific families. Thus family cannot be used as an indicator of 
bioactivity, at least not for the types of bioactivity screens and families examined in this study. 
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Figure 5: Correspondence map of bioactivity and growth form. Codes used for bioactivity data point labels 
(represented by open circles) are: AB = antibacterial, AF = antifungal, AH = antihelmintic, AO = antioxidant, PI = 




Figure 6: The percentage of annual and perennial species per type of bioactivity. Codes for bioactivity are: AB = 
antibacterial, AF = antifungal, AH = antihelmintic, AO = antioxidant, PI = protease inhibition.  
 
3.3.2. The relationship between bioactivity and growth form 
Similarly to the results of the previous correspondence analysis, the chi-square test revealed no 
significant association between growth form and activity at the 5% level (p = 0.8359). The cumulative 
percentage of inertia explained by the first two dimensions resulting from correspondence analysis is 
95.89%. The correspondence map of these two dimensions clearly shows a lack of relationship between 
bioactivity and growth form, as indicated by the chi-square test (Figure 5). The lack of any significant 
relationship or clustering on the correspondence map suggests that bioactivity is not correlated with any 
specific growth form. Hence, growth form cannot be used as an indicator of bioactivity. 
3.3.3. The relationship between bioactivity and seasonality 
The percentage of annual and perennial species exhibiting each bioactivity was plotted in a bar chart 
(Figure 6). It is clear that many more species with perennial seasonality are bioactive than those with 
annual seasonality across all categories of bioactivity. Annuals were in the minority, with over a 5:1 ratio 
of perennials to annuals in all categories. 
3.3.4. The relationship between bioactivity and succulence 
The percentage of succulent and non-succulent species exhibiting each bioactivity was plotted in a bar 
chart (Figure 7). From this we can see that non-succulent species were in the majority in the 




Figure 7: The percentage of the active species that were succulent vs. the percentage that were not per type of 
bioactivity. Codes for bioactivity are: AB = antibacterial, AF = antifungal, AH = antihelmintic, AO = antioxidant, PI 
= protease inhibition. 
 
protease activity (100%) and protease inhibition (86.7%) assays. Succulents and non-succulence were 
equally as active in the antihelmintic assay. 
3.4. Choice of candidates for next phase 
The aim of this section was to identify potential candidates from species screened in this study for 
further phytochemical and metabolomic analysis. Criteria for selection were determined and ten species 
were chosen accordingly (Table 5). The most important selection criterion was bioactivity. Those species 
that had particularly strong activity or multiple activities were prioritised. Then the ease of their 
collection and relative local abundance was considered. Species that were readily available, not 
seasonally constrained, and locally abundant were prioritised. After this the candidates were assessed to 
see if they were used in the preparation of traditional medicines in Paulshoek, and if there was existing 
literature on them. Those that are used in traditional medicine and that had no existing literature were 
prioritised. 
Large collections, between 1 and 3kg, of the ten chosen species were gathered during a field trip 
undertaken in October 2011. Large samples were taken directly back to the laboratory at the University 
of Cape Town and extracted according to modified version of the GIBEX protocol. Modifications to the 
protocol involved changes necessary to accommodate the large scale of the samples being processes 
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and not to modify the extraction process. Samples were washed to remove dirt, separated according to 
plant part, and extracted with 70% EtOH in a ratio of 1g sample: 2ml EtOH. In order to accommodate the 
large sample size, parts of interest were macerated in a blender (rather than by hand). The resulting 
ethanolic plant slurry was filtered through Whatman No. 1 filter paper and stored in sterile brown glass 
Winchester bottles at 10 °C. Extracts were dried under vacuum at temperatures not greater than 40°C to 
remove EtOH solvent. Remaining liquid was lyophilized to remove residual water. Powdered crude 
extracts were stored in glass jars at 4°C until further analysis as outlined in chapter 4. 
Table 5: Details of which species were selected for further investigation and the criteria for their inclusion 
Species Activity Ease of 
collection/ 
abundance 
Medicinal use Other 
research being 
done 
Ballota africana Strong antifungal 
activity 
Relatively easy, 
not as locally 
abundant 






East to collect, 
locally abundant 
Medicinal use in 
Paulshoek, recorded 





Active in four 
assays 
Easy to collect, 
locally abundant 
No medicinal use, 
flowerstalks reported to be 




Active in four 
assays 
Easy to collect, 
locally abundant 






to collect, locally 
abundant 

















Easy to collect, 
locally abundant 
Medicinal use in Paulshoek No 
Salvia dentata Strong antibacterial 
activity 
Easy to collect, 
locally abundant 
Medicinal use in Paulshoek No 
Searsia undulata Active in four 
assays 
Easy to collect, 
locally abundant 







to collect, less 
abundant than 
other species but 
plants are large 





4.1. Is Namaqualand a potential “bioactivity hot spot”? 
Namaqualand is considered one of the 25 top priority “conservation hot spots” globally on the basis of 
its great endemism and biodiversity (Myers et al., 2000). This biodiversity is thought to stem from a 
stable local climate during global glacial periods, combined with a series of rapid, adaptive allopatric 
speciation events (Cowling et al., 2009; Ellis et al., 2006). Thus Namaqualand is home to a unique 
collection of flora and fauna which may contain novel bioactive compounds of interest. Namaqualand 
also has a long history of traditional medicinal plant use. It can be assumed that centuries of consistent 
plant use is indicative of some level of efficacy, and therefore scientifically demonstrable biological 
effectiveness (Salis-Lagoudakis et al., 2011). This theory was confirmed when 86.3% of species tested for 
activity in this study showed antioxidant activity, and 73.5% showed antibacterial activity. Most plants 
were active in two of the six assays performed on extracts. Some (5.88%) were active in four assays and 
only very few (2.94%) showed no activity in any of the assays. However, this does not mean that they do 
not possess any biological activity. The few samples inactive in this study may possess a type of 
biological activity not tested for e.g. anti-inflammatory or antiviral. Nevertheless, 97.1% of tested plants, 
which consisted of some species with recorded medicinal use and some without, showed activity of one 
sort or another in this limited battery of tests. Such a high hit rate is sometimes experienced, but usually 
with sets of extracts which all have traditional medicinal use (i.e. traditional use was used to guide 
species selection). In this study, some species had traditional medicinal use, while others were selected 
at random, so we would expect a lower percentage of the randomly selected species to have activity. 
However, this was not the case. It would appear that almost all species in this study, and possibly in the 
area generally, may possess activity of varying types and strengths making Namaqualand a “bioactivity 
hot spot” as well as a centre of endemism and diversity. 
The high level of bioactivity in Namaqualand species may be a direct result of the rapid allopatric 
speciation experienced in the region. Species have adapted to survive Namaqualand’s environmental 
conditions - extreme heat, low rainfall and a high level of UV exposure. Some species have even evolved 
a different type of photosynthesis - Crassulacean Acid Metabolism (CAM) photosynthesis - in order to 
thrive in the often harsh environment (Rundel et al., 1999). Adaptations such as CAM introduce new 
biochemical pathways which produce novel chemical compounds. Such compounds, and those required 
for protection may confer additional bioactivity not seen in other species in other areas. For example, 
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flavonols in epidermal cells provide UV protection. (Crozier et al., 2006) and flavonoids (including 
flavonols) have been linked to antioxidant activity that reduces risk for cancer, diabetes etc, (Clifford & 
Brown, 2006). Thus species adapted to a hot sunny climate may produce a greater amount of more 
structurally diverse flavonoids, which could result in a higher level of bioactivity. 
In this study, species of Mesembryanthemaceae and Asteraceae were among some of the most active in 
antibacterial and antifungal assays (Ruschia fredericii with an MIC value of 2.6 mg/ml, Leipoldtia 
schultzei with an MIC value of 5.2 mg/ml, and Arctotis fastuosa with an MIC value of 20.8 mg/ml). These 
families are also some of the most diverse and specious in Namaqualand and species belonging to them 
are highly adapted to Namaqualand’s environment. This suggests that many other plants that have 
evolved similarly can be expected to have similar activity. Thus Namaqualand species may be worth 
noting for future screening endeavors. 
4.2. Finding potential drug leads from bioactive Namaqualand plants - the way forward? 
The Succulent Karoo biome in Namaqualand is home to approximately 3500 species and is one of 
several unique and speciose South African biomes (Desmet, 2007). Endemism in biomes such as the 
Succulent Karoo and Fynbos is high and many of the thousands of species in each have never been 
tested for bioactivity. Testing these plants against multiple screens would be costly and time consuming 
if conventional laboratory methods of extraction and screening were to be followed. However, the 
process could be fast tracked if assays were conducted in the field. Portable, field deployable systems, 
such as the GIBEX set of screens (Josephs, 2008), allow testing of traditional medicinal plants in the field 
as an initial screen. Only plants with bioactivity of interest are collected and taken back to a laboratory 
for further testing, reducing time requirements in the field and allowing screening efforts to focus on 
plants with potential (Prescott et al., 2012). GIBEX assays have been proven to be simple yet accurate 
indicators of activity. Pilot projects in Botswana and other African countries have proved that they are 
field deployable with minimal requirements and that local traditional healers are interested to get 
involved in screening projects and medicinal plant workshops (Andrae-Marobela et al., 2012). A similar 
portable system for in-field antibacterial testing was successfully employed to test traditional medicinal 
plants used by the Bulu and Kaulong people of Papua New Guinea (Prescott et al., 2012). With 
improvements to field kits and better portable equipment researchers can get more reliable and 
accurate results faster. Field assays used in combination with new and better laboratory assays that are 
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specific, sensitive and cost effective will improve screening efforts and make screening of more remote 
locations viable (McChesney et al., 2007). 
Other methods of evaluating bioactivity would be useful to identify plants with activity of interest early 
on. In addition to in-field “pre-screening” other measurable indicators of bioactivity should be 
considered when selecting plants for extraction and testing. Previous studies have suggested that 
weedy, herbaceous species are most likely to contain small bioactive molecules (Stepp, 2004; Stepp & 
Moerman 2001). Herbs and annuals are often the most utilised medicinal species, and perennial trees 
and shrubs least often (Voeks, 1996). Therefore we would expect herbaceous annual species to contain 
the most bioactive compounds. However, the results of this study showed that more perennial species 
are bioactive than annual species. This is a similar result to that found by de Almeida in a study of the 
medicinal plant of Northeast Brazil, where a greater number and wider variety of active compounds was 
found in K strategist species (which tend to be woody trees and perennial shrubs) (De Almeida et al., 
2005). The results of this study also showed that there was no relationship between growth form and 
bioactivity, so it cannot be said that a certain type of activity can be found in plants with a certain 
growth form. Succulence seemed to indicate protease activity and protease inhibition activity, but other 
than that was also not a useful indicator of bioactivity. This suggests that initial screening efforts be 
focused on herbaceous and woody perennial species of traditional medicinal plants.  
Once a bioactive species is identified, the time consuming process of isolating the active compound and 
developing a pharmaceutical preparation from this molecule begins. This can take years and is fraught 
with problems. The lengthy process of isolating the active compound/s from a bioactive medicinal plant 
may be avoided by simply using the plant as a “botanical”. Botanicals may consist of the whole dried 
powdered plant or the dried powdered crude plant extract. In both cases, the powder may be 
administered in capsule form or included in an ointment for topical application. Such products are also 
not subject to the usual process of clinical trials, as they are considered “dietary supplements” rather 
than pharmaceuticals (Schmidt et al., 2008). Botanicals may also be more readily accepted in 
communities that are used to using plant medicines. In some areas where a drug has successfully been 
developed from a medicinal plant, the people who had originally used the medicinal plant did not want 
to use the drug. For example, a study of a group of rural people in the Amazon forest showed that the 
majority of them did not like the pharmaceutical and stated that they “wanted to go back to the natural 
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way” (Wayland, 2004). In such instances a powdered “botanical” may be an acceptable alternative - one 
that has at least been tested for toxicity. 
Botanicals are crude mixtures of phytochemicals in varying concentrations. Bioactivity may not be due 
to a single compound but to a large number of structurally related and unrelated compounds which 
contribute to the effect (Heinrich et al., 2005). There is a basic supposition that any plant possessing 
clinical effectiveness must contain an active principle which can completely replace the whole plant 
extract (Phillipson, 2001). But this isn’t necessarily true. Constituent phytochemicals may work together 
or with concomitantly administered pharmaceuticals to create beneficial additive or synergistic effects.  
Additive effects are created  when the combined effect is equal to the sum of the effects of the 
individual components, while synergistic effects are created when the combination of bioactive 
substances exert effects that are greater than the sum of the effects of the individual components 
(Schmidt et al., 2008). The idea that compounds work synergistically is not new. In 1936 Szent-Györgyi 
reported the presence of what he first called ‘‘vitamin P” in citrus fruits and hypothesized that 
flavonoids and vitamin C worked synergistically to strengthen capillaries (Rusznyák & Szent-Györgyi, 
1936). Phytochemicals tend to work synergistically to increase therapeutic effects in one of three ways: 
1) by blocking one or more targets of the signal transduction pathway 2) by increasing the bioavailability 
of another drug or 3) by stabilizing another drug in the system (Hemalswarya & Doble, 2006). For 
example, quercitin has been found to act synergistically with triazofurin in human ovarian carcinoma 
cells and can enhance the action of carboxytriazole in human breast carcinoma MDA-MB-435 cells (Shen 
et al., 1999; Yeh et al., 1995). Natural products have even been shown to to work synergistically with 
existing antibiotics restoring antibiotic activity against resistant strains of S. aureus, E. coli and Shigella 
(Sato et al., 2004a; Sato et al., 2004b; Sato et al., 2004c). 
Botanicals containing a mixture of compounds may also be beneficial as they are able to affect multiple 
targets. Studies have shown that drugs that bind to multiple targets may be more effective than those 
that only bind to a single target. Compounds that bind to multiple targets do so much more weakly than 
those with a single target, and therefore have a partial effect on the substrate. However, this partial 
inhibition of multiple targets may still be as effective, if not more effective, than the single compound: 
single target approach (Csermely et al., 2005). Thus mixtures of compounds may be more effective than 
a single drug compound as they can affect multiple targets (Schmidt et al., 2007). However, there is the 
need to characterize the majority, if not all, of the compounds in an extract before this approach can be 
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used for drug development (Schmidt et al., 2007; Williamson, 2001; Heinrich, 2008). Such analysis may 
be possible with modern techniques such as metabolomics. 
However, synergistic action also causes side-effects and negative interactions with western 
pharmaceuticals. It is very difficult to determine all the effects of all compounds present in a crude plant 
mixture and how they will interact with other drug molecules in the human body. Many phytochemicals 
produce negative side effects such as cardio or hepatotoxicity or they may alter metabolism 
(Hemalswarya & Doble, 2006). There is also the problem with standard dosing. The concentration of an 
active compound in a plant extract depends on many factors including environmental and genetic 
factors affecting the plant, as well as extraction and storage methods used to create the extract. Thus, 
creating a standard dose is difficult. These problems are avoided when the bioactive compounds are 
isolated, purified and standardized. Active secondary metabolites isolated from plant material may, with 
the help of a medicinal chemist, be improved upon to produce a safer, more effective final 
pharmaceutical product. The process is laborious, and harvesting raw plant material may not be viable 
for large scale production, but technology such as plant cell suspension and “plant cell factories” may 
help to speed production of plant compounds of interest. Plant tissue culture for the production of 
secondary metabolites negates the problems of cultivation or wild harvesting (Moyo et al., 2011). Plant 
tissues may also be manipulated, through environmental stimuli or genetic alteration, to produce more 
of the bioactive compounds of interest (Shaik et al., 2011). Liquid suspension of plant cells can also be 
used to produce antibodies, vaccines, therapeutic enzymes and other proteins (Xu et al., 2011). Activity 
of compounds produced in these ways seems to be comparable to those of compounds extracted from 
raw plant material. For example, in a study of the antibacterial plant Tulbaghia violaceae (wild garlic) 
Ncube et al., (2011) found that in vitro and wild extracts were equally effective. This method also has 
the potential for development of veterinary products (Rybicki et al., 2012). However there are still many 
problems with scale-up that need to be overcome (Guillon et al., 2006). 
Despite the fact that there are benefits and applications for the use of botanicals as well as the 
increased ease of production of single isolated compounds, drug companies are reluctant to engage in 
non-targeted bioprospecting because there is a low probability of finding useful compounds (about one 
in 10 000 plants will show something interesting) (Macilwain, 1998). Therefore, random screening, even 
in an area of plants with a high level of activity such as Namaqualand, is not preferred. Screening efforts 
need to be directed in order to maximise hit rate and minimise cost and effort. In many instances it is 
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more beneficial to isolate and characterise the active compounds from plants used traditionally as 
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Chapter 5: General Discussion and 
Conclusions 
A return to natural products based drug discovery 
There has been recent interest in returning to plants as a source of new drugs after many 
pharmaceutical companies abandoned their natural products research in the late 1990s and early 
2000s. However, for plants to become a relevant and a viable option for drug discovery, the process 
by which active natural compounds are identified and characterized must be streamlined. 
Historically, hit rate for bioactive plants has been low, even when HTS approaches are employed 
(Zhang et al., 2012). Testing every available plant for every type of activity is not a viable endeavour 
when considering the vast numbers of unscreened species and the available resources (Firn, 2003). 
Additionally, the often laborious isolation and determination of an active compound once a hit has 
been found has often proved fruitless - either resulting in the “rediscovery” of a known compound 
or just failing outright. Thus, for plant-based drug development to continue, new approaches are 
required. New ways of thinking about plant based drug discovery are needed and better methods for 
selecting screening targets and structural determination of active compounds are needed (Salis-
Lagoudakis et al., 2011). 
Incorporating traditional knowledge to guide selection of screening targets 
How did people in ancient times find the important drugs which are still at the core of our 
pharmacology? Traditional medicine is a good starting point for selecting plants for screening 
(Verpoorte et al., 2005). It is well known that ethnopharmacological sampling, which involves 
sampling and screening only plants that are used for traditional medicinal purposes, is likely to 
produce positive bioactive hits (Martin, 1995). Despite this, traditional medicine is often seen as 
“unscientific”, on account of being based on non-testable hypotheses and beliefs. However parallels 
can be drawn between the “traditional scientists” using “traditional selection criteria” and “research 
based scientists” using “assays, statistics and computers”. Both aim to discover plant-based 
medicines; they just use different approaches to do so. For example, constituents present in the 
plants used for digestive complaints are responsible for both astringent taste and efficacy in the 
treatment of intestinal disorders. (Etkin 2001; Ankli et al., 1999; Brett & Heinrich, 1998). Traditional 
methods of selection highlight these species for use because of their taste, but scientific methods 
use laboratory analysis and biological assays to indicate their suitability for treating gastro-intestinal 
illness. Researchers need to link broad-level ethnobotanical and anthropological studies with the 
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more focused metabolomic and phytochemical studies in order to understand the pharmacological 
basis of culturally significant plants. This study attempted to addresses this by examining medicinal 
plants from different perspectives in an effort to highlight the areas where they complement and 
overlap each other. 
Specificity is needed to guide plant selection in drug discovery efforts. Understanding why different 
plants produce different secondary metabolites is also an important consideration to facilitate 
optimising plant selection (Douwes et al., 2008).  Investigation into evolutionary mechanisms that 
regulate bioactivity highlights the links between systems (metabolic pathways) and bioactive 
chemicals. In some instances, certain chemicals are linked to specific life strategy adaptations 
embedded in the phylogeny of families or genera, and these may give rise to specific bioactivity 
(Wink, 2003). Traditional knowledge, when considered from a scientific point of view, can act as a 
proxy for detecting bioactive molecules (Gottlieb et al., 2002) and the preferential selection of 
certain families for medicinal use may be used as an indicator of underlying bioactive 
phytochemistry. Repeated selection and use in traditional preparations over hundreds of years could 
indicate some underlying efficacious phytochemical compounds.  
The work reported in this thesis demonstrated that plant selection is not random: species of certain 
families are actively sought out (or avoided) by the people of Paulshoek for treating certain types of 
illness. Regression analysis was used to show which plant families are preferred in the preparation of 
traditional medicine. For example, regression analysis performed on the traditional knowledge 
recorded during interviews with the people of Paulshoek indicated that species of the family 
Lamiaceae are traditionally preferred to treat pulmonary ailments including asthma, coughs and TB. 
One of the species of Lamiaceae used for this purpose is Ballota africana. Studies have shown that 
compounds present in this plant, such as premarrubiin, are effective expectorants and antibacterial 
assays performed during the course of this study showed the extract to have high antimicrobial 
activity.  This is an example of the use of “hot families” to indicate which species have underlying 
chemistry of with potential for selecting candidates for future screening (Douwes et al., 2008). 
Certain classes of compounds are sometimes restricted taxonomically. As a general rule, a few major 
secondary metabolites tend to dominate a given clade, and usually almost all members of a 
monophyletic clade share the same chemicals (Wink, 2003). For example, species in families 
Fabaceae and Anacardiaceae have been shown to contain a large percentage of flavonoids. In 
contrast, species of the families Asteraceae and Euphorbiaceae are known to contain large amounts 
of terpenoids (Balandrin et al., 1985). Dominance of certain types of compounds may infer particular 
bioactivity in certain families, and thus general bioactivity (of different sorts) may be indicated by 
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family. However, the results from this study showed that there is no relationship between specific 
bioactivity and family i.e. there is no direct correlation between family and antibacterial activity for 
example. Traditional preference can be used to indicate which families are most likely to contain 
bioactive species, but cannot in all instances indicate the specific type of bioactivity. For example, 
plants of a certain family that contains a high percentage of flavonoids may each have febrifuge, 
anti-inflammatory or antibacterial activity, and may all be used to treat influenza and associated 
secondary infections. The family is preferred for treatment of influenza but the species all have 
different modes of activity for alleviating influenza symptoms (and thus will have different 
bioactivity when screened). However, plants that are preferred to treat urinary tract infections 
(UTI’s) are, for example, much more likely to contain compounds that work in a similar manner (as 
UTI’s are more specifially caused by bacteria or fungus), and would therefore have similar 
antibacterial or antifungal activity. The same is true of the previous example of B. africana. 
Detection of localized bioactive phytochemicals through the use of indicators such as traditional 
preference should enhance the rate of natural product drug discovery from plants. Additional 
indicators of bioactivity, such as those that indicate more specifically which types of bioactivity are 
likely in a given category of plants, would be greatly beneficial in further refining screening choice to 
maximize hit rates. This study showed that more perennial species than annual species tended to 
have bioactivity. Thus screening efforts should focus first on traditionally preferred families, and on 
perennial species in those families. Succulence could also be used to indicate type of activity (e.g. 
protease activity), and these plants should be prioritized when searching for new protease inhibitors. 
However, growth form could not be directly linked with bioactivity of a specific type. Surprisingly 
little is known about the relationships of natural products with morphology, ecology and evolution 
of their plant source (Gottlieb et al., 2002). More systems level studies are needed to fill in these 
gaps and to link all available data together. This approach could be similarly applied on a larger scale 
to identify “hot” areas or ecosystems, where screening efforts should be focused. 
Aligning the biomedical objectives with those of traditional medicinal systems can further increase 
the chance of positive hits from plant sources. This occurs naturally in certain areas. For example, in 
the course of this study it was demonstrated that in Paulshoek medicinal plants are mainly used to 
create home remedies to treat “everyday” ailments such as colds and stomach upsets. These types 
of illnesses are largely microbial in nature. With the increasing resistance of microbes to mainstream 
antibiotics, drug discovery research has focused on finding novel, highly effective antimicrobial 
compounds. Thus the aims of the traditional medicine overlap with the biomedical ones and the 
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chance of finding active compounds of this nature are increased. Other overlapping areas of interest 
are in treating diabetes and high blood pressure as well as ethnoveterinary applications. 
Once target species have been selected, screening and identification of species for full analysis can 
be fast tracked by the use of in-field test kits such the GIBEX “screens-to-nature” (STN). During the 
course of this study, results of simplified GIBEX assays were shown to correlate with more 
sophisticated MIC assays performed in a laboratory. Thus, in-field testing gives a rough indication of 
activity so that the number of plants harvested and taken to a laboratory for phytochemical analysis 
is reduced, thereby streamlining the process. Local satellite stations could be established to get 
communities involved in testing plants and free up time for researchers to focus on other aspects of 
the process. This has already been proven to be successful in pilot projects in Botswana (Andrae-
Marobela et al., 2012).  Interviews conducted in the study area during the course of this research, 
indicate that similar projects are viable in South Africa. Inhabitants of Paulshoek attended 
community meetings to discuss the use of traditional plant medicines and expressed an interest in 
learning more about the plants they use and how to test them themselves using in-field assay kits. 
The presence of a trained para-ecologist (resident Ms. Marianna Lot) in the village to guide such 
testing would enable broad scale preliminary plant extract screening in the communal area of 
Namaqualand. 
The method of identifying “hot” families using regression analysis can also be applied to existing 
literature, removing the need for extensive field work altogether. Research into this has shown that 
correlations between ancient and current plant use practice may indicate efficacious plants (Buenz 
et al., 2004; Buenz et al., 2005). Mining old texts has proved useful in identifying good targets for 
screening for flora in other parts of the world. However, this method may not be as applicable in 
South Africa as there is oral tradition rather than written history and historical medicinal texts are 
limited.  
Using whole extract analysis to improve the isolation and characterization of 
bioactive compounds  
Better target selection increases the chances of discovering bioactive plant species. But in order to 
streamline characterizing of the active constituents, the chemical screening process should be 
optimized so as to rapidly identify already known compounds so as to avoid unnecessary isolation 
(Wolfender et al., 2003). Thus “dereplication” of already known compounds is a vital part of the 
discovery process that saves time and resources and allows isolation efforts to be focused on novel 
or unusual compounds (Nielsen et al., 2011). This study demonstrated that a good method for doing 
this is a combined approach using LC-MS spectrometry and NMR spectroscopy to analyze whole 
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crude extracts. An ideal experimental set up to achieve this, as discussed in chapter 4, is to couple 
LC-NMR-MS in an online system (Corcoran & Spraul, 2003). Effluent is diverted post column to NMR 
and MS for analysis and to a fraction collection in order for bioassays to be performed (Moco et al., 
2007b). This optimizes rapid dereplication, and also allows biological testing, and possible further 
characterizing, of unknown compounds of interest. Unfortunately such systems are costly to set up 
and run and alternatives must be considered.  
In this study it has been demonstrated that parallel use of NMR spectroscopy and LC-MS 
spectrometry for whole crude analysis can yield a wealth of information about constituent 
compounds in a short amount of time, and is therefore a viable alternative to an online system. The 
crude extract of Crassula brevifolia was rapidly dereplicated and the major constituent compounds 
were characterized using LC-MS/MS spectrometry and 1D and 2D NMR spectroscopy methods. The 
combined use of these approaches has several benefits most notably that it requires very little 
sample material and is quick to obtain results. The combined use of these methods compensates for 
the inherent weaknesses in each. For example, NMR spectroscopy sensitivity is low, peaks can be 
obscured and compounds must be fully dissolved in a deuterated solvent. LC-MS spectrometry is 
much more sensitive and is performed on the whole crude extract in the extraction solvent. In the 
case of the C. brevifolia extract NMR spectroscopy was used to confirm the presence of flavonoids 
tentatively identified from LC-MS/MS data. Additionally, NMR spectroscopy confirmed glycosidic 
substitution patterns of flavonoids, where LC-MS spectrometry was not able. Additionally, NMR 
spectroscopy was used to determine the absence of a compound tentatively suggested to be 
present by LC-MS/MS data. Conversely, LC-MS/MS data was used in the case of C. cuneata extract to 
determine the presence of flavonoids, where relatively weak NMR signals in the aromatic region 
were obscured due to scaling and solubility problems. These examples highlight how the approaches 
complement each other and can be used to effectively determine what is known and what remains 
unknown in a plant extract. With the addition of a fraction collector, this approach can also be used 
to test bioactivity of unidentified compounds present in the crude extract. Repeat runs can be used 
to accumulate enough of the bioactive fractions for NMR spectroscopy to be performed to 
characterize any new unknown bioactive compounds. 
Metabolic profiling could also be used in a number of areas to provide biological information beyond 
the simple identification of plant constituents (Sumner et al., 2003). The development of databases 
of metabolite information can lead to a better understanding of biochemical composition and 
contributes to a greater overall insight into the functioning of the biological system. A variety of 
biological functions have been assigned to certain classes of secondary metabolite - those involved 
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in pollination, photoprotection and defense for example (Moco et al., 2007b). Placing metabolites in 
context of the metabolic systems allows us to infer their use in plants, and their possible use in 
humans. Knowing which metabolites have which biological function and which species they are likely 
to occur in facilitates better target selection for screening. Knowledge of compound class 
proportions in plants could potentially be applied in addition to regression analysis to prioritise 
candidate taxa for bioactivity evaluation, thereby further increasing the likelihood of success 
(Douwes et al., 2008). 
Making better use of what is already known - data mining and computational 
methods  
There is a considerable body of literature and numerous journals dedicated to bioactive natural 
products, phytochemistry and ethnopharmacology. This immense resource could be used more 
effectively to improve drug discovery and development from natural products. Although the 
traditional method of analyzing plant extracts is still widely used to isolate active compounds for 
further drug development, many researchers are now turning to virtual screening of existing data. 
Bioactive chemicals exert their function through binding to one or more protein targets. Therefore, 
identifying important target proteins for medicinal compounds is a vital step in drug discovery. 
Computational drug-target prediction is an attractive option for exploring the interaction between 
potential protein targets and bioactive chemicals (Iskar et al., 2012). For example, a target based 
virtual screening approach was proven to be effective in the search for neuraminidase (NA) 
inhibitors for influenza viruses A and B. The 3D structure of NA was used for the enzyme 
conformation, and an existing NA inhibitor (Zanamivir) was used as a reference inhibitor structure. 
Target structure and shape was reviewed and molecular docking and post docking was computed for 
known natural products and synthetic compounds (Baker et al., 2007).   
There are various other “virtual” approaches to developing new potentially highly active drug 
molecules from natural products. For example, natural products can be used as structural scaffolds. 
Active structural motifs can be identified from biologically active molecules and new compounds can 
be developed by diversifying around the central active core (Nielsen, 2002). The common core 
structure present in a number of natural products with the same or similar bioactivity must be 
identified. Combining this with protein structure similarity clustering to identify similar ligand-
binding cores in different proteins allows the possibility of using the scaffold to develop multiple 
drugs (Zhang & Wilkinson, 2007; Koch et al., 2005). In this study we saw that the central skeleton of 
flavonoids identified in the whole extract of C. brevifolia could possibly be used in this way. 
Flavonoids have multiple sites for chemical modification on the basic structure, and activity is linked 
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to substitution type and pattern. Thus, the central skeleton could be used as a starting point for 
virtual drug development. 
Known natural products can also be used as building blocks in the creation of larger molecules. 
Fragments are defined as low molecular weight (<300 Da), moderately lipophilic highly soluble 
organic molecules which typically bind with low affinity (Chessari & Woodhead, 2009). Such 
molecule fragments that bind to the active sites of a specific target protein can be identified using 
molecular modeling and docking software. Two or more fragments binding at different sites can 
possibly be linked into one highly active, high affinity molecule (Challis & Hopwood, 2007).  Thus 
new drugs may be developed without the need for extensive field or laboratory work. However, 
these methods require specific training and experience to obtain meaningful results. 
Many combinatorial libraries of “created” potential drug molecules have now been create by these 
methods. Lipinski’s “rule of five” was introduced as a way of reducing the number of molecules in 
libraries - removing molecules that are too large, too polar or too flexible as this makes them less 
likely to make good orally bioavailable drugs (Zhang & Wilkinson, 2007). Orally bioavailable small-
molecule drugs are desirable because of the huge advantage of requiring the patient to take a pill 
rather than having an injection administered (Challis & Hopwood, 2007). This narrows the search for 
new drugs using this method and allows medicinal chemists to focus on optimizing only the top 
candidates created via virtual methods.  
Alternatively, multivariate analysis of NMR spectroscopy or LC-MS spectrometry data could be used 
as a first pass screen to rapidly determine and characterize differences in molecular composition of 
plant samples (Ward et al., 2003). Patterns in the data can be visualized, interpreted and compared 
to distinguish differences or establish similarities between samples prior to full phytochemical 
analysis. Extraction and isolation efforts could be focused on plants with similar profiles, if similar 
compounds are desired or on species with unusual fingerprints if completely novel structures are to 
be discovered. When compared with reference spectra of bioactive plant species, such “fingerprints” 
could also give insight into potential biological activity (Heinrich, 2008).  
Similarly, multivariate analysis of NMR spectra acquired from “botanicals”, tinctures and other 
herbal products can be used to ensure batch homogeneity and for quality control (Heyman & Meyer 
2012; Politi et al., 2009). For example, angostura bark (Galipea officinalis) is a South American tree 
which is traditionally used to treat dysentery and to make bitter liquor (Jacquemond-Collet et al., 
1999). However, products sold in markets and herbal shops as “angostura bark” often contain “false 
angostura”. Multivariate analysis of the NMR spectrum of “false angostura” as compared with 
reference spectra showed that it should to be a sample of Strychnos nux-vomica root bark (Frédérich 
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et al., 2004). Species of Strychnos belonging to the family Loganiaceae often contain dangerous 
levels of strychnine. Thus the identification of this toxic adulterant in traditional preparations was 
vital in preventing illness and possible death as a result of ingesting “angostura”. An additional 
application of multivariate analysis of NMR spectra is found in taxonomy. Classification based on the 
chemical profiles of species can help correctly place species in the correct families and assist with 
species, genus and family level delimitation. This method has been successfully used to identify and 
separate species of Glycorrhiza (liquorice, Yang et al., 2010) as well as species of American Ilex 
(mate, Kim et al., 2010a). Any way one views it, fingerprinting could be used as a guide to plant 
extraction and screening if the traditional “wet” method is to be followed. 
An additional application of NMR fingerprinting is to identify biomarkers of toxicity in crude plant 
extracts. As many people make use of traditional medicinal preparations, it is important to validate 
them and test their toxicity (Fennel et al., 2004b). Problems with the isolation of a single active 
ingredient and acceptance of drugs developed from traditionally used medicinal plants mean that 
botanical preparations have become an alternative to pure compound drugs. Even in Paulshoek, 
some people when interviewed stated that they believe plants are better and would not take the 
developed product. PCA can be used to screen botanicals for toxicity markers and can also be used 
to select candidates for cultivation studies if a botanical product is viable. 
An integrated approach to plant based drug discovery? 
Can a study of medicinal plants from several different views allow us to find an integrated approach 
to drug discovery from natural products? How do the different ways of approaching medicinal plants 
and natural products overlap and complement each other? 
The pharmacopeia and traditions of many regions of South Africa, and the world, remain 
unexplored. Namaqualand (and the Succulent Karoo) is a biodiversity hotspot. But other hotspots of 
diversity and endemism exist in South Africa. For example, the fynbos kingdom exists only in the 
Cape region of South Africa and the area surrounding Van Rhynsdorp is the “bulb capital of the 
world” with approximately 20 000 bulbs per cubic metre of soil. This study demonstrated how 
bioactive plants from Namaqualand can be identified for screening using traditional knowledge and 
how the active components can be rapidly determined using combined whole-crude analysis 
methods. This method (Figure 1) can be used as a model for similar studies in other regions in South 
Africa. 
Natural products are not just a source of drugs for treating human illness. Food production and 
agriculture also benefit from natural products. Active compounds in plants may be developed into 
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herbicides, pesticides and microbicides (against bacteria and fungi) for use in agriculture. This 
method can also be used to identify active compounds for these purposes. In particular, species 
traditionally preferred for the treatment of veterinary illnesses may yield compounds of interest, but 
this was beyond the scope of this research. 
 
 
Figure 1: Suggested workflow for future studies of bioactive medicinal plants combining traditional 
knowledge, whole extract metabolomics and pc based analysis methods. 
An evaluation of the demographics of the people using traditional medicinal plants, their thoughts 
and attitudes towards traditional medicine were contrasted with the aims of drug development 
research. Ultimately it is the aim of both traditional medicine and drug development studies to 
identify and create safe and effective medicines. Ideally, a pluralistic medical system would be 
developed, as has been done in other areas of the world, such as Thailand.  In areas where 
“Western” pharmaceuticals are not readily accepted by local communities, standardized botanical 
extracts become a viable alternative. The use of botanicals allows people to retain their culture and 
tradition while providing them with good healthcare options. This also allows the continued 
evolution of traditional medical systems, which is vital if the suggested integrated approach to drug 
discovery is to be implemented.  
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This study has therefore proposed that  traditional knowledge used in combination with modern 
analytical techniques, such as those discussed earlier in this chapter, may accelerate natural 
product-based drug development, since it allows for a more rapid, efficient and focused effort on 
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Question set one - Basic Household Use of Medicinal Plants 
 
House number:  
 
Explain the purpose of the project: 
- The project is about the use of medicinal plants that are still used in households on a regular 
basis. Which plants are used for which ailment and which plants are preferred? Are certain 
plants better (preferred to) than Western medicine/medicine from the clinic? We would like 
to find out how many people still use the traditional ways of making medicine and what 
their opinions of traditional plant medicine are. 
Ask if there are any questions about the project. 
Answer the following questions: 
1) Have you used medicinal plants for any purpose in the past year? 
 
2) If yes, did you collect them from the wild (veld) or from the garden? 
 
3) What did you use the plants for (which illnesses)? 
 
4) Please give the names of the plants (common/local names) and what they are used for. 
 
5) How often do you use medicinal plants? 
 
6) In which season do you use medicinal plants the most? 
 
7) Do you have anything else to add – about medicinal plants, history, personal experiences? 










Name of interviewed person: 
 
Answer the following questions: 
1) How many people live in your house? 
 
2) How many are younger than 18? What are the ages of the other people (older than 18) in 
the house? 
 
3) How many people in the house use medicinal plants to treat sickness? 
 
4) Who collects the plants? How old are they? 
 
5) Who prepares the medicine? How old are they? 
 
6) How did the person/people who collect and/or prepare the medicine learn about medicinal 
plants? 
 
7) Do you think than the young people will continue to use the medicinal plants in the old way? 
 
8) Has anyone consulted a kruiedoktor (traditional healer) in the past year? 
 
9) Are there sicknesses that you would rather use plants to make your own medicine rather 
than visit the kruiedoktor (traditional healer)? 
 
10) Has anyone visited the clinic in the past year? 
 
11) Are there sicknesses that you would rather use plants to make your own medicine rather 
than visit the clinic? 
 
12) Would you like to know more about the plants and their uses at the end of the study? 
 
13) Are there any comments or questions? 
 
 
Thank you 
 
 
